<SEC-DOCUMENT>0001724521-25-000052.txt : 20250422
<SEC-HEADER>0001724521-25-000052.hdr.sgml : 20250422
<ACCEPTANCE-DATETIME>20250422160920
ACCESSION NUMBER:		0001724521-25-000052
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20250610
FILED AS OF DATE:		20250422
DATE AS OF CHANGE:		20250422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcus Biosciences, Inc.
		CENTRAL INDEX KEY:			0001724521
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473898435
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		25857818

	BUSINESS ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
		BUSINESS PHONE:		(510) 694-6200

	MAIL ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>rcus-20250422.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:82caba53-fe79-45a6-b4b8-8a6bfaea78ec,g:80351a8a-ce6d-4070-8aef-aa80c9a7e4f9,d:3be39c5b0a4e4bb6bffeea39d605508e-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rcus="http://arcusbio.com/20250422" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rcus-20250422</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-2">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-3">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-4">0001724521</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rcus-20250422.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A INFORMATION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amendment No.__)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:58.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:2.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary Proxy Statement</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Proxy Statement</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Additional Materials</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting Material Pursuant to &#167; 240.14a-12</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Arcus Biosciences, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified in Its Charter)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check all boxes that apply)</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fee required.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee paid previously with preliminary materials.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:18pt;padding-right:6pt"><span><br/></span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARCUS BIOSCIENCES, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3928 Point Eden Way</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayward, CA 94545</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(510) 694-6200</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held on June&#160;10, 2025</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the "Annual Meeting"), of Arcus Biosciences, Inc., a Delaware corporation (&#8220;Arcus&#8221;). The Annual Meeting will be held on Tuesday, June&#160;10, 2025, at 8:30 a.m. Pacific Time. The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the Annual Meeting and submit your questions and vote your shares online during the meeting by visiting www.virtualshareholdermeeting.com/RCUS2025 and using your 16-digit control number to enter the Annual Meeting. The stockholder list and instructions on how stockholders of record can view the stockholder list will also be available during the Annual Meeting at www.virtualshareholdermeeting.com/RCUS2025. In addition, the stockholder list will be available for examination for any purpose germane to the Annual Meeting during normal business hours for ten days prior to the Annual Meeting at our corporate headquarters. The Annual Meeting will be held for the following purposes:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">To elect the Board of Directors&#8217; four nominees to hold office as Class I directors until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of Arcus for its fiscal year ending December 31, 2025.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">To approve, on an advisory basis, the compensation of Arcus&#8217;s named executive officers, as disclosed in this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">To conduct any other business properly brought before the meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These items of business are more fully described in the Proxy Statement accompanying this Notice.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The record date for the Annual Meeting is April&#160;21, 2025. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </span></div><div style="margin-top:6pt;text-indent:54pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#8217; Meeting to Be Held on Tuesday, June&#160;10, 2025.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Proxy Statement and Annual Report are available at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.proxyvote.com</span></div></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Order of the Board of Directors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Terry Rosen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman of the Board of Directors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayward, California</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;22, 2025</span></div><div style="margin-top:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">You are cordially invited to attend our Annual Meeting virtually via live webcast at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">www.virtualshareholdermeeting.com/RCUS2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. Whether or not you expect to attend the meeting, please vote as soon as possible. You may vote over the Internet or by a toll-free telephone number. If, however, you requested to receive paper proxy materials, then you may vote by mailing a completed, signed and dated proxy card or voting instruction card in the envelope provided with the proxy card or voting instruction card. Please note that any stockholder attending the Annual Meeting that has received a 16-digit control number with their proxy materials may vote online during the meeting, even if the stockholder has already returned a proxy card or voting instruction card. Please see the instructions in the attached proxy statement and on your proxy card or voting instruction card, or on your Notice of Internet Availability of Proxy Materials.</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARCUS BIOSCIENCES, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3928 Point Eden Way</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hayward, CA 94545</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(510) 694-6200</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO BE HELD ON JUNE&#160;10, 2025</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be held virtually at www.virtualshareholdermeeting.com/RCUS2025 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Tuesday, June&#160;10, 2025 at 8:30 am Pacific time</span></div><div style="margin-top:25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IMPORTANT NOTICE REGARDING THE INTERNET AVAILABILITY OF PROXY MATERIALS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE&#160;10, 2025</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This proxy statement and our annual report are available on our website at www.proxyvote.com. We intend to mail the Notice of Internet Availability of Proxy Materials on or about April&#160;24, 2025 to all stockholders of record entitled to vote at the Annual Meeting.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.053%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEETING AGENDA</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proposal No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Board Vote<br/>Recommendation</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To elect the Board of Directors&#8217; four nominees to hold office as Class I directors until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each Arcus director nominee</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of Arcus for its fiscal year ending December 31, 2025.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To approve, on an advisory basis, the compensation of Arcus&#8217;s named executive officers, as disclosed in this Proxy Statement.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_16">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_16">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_19">PROPOSAL 1 ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_19">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_22">Director Nominees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_25">Other Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_28">Director Diversity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_28">11</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_31">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_31">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_34">Independence of The Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_34">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_37">Board Leadership Structure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_37">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_40">Role of the Board in Risk Oversight</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_40">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_43">Meetings of The Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_43">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_46">Information Regarding Committees of the Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_46">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_49">Audit Committee</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_49">13</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_52">Compensation Committee</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_52">14</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_55">Nominating and Corporate Governance Committee</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_55">15</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_58">Science Committee</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_58">16</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_61">Stockholder Communications with The Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_61">16</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_64">Code of Conduct and Ethics</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_64">16</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_67">Corporate Governance Guidelines</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_67">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_70">Clawback Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_70">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_527">Equity Administration Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_527">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_73">Insider Tradi</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_73">ng</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_73"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_73">Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_73">17</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_76">PROPOSAL 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_76">18</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_79">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_79">18</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_82">Pre-Approval Policies and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_82">18</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_85">PROPOSAL 3 ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_85">19</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_88">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_88">20</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_91">EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_91">22</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_94">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_94">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_97">Compensation Discussion and Analysis</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_97">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_100">Summary Compensation Table</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_100">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_103">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_103">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_103"> Grants of Plan-Based Awards</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_103">30</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_106">Outstanding Equity Awards at 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_106">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_106"> Fiscal Year End</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_106">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_109">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_109">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_109"> Option Exercises and Stock Vested</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_109">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_112">Severance and Change in Control Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_112">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_118">CEO Pay Ratio</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_118">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_121">Pay versus Performance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_121">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_124">Compensation Committee Interlocks and Insider Participation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_124">36</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_127">COMPENSATION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_127">37</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_130">EQUITY COMPENSATION PLAN INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_130">39</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_133">RELATED PERSON TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_133">40</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_136">Policies and Procedures for Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_136">40</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_139">Certain Related-Person Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_139">40</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_142">HOUSEHOLDING OF PROXY MATERIALS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_142">42</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3be39c5b0a4e4bb6bffeea39d605508e_145">OTHER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i3be39c5b0a4e4bb6bffeea39d605508e_145">43</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why did I receive a notice regarding the availability of proxy materials on the internet?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to rules adopted by the Securities and Exchange Commission (the &#8220;SEC&#8221;), we have elected to provide access to our proxy materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;) because the Board of Directors (the &#8220;Board&#8221;) of Arcus Biosciences, Inc. ("Arcus") is soliciting your proxy to vote at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"), including at any adjournments or postponements of the meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is included in the proxy materials?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proxy materials include:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">this proxy statement, which includes information regarding the proposals to be voted on at the Annual Meeting, the voting process, corporate governance, the compensation of our directors and certain executive officers, and other required information;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our Annual Report on Form 10-K for the year ended December 31, 2024 ("Annual Report"); </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Notice; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the proxy card or a voting instruction card for the Annual Meeting (which you will receive if you have requested paper copies of this proxy statement and our Annual Report).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to mail the Notice on or about April&#160;24, 2025 to all stockholders of record entitled to vote at the Annual Meeting.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How do I attend the Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be hosting the Annual Meeting only by means of a live audio webcast. There will not be a physical meeting location and you will not be able to attend the meeting in person physically. The live audio webcast will be held on Tuesday, June&#160;10, 2025, and will begin promptly at 8:30 a.m. local time. Online check-in will begin approximately 15 minutes prior to the start of the Annual Meeting. We encourage our stockholders to access the meeting in advance of the designated start time to have ample time for check-in procedures. To attend the Annual Meeting virtually via the internet, please visit www.virtualshareholdermeeting.com/RCUS2025. You will need the 16-digit control number included in the Notice, on the proxy card or on the voting instruction card.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why are you holding a virtual Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Meeting will be conducted via a live audio webcast and online shareholder tools. We have implemented the virtual format in order to facilitate stockholder attendance and participation from any location around the world, at no cost. However, you will bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. A virtual annual meeting makes it possible for more stockholders (regardless of size, resources or physical location) to have direct access to information more quickly, while saving our stockholders time and money. We also believe that the online tools we have selected will increase stockholder communication. For example, the virtual format allows stockholders to communicate with us in advance of, and during, the Annual Meeting so they can ask us questions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who can vote at the Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders of record and beneficial owners at the close of business on April&#160;21, 2025 (the "Record Date"), will be able to vote their shares electronically during the Annual Meeting by using the 16-digit control number they should have received with their proxy materials. Instructions on how to vote while participating in the Annual Meeting live via the Internet are posted at www.virtualshareholdermeeting.com/RCUS2025. On the Record Date, there were 105,885,138 shares of common stock outstanding and entitled to vote.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you do not have your 16-digit control number, you will be able to access and listen to the Annual Meeting, but you will not be able to vote your shares or submit questions during the Annual Meeting. See caption below titled &#8220;Attending the Annual Meeting as a Guest.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If on the Record Date, any of your shares were registered directly in your name with our transfer agent, Computershare Trust Company, N.A., then you are the "stockholder of record" for such shares. As a stockholder of record, you may vote such shares online at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Owner: Shares Registered in the Name of a Broker or Bank</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If on the Record Date, any of your shares were held, not in your name, but rather in an account at a brokerage firm, bank or other similar organization, then you are considered a "beneficial owner" since you are the beneficial owner of such shares held in &#8220;street name&#8221; (and not the stockholder of record). If you are a beneficial owner, the Notice will be forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting such shares at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. Beneficial owners as of the Record Date who want to be able to attend and vote such shares at the Annual Meeting can attend using the 16-digit control number found on the notice and instructions received from their broker or other nominee. Beneficial owners as of the Record Date who have not received a 16-digit control number should contact their broker or other nominee for instructions on how to vote.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Attending the Annual Meeting as a Guest</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guests may enter the Annual Meeting in &#8220;listen-only&#8221; mode by entering the Annual Meeting at www.virtualshareholdermeeting.com/RCUS2025 and entering the information requested in the &#8220;Guest Login&#8221; section. Guests will not have the ability to vote at the Annual Meeting. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who can ask questions at the Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are attending the Annual Meeting as a stockholder of record or as a beneficial owner, questions can be submitted by accessing the meeting center at www.virtualshareholdermeeting.com/RCUS2025, entering your 16-digit control number and following the instructions. Instructions on how to ask questions and participate in the Annual Meeting are posted at www.virtualshareholdermeeting.com/RCUS2025. Guests will not have the ability to ask questions during the Annual Meeting.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">List of Stockholders</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A list of stockholders entitled to vote at the Annual Meeting will be available for examination for any purpose germane to the Annual Meeting during normal business hours for ten days prior to the Annual Meeting at our corporate headquarters. Please email us at investorinfo@arcusbio.com to arrange a time to review. The stockholder list will also be available during the Annual Meeting at www.virtualshareholdermeeting.com/RCUS2025. Instructions on how stockholders of record can view the stockholder list during the Annual Meeting are posted at www.virtualshareholdermeeting.com/RCUS2025. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What am I voting on?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are three matters scheduled for a vote: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Election of the Board's four nominees for Class I director (Proposal 1);</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Ratification of appointment by the Audit Committee of the Board of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (Proposal 2).</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement (Proposal 3).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What if another matter is properly brought before the meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote, to the extent permitted by rules promulgated by the SEC, on those matters in accordance with their best judgment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How do I vote?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may either vote &#8220;For&#8221; all of the nominees to the Board or you may &#8220;Withhold&#8221; your vote for any nominee you specify. For the ratification of appointment by the Audit Committee of the Board (the "Audit Committee") of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. For the approval, on an advisory basis, of the compensation of our named executive officers, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The procedures for voting are fairly simple:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a stockholder of record (see "Who can vote at the Annual Meeting?&#8212;Stockholder of Record: Shares Registered in Your Name" above), you may vote online at the Annual Meeting, vote by proxy over the telephone, vote by proxy through the internet, or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote online even if you have already voted by proxy.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">To vote online during the Annual Meeting, attend the Annual Meeting at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/RCUS2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and vote your shares during the Annual Meeting. You will need your 16-digit control number provided in the Notice or proxy card in order to gain access to the Annual Meeting.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">To vote using the proxy card, simply complete, sign and date the proxy card that may be delivered to you and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the Notice. Your telephone vote must be received by 11:59 p.m. Eastern Time, on June 9, 2025, to be counted. </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">To vote through the internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and control number from the Notice. Your internet vote must be received by 11:59 p.m. Eastern Time, on June 9, 2025, to be counted. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Owner: Shares Registered in the Name of Broker or Bank</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a beneficial owner (see "Who can vote at the Annual Meeting?&#8212;Beneficial Owner: Shares Registered in the Name of a Broker or Bank" above) you should have received a notice or voting instruction card containing voting instructions from the broker, bank or other agent in whose name such shares are held, rather than from us. Simply follow the voting instructions in such notice or voting instruction card to ensure that your vote is counted. To vote online at the Annual Meeting, you can do so using the 16-digit control number found on the notice and instructions received from your broker or other agent. Beneficial owners as of the Record Date who have not received a 16-digit control number should contact their broker or other nominee for instructions on how to vote. Whether or not you plan to attend the Annual Meeting, please vote by proxy as directed in your Notice or voting instruction card as soon as possible to ensure your vote is counted. You may still attend the Annual Meeting and vote online during the meeting even if you have already voted by proxy.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. </span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Can I vote my shares by completing and returning the Notice?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. The Notice will, however, provide instructions on how to vote by telephone, by Internet, by requesting and returning a paper proxy card or voting instruction card, or by voting online at the Annual Meeting.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How many votes do I have?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On each matter to be voted upon, you have one vote for each share of common stock you own as of the Record Date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a stockholder of record (see "Who can vote at the Annual Meeting?&#8212;Stockholder of Record: Shares Registered in Your Name" above) and do not vote by completing your proxy card by telephone, through the internet or online at the Annual Meeting, your shares will not be voted. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of all nominees for Class I director (Proposal 1), &#8220;For&#8221; the ratification of the independent registered public accounting firm (Proposal 2), and &#8220;For&#8221; the approval, on an advisory basis, of the compensation of our named executive officers (Proposal 3). If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares, to the extent permitted by rules implemented by the SEC, in accordance with the Board's recommendations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, may my broker or bank vote my shares?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a beneficial owner (see "Who can vote at the Annual Meeting?&#8212;Beneficial Owner: Shares Registered in the Name of a Broker or Bank" above) and you do not instruct your broker, bank or other agent how to vote your shares, your broker, bank or other agent may still be able to vote your shares in its discretion. In this regard, under the rules of the New York Stock Exchange ("NYSE"), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to &#8220;non-routine&#8221; matters. In this regard, Proposals 1 and 3 are considered to be &#8220;non-routine&#8221; under NYSE rules meaning that your broker may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal 2 is considered to be a &#8220;routine&#8221; matter under NYSE rules meaning that if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposal 2. However, if you attend the Annual Meeting using your 16-digit control number and vote your shares, then your vote will override any vote of your shares by your broker, bank or other agent.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who is paying for this proxy solicitation?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What does it mean if I receive more than one Notice?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Notices to ensure that all of your shares are voted.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Can I change my vote after submitting my proxy?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes. You can revoke your proxy at any time before the final vote at the meeting. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a stockholder of record (see "Who can vote at the Annual Meeting?&#8212;Stockholder of Record: Shares Registered in Your Name" above), you may revoke your proxy in any one of the following ways:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">submit another properly completed proxy card with a later date;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">grant a subsequent proxy by telephone or through the internet;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">send a timely written notice that you are revoking your proxy to our General Counsel at 3928 Point Eden Way, Hayward, CA 94545; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">attend the Annual Meeting and vote online. Simply attending the meeting will not, by itself, revoke your proxy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your most current proxy card or telephone or internet proxy is the one that is counted. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Owner: Shares Registered in the Name of Broker or Bank</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a beneficial owner (see "Who can vote at the Annual Meeting?&#8212;Beneficial Owner: Shares Registered in the Name of a Broker or Bank" above), you should follow the instructions provided by your broker, bank or other agent, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or if you have your 16-digit control number you may attend the Annual Meeting and vote online. Simply attending the meeting will not, by itself, revoke your proxy.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">When are stockholder proposals and director nominations due for next year&#8217;s Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you wish to submit a proposal to be considered for inclusion in the proxy materials we prepare for next year&#8217;s annual meeting, your proposal must be submitted in writing by December 25, 2025, to Arcus Biosciences, Inc., 3928 Point Eden Way Hayward, CA 94545, Attention: General Counsel. However, if our 2026 annual meeting of stockholders is held before May 11, 2026, or after July 10, 2026, then your proposal must be received a reasonable time before we print and mail our proxy statement for the 2026 annual meeting of stockholders. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you wish to submit a proposal (including a director nomination) for consideration at next year's annual meeting that is not to be included in next year&#8217;s proxy materials, you must do so no earlier than February 10, 2026, and no later than March 12, 2026, to Arcus Biosciences, Inc., 3928 Point Eden Way Hayward, CA 94545, Attention: General Counsel. If such proposal is submitted after March 12, 2026 or before February 10, 2026, it will be considered untimely; provided, however, that if our 2026 annual meeting of Stockholders is held before May 11, 2026, or after August 9, 2026, then your proposal must be received no earlier than 120 days prior to such annual meeting and not later than the close of business on the later of (a) the 90th day prior to such meeting and (b) the 10th day following the day on which notice of the date of the 2026 annual meeting of Stockholders is mailed or public disclosure is made, whichever occurs first. You are also advised to review our bylaws, which contain a description of the information required to be submitted as well as additional requirements about advance notice of stockholder proposals and director nominations. Please refer to our bylaws for additional information required for your proposal (including a director nomination) to be considered.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice that sets forth the information required by Rule 14a-19 under the Securities Exchange Act of 1934 (as amended, the "Exchange Act") no later than April 11, 2026; provided, however, that, in the event that the annual meeting is held before May 11, 2026, or after July 10, 2026, for your notice to be timely, it must be so received by the Secretary not earlier than the close of business on the date the later of sixty (60) days prior to such annual meeting and the tenth (10th) day following the day on which public announcement of the date of such meeting is first made by us. Please refer to our bylaws Rule 14a-19 under the Exchange Act for additional information and requirements regarding stockholder proposals and director nominations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not consider any proposal or nomination that is not timely or otherwise does not meet our bylaws and the SEC&#8217;s requirements for submitting a proposal or nomination, as applicable. We reserve the right to reject, rule out of order or take other appropriate action with respect to any proposal or nomination that does not comply with these and any other applicable requirements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to file a proxy statement and WHITE proxy card with the SEC in connection with our solicitation of proxies for our 2026 annual meeting of stockholders. Stockholders may obtain our proxy statement (and any amendments and supplements) and other documents as and when filed by us with the SEC without charge from the SEC&#8217;s website at www.sec.gov.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How are votes counted?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Votes will be counted by the inspector of election appointed for the meeting. For Proposal 1, the inspector of election will separately count the "For" and "Withhold" votes and the broker non-votes for each nominee. For proposals 2 and 3 votes the inspector of election will separately count the &#8220;For&#8221; and &#8220;Against&#8221; votes and the abstentions and broker non-votes for each proposal. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What are &#8220;broker non-votes&#8221;? </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be &#8220;non-routine under NYSE rules, the broker, bank or other such agent cannot vote the shares. Even when such matters are deemed &#8220;routine,&#8221; the broker, bank or other such agent may choose not to exercise its discretionary power to vote such shares. These un-voted shares are counted as &#8220;broker non-votes.&#8221; Proposals 1 and 3 are considered to be &#8220;non-routine&#8221; under NYSE rules and we therefore expect broker non-votes to exist in connection with those proposals. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How many votes are needed to approve each proposal? </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Proposal 1, the election of Class I directors, the four nominees receiving &#8220;For&#8221; votes from a plurality of the voting power of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">election of the Class I directors will be elected. Only votes &#8220;For&#8221; will affect the outcome. &#8220;Withheld&#8221; and broker non-votes will have no effect.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be approved, Proposal 2, ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, must receive &#8220;For&#8221; votes from the holders of shares of stock having a majority in voting power of the votes cast by the holders of all of the shares of stock present or represented at the Annual Meeting and voting affirmatively or negatively on such matter. Only votes &#8220;For&#8221; or &#8220;Against&#8221; will affect the outcome. Abstentions and broker non-votes will have no effect. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be approved, Proposal 3, approval of the compensation of our named executive officers, must receive &#8220;For&#8221; votes from the holders of shares of stock having a majority in voting power of the votes cast by the holders of all of the shares of stock present or represented at the Annual Meeting and voting affirmatively or negatively on such matter. Only votes &#8220;For&#8221; or &#8220;Against&#8221; will affect the outcome. Abstentions and broker non-votes will have no effect. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is the quorum requirement? </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if the holders of at least a majority of the outstanding shares entitled to vote are present virtually at the virtual meeting, or represented by proxy. On the Record Date, there were 105,885,138 shares outstanding and entitled to vote. Thus, the holders of 52,942,570 shares must be present at the virtual meeting or represented by proxy at the virtual meeting to have a quorum.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote online at the virtual meeting. If there is no quorum, the chairman of the meeting or the holders of a majority of shares present at the virtual meeting or represented by proxy may adjourn the meeting to another date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How can I find out the results of the voting at the Annual Meeting?</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the meeting, we intend to file a Form 8&#8209;K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 1</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board is divided into three classes, and each class has a three-year term. The terms of the Class I directors expire at the Annual Meeting, the terms of the Class II directors expire at the 2026 annual meeting of stockholders and the terms of the Class III directors expire at the 2027 annual meeting of stockholders. Vacancies on the Board may be filled only by persons appointed by a majority of the remaining directors. A director appointed by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#8217;s successor is duly elected and qualified. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are four Class I directors whose terms of office expire at the Annual Meeting. If elected at the Annual Meeting, each of the nominees would serve as Class I directors until the 2028 annual meeting and until his successor has been duly elected and qualified, or, if sooner, until his death, resignation or removal. Dr. Kaneko, Mr. Machado, Dr. Perlman and Dr. Ribas were all previously elected to the Board by our stockholders in June 2022. We invite and encourage our directors and nominees for director to attend the Annual Meeting, but have no formal policy regarding their attendance at our annual meetings. Nine of our eleven then-current members of the Board attended the 2024 annual meeting of stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are elected by a plurality of the votes of the holders of shares present or represented by proxy and entitled to vote on the election of directors. Accordingly, the four nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the four nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by the Board. Each nominee has agreed to serve if elected. We have no reason to believe that any nominee will be unable to serve. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our directors as of April 1, 2025:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NAME</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CLASS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POSITION HELD WITH THE COMPANY</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer, Director and Chairman</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dietmar Berger, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kathryn Falberg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Linda Higgins, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Lacey, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicole Lambert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick Machado, J.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Johanna Mercier</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antoni Ribas, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Berger joined our Board in February 2025 in connection with the resignation of Merdad Parsey, M.D., Ph.D. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Audit Committee.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Compensation Committee.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Nominating and Corporate Governance Committee.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Science Committee.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Nominees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below we provide a brief biography of each nominee for election to a three-year term as a Class I Director at the Annual Meeting:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Yasunori Kaneko, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since May 2015. Dr. Kaneko was a Managing Director at Skyline Venture Partners, L.P., a venture capital firm, from January 1999 to January 2019. Dr. Kaneko previously served as Chief Financial Officer and Vice President, Business Development at Tularik, Inc., a biopharmaceutical company, at various times from 1992 until 1999. Dr. Kaneko served as a Senior Vice President and Chief Financial Officer of Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), a pharmaceutical company, which went public in May 1991 during his tenure from 1991 to 1992. Dr. Kaneko began his career at Genentech, Inc., a biotechnology company, where he served in a business development role, from 1981 to 1987 and as head of corporate finance in the investment banking division of Paribas Capital Markets LTD, from 1987 to 1991. Dr. Kaneko is a member of the Stanford Interdisciplinary Life Sciences Council and serves on the board of Provigate Inc. Dr. Kaneko served on the board of Nippon Paint Holdings Co., Ltd. (TYO: 4612) from March 2018 to March 2020, and LeukoSite Inc., a biopharmaceutical company, from February 1998 until its merger with Millennium Pharmaceuticals, Inc. in December 1999. Dr. Kaneko received an undergraduate degree and a medical degree from Keio University in Tokyo, and an M.B.A. from Stanford Graduate School of Business. We believe Dr. Kaneko is able to make valuable contributions to the Board due to his educational background in medicine, as well as his experience in the life science, pharmaceutical and related financial industries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patrick Machado, J.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as a member of the Board since December 2019. Mr. Machado has over two decades of experience growing biopharmaceutical organizations from development through commercialization. He has extensive operational experience, having led finance, business development and legal functions at multiple companies. Mr. Machado co-founded and served as Chief Financial Officer and Chief Business Officer at Medivation, Inc. from August 2003 until his retirement in April 2014 and served as a member of Medivation&#8217;s board of directors from April 2014 until its acquisition by Pfizer Inc. in September 2016. During his tenure at Medivation, Mr. Machado helped lead the company through substantial growth and challenges, providing strong leadership during the clinical development and successful commercial launch of XTANDI&#174; in prostate cancer. Prior to Medivation, Mr. Machado worked at ProDuct Health, Inc. from 1998 until 2001 where he held positions as Chief Financial Officer, Senior Vice President of Business Development and General Counsel; Mr. Machado was also responsible for working with national health plans in the U.S. to expand access to patients in need of ductal lavage. Earlier in his career, Mr. Machado served as chief legal counsel to the Chiron Technologies business unit at Chiron Corporation from 1996 until 1998 and led the transaction teams for all substantial Chiron Technologies collaborations. Prior to joining Chiron, Mr. Machado worked for Morrison &amp; Foerster LLP from 1990 until 1996, a leading international law firm, and for the Massachusetts Supreme Judicial Court from 1989 until 1990. Mr. Machado also serves as a member of the board of directors of Adverum Biotechnologies, Inc. (Nasdaq: ADVM), Xenon Pharmaceuticals (Nasdaq: XENE), Alumis Inc (Nasdaq: ALMS) and ACELYRIN, Inc. (Nasdaq: SLRN), all of which are publicly traded biopharmaceutical companies. Mr. Machado previously served on the board of directors of Turnstone Biologics Corp. (Nasdaq: TSBX) from August 2018 until April 2024, Sio Gene Therapies Inc. (f.k.a. Axovant Sciences, Inc.) (Nasdaq: SIOX) from June 2017 until February 2018, Endocyte, Inc. from February 2018 until December 2018, Rocket Pharmaceuticals, Inc. (f.k.a. Inotek Pharmaceuticals Corporation) (Nasdaq: RCKT) from August 2016 until January 2018, Principia Biopharma Inc. from June 2019 until its acquisition by Sanofi S.A. in September 2020, Roivant Sciences Ltd. (Nasdaq: ROIV) from October 2016 until June 2022, SCYNEXIS, Inc. (Nasdaq: SCYX) from October 2016 until June 2022, Turning Point Therapeutics, Inc. from May 2019 until its acquisition by Bristol-Myers Squibb Co. in September 2022 and Chimerix Inc. from May 2014 to June 2024. Mr. Machado received his J.D. degree from Harvard Law School and holds both a Bachelor of Science degree in Economics and a Bachelor of Arts degree in German from Santa Clara University in California. We believe Mr. Machado is able to make valuable contributions to the Board due to his extensive business experience as an executive and public company director in the pharmaceutical industry.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Andrew Perlman, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since December 2020. Dr. Perlman currently serves as Managing Director and Head of non-clinical Development of X-37, LLC, an artificial intelligence-enabled drug discovery company since November 2018. He is also Managing Director and Chief Medical Officer of Velocity Pharmaceutical Development LLC, a pharmaceutical company that acquires attractive drug candidates and rapidly advances them through a commercially relevant clinical proof-of-concept, a position he has held since 2011. Dr. Perlman also served as President of Vitesse Biologics, LLC, a biotech company focused on the development of antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology, which was a joint collaboration among Velocity Pharmaceutical Development LLC, Shire plc and the Mayo Clinic, until its acquisition in December 2020. From 2004 to October 2016, Dr. Perlman was Chief Executive Officer at Innate Immune Inc., a biotech company focused on developing therapies for asthma and autoimmune diseases. From 1993 to 2004, Dr. Perlman served as Vice President and then Executive Vice President of Tularik Inc. (acquired by Amgen Inc.), except for nine months in 2002 when he served as </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer of Affymax Inc. At Tularik Inc., Dr. Perlman&#8217;s responsibilities included clinical trial design and implementation, business development and financing activities, culminating with Tularik Inc.'s acquisition by Amgen Inc. in 2004 for $1.3 billion. Dr. Perlman began his notable career in drug development at Genentech, Inc., where he played a key role in the development, FDA approval, and marketing of Nutropin, a human growth hormone, and was responsible for the development of Genentech&#8217;s portfolio of endocrine drugs and drug candidates. Dr. Perlman also serves as an advisor to various companies, including venture capital firms 8 VC, Avestria Ventures Management LLC and V2M Capital LLC, and biotechnology companies Hexagon Bio, Inc., Hinge Bio, Inc., Shasqi, Inc., Acelot Inc. and Escalante, Inc. Dr. Perlman has a B.S. in Physics from MIT and an M.D. and Ph.D. in physiology from New York University. He did his Ph.D. research in the laboratory of Nobel laureate Professor Eric Kandel and received postgraduate clinical training at Stanford School of Medicine and NYU. From 1984 to 1987 he was an assistant professor at Stanford University where he engaged in clinical work, teaching and research on hypertension. We believe Dr. Perlman is able to make valuable contributions to the Board due to his extensive business, finance and development experience in the biopharmaceutical industry.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Antoni Ribas, M.D., Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as a member of the Board since October 2019. Dr. Ribas has also served as a member of the Scientific Advisory Board since its creation in 2015. Dr. Ribas is an internationally recognized physician-scientist who conducts translational and clinical research aimed at understanding how the immune system can be used to treat cancer. He has been a leader in the research and clinical development of multiple types of therapeutic agents, including immune checkpoint inhibitors, gene-engineered T cells, and BRAF-targeted therapies. His efforts have been instrumental in transforming the treatment paradigm for oncology patients, particularly those with malignant melanoma, having served as principal investigator for multiple trials, including those involving the breakthrough cancer therapy, Keytruda&#174;. Dr. Ribas has served as Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) since July 2011, Director of the Tumor Immunology Program at the UCLA Jonsson Comprehensive Cancer Center since June 2010, and Director of the Parker Institute for Cancer Immunotherapy Center at UCLA since 2016. He was the President for the American Association for Cancer Research (AACR) from April 2020 to April 2021. Dr. Ribas has founded or advised several successful biopharma companies, such as Kite Pharma Inc. and Flexus Biosciences, Inc. Dr. Ribas received MD and Ph.D. degrees from the Universidad de Barcelona (Spain). He completed his internship and residency in medical oncology at the University Hospital Vall d&#8217;Hebron (Barcelona, Spain) and conducted postdoctoral research at UCLA. Following a fellowship in hematology/oncology in the Department of Medicine at UCLA, he has held numerous faculty and administrative positions at UCLA since 2001. Dr. Ribas has received a myriad of awards and honors, including the AACR-CRI Lloyd J. Old Award in Cancer Immunology, the AACR Richard and Hinda Rosenthal Award and the National Cancer Institute Outstanding Investigator Award. Dr. Ribas has also served on the board of directors of leading scientific organizations such as the AACR and the Society for Immunotherapy for Cancer. He is an elected Fellow of the AACR Academy, the American Society for Clinical Investigation, the Association of American Physicians and the US National Academy of Medicine. We believe Dr. Ribas is able to make valuable contributions to the Board due to his extensive experience in medicine and clinical research.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AVOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ACH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OMINEE.</span></div><div style="margin-top:12pt"><span><br/></span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_25"></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span id="ia4a433966ca943c998765eaf5c3299d3_16747"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a brief biography of each director who is not up for reelection at the Annual Meeting and whose term on the Board will continue as noted below:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class II Directors Continuing in Office until the 2026 Annual Meeting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dietmar Berger, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our Board since February 2025. Dr. Berger joined Gilead Sciences, Inc. (Nasdaq: GILD) in January of 2025 as its Chief Medical Officer. In his role at Gilead, he is responsible for leading the company&#8217;s clinical development and medical affairs strategy for all of Gilead&#8217;s medicines throughout the product lifecycle. With over 25 years of experience in preclinical and clinical drug development, Dr. Berger plays a pivotal role in advancing Gilead&#8217;s mission to deliver transformative therapies to patients worldwide. Prior to Gilead, Dr. Berger served in executive leadership positions at Sanofi, Genentech, Bayer HealthCare and Amgen. Dr. Berger is a board-certified Internist, Hematologist and Oncologist with full academic credentials and clinical experience. Dr. Berger was selected to be appointed to the Board pursuant to the Investor Rights Agreement and we believe he is able to make valuable contributions to the Board due to his extensive clinical development experience.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">David Lacey, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since May 2020. From 1994 until his retirement in 2011, Dr. Lacey held various positions at Amgen Inc. (Nasdaq: AMGN), including Senior Vice President of Discovery Research. By the end of his tenure, he oversaw a research organization of approximately 1200 employees, encompassing four broad therapeutic areas: Inflammation, Oncology, Metabolic Disorders and Neurosciences that utilized both large and small molecules to interdict validated targets across these focus areas. Kepivance, Prolia, Xgeva, and Repatha were among a number of drugs that emerged from Amgen laboratories while under his supervision. Since July 2011, Dr. Lacey has provided services as a biopharmaceutical consultant to a number of private companies, academic institutions and venture capital firms through his company, David L. Lacey LLC. He currently serves on the board of directors of Atreca, Inc. (Nasdaq: BCEL), Nurix, Inc. (Nasdaq: NRIX) and Inbiomotion SL. Previously, Dr. Lacey served on the Boards of Directors of Argenx SE (Nasdaq: ARGX) from July 2014 until May 2021 and UNITY Biotechnology, Inc. (Nasdaq: UBX) from February 2018 to December 2020. He obtained both his B.A. in Biology and M.D. from the University of Colorado and received his formal training in Anatomic Pathology at Washington University in St. Louis, Missouri. We believe Dr. Lacey is able to make valuable contributions to the Board due to his extensive experience in drug discovery and management of large research organizations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Johanna Mercier</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since January 2024. Ms. Mercier has served as the Chief Commercial Officer of Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company, since May 2019. In her role at Gilead, she is responsible for overseeing the global commercialization of all of Gilead&#8217;s medicines throughout the product lifecycle. Prior to Gilead, she served in a number of executive leadership positions over 25 years at Bristol-Myer Squibb including as President, U.S. &amp; Large Markets from September 2018 until May 2019, President, U.S. from August 2017 until October 2018 and President, European Markets, Australia &amp; Canada from August 2016 until August 2017. In her roles at Bristol-Myer Squibb, she gained broad experience across geographies and in all aspects of the commercial business and she led the execution of multiple launches that changed the standard of care in melanoma and renal cancers. Ms. Mercier holds a bachelor&#8217;s degree in biology from the University of Montreal and an MBA from Concordia University. She currently serves on the board of directors of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and the University of Southern California&#8217;s Leonard D. Schaeffer Center for Health Policy and Economics. Ms. Mercier was selected to be appointed to the Board pursuant to the Investor Rights Agreement and we believe she is able to make valuable contributions to the Board due to her extensive commercial experience and her current role at Gilead Sciences, Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class III Directors Continuing in Office until the 2027 Annual Meeting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kathryn Falberg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since September 2017. She served as the Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a biopharmaceutical company, from March 2012 to March 2014, after serving as its Senior Vice President and Chief Financial Officer since December 2009. From 2001 through 2009, Ms. Falberg worked with a number of smaller companies while serving as a corporate director and audit committee chair for several companies. From 1995 to 2001, Ms. Falberg was employed by Amgen, Inc. (Nasdaq: AMGN), where she served in various roles including Senior Vice President, Finance and Strategy, Chief Financial Officer, Vice President, Chief Accounting Officer, and Vice President, Treasurer. Ms. Falberg also serves as a member of the boards of directors, and on the audit committee, of biopharmaceutical company Nuvation Bio Inc. (NYSE: NUVB) and is a member of the board of directors of The Trade Desk, Inc. (Nasdaq: TTD), a technology company. Ms. Falberg has previously served on the boards of directors of multiple companies including Tricida, Inc. from April 2018 to June 2022, Urogen Pharma Ltd. (Nasdaq: URGN), from May 2015 until June 2022, Aimmune Therapeutics, Inc. from May 2015 until its acquisition by Nestl&#233; S.A. in October 2020, Sio Gene Therapies Inc. (f.k.a. Axovant Sciences, Ltd.) (Nasdaq: SIOX) from April 2017 until February 2018, BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) from July 2016 until June 2017, aTyr Pharma, Inc. (Nasdaq: LIFE) from July 2014 until May 2017, Medivation, Inc. from January 2013 until its acquisition by Pfizer Inc. in September 2016 and Halozyme Therapeutics, Inc. (Nasdaq: HALO) from May 2007 until May 2016. Ms. Falberg holds an M.B.A. in Finance and B.A. in Economics from the University of California, Los Angeles and is an inactive certified public accountant. We believe Ms. Falberg is able to make valuable contributions to the Board due to her extensive business experience as an executive in the pharmaceutical industry and her service as a director and audit committee member of multiple other biopharmaceutical companies during her career.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Linda Higgins, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since August 2021. Dr. Higgins is currently the Senior Vice President Research, Strategy, Innovation and Portfolio at Gilead Sciences, Inc. (Nasdaq: GILD). Dr. Higgins joined Gilead in December 2010 and during her first nine years led its Biology group. Prior to joining Gilead, Dr. Higgins previously served as the President &amp; Chief Executive Officer of InteKrin Therapeutics from April 2007 until November 2010 and as Head of Research at Scios, Inc., a Johnson &amp; Johnson company, from September 1991 until March 2007, where she provided leadership for drug discovery, preclinical development, and translational medicine. Dr. Higgins obtained her B.A. degree in Behavioral Physiology from Kenyon College and her Ph.D. in Neuroscience from the University of California, San Diego School of Medicine and conducted her post-doctoral research in Molecular Genetics at </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Howard Hughes Medical Institute at the University of California, Berkeley. Dr. Higgins also currently serves on the Supervisory Board of Galapagos NV (Nasdaq: GLPG) and previously served on the board of directors of Tizona Therapeutics, Inc. from September 2020 until December 2023. Dr. Higgins was selected to be appointed to the Board pursuant to the Investor Rights Agreement and we believe she is able to make valuable contributions to the Board due to her extensive research and business experience and her current role at Gilead Sciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nicole Lambert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of the Board since August 2021. Ms. Lambert is currently an Executive Director/Consultant at Russell Reynolds and previously served as the Chief Operating Officer of Myriad Genetics, Inc. from December 2021 until October 2023. Prior to her role as Chief Operating Officer, Ms. Lambert had served in various roles since joining Myriad Genetics in 2001 including Group President of Myriad Oncology, Myriad Women&#8217;s Health and Myriad International from March 2019 until December 2021, General Manager for Myriad Genetics' Oncology business from July 2018 to February 2019, and General Manager for its Urology business unit from June 2015 to June 2018. Prior to Myriad Genetics, she was a genetic councilor at Laboratory Corporation of America Holdings from February 2000 to May 2001. Ms. Lambert received her bachelor's degree in Biology and Sociology from Boston College and her master&#8217;s degree in Genetic Counseling from Mt. Sinai School of Medicine at New York University. We believe Ms. Lambert is able to make valuable contributions to the Board due to her extensive commercial experience. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terry Rosen, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our co-founder and has served as the Chairman of the Board since December 2017, our Chief Executive Officer since May 2015 and as a member of the Board since April 2015. Previously, Dr. Rosen co-founded (with Dr. Jaen) and served as the Chief Executive Officer of Flexus Biosciences, Inc. from October 2013 to April 2015, when it was acquired by Bristol-Myers Squibb. Prior to that, Dr. Rosen was at Amgen, Inc. (Nasdaq: AMGN), a biopharmaceutical company, from 2004 to January 2013 where he most recently served as Vice President of Therapeutic Discovery from 2011 to January 2013. He also worked at Tularik Inc., a biopharmaceutical company, from 1993 to 2004 when it was acquired by Amgen, Inc., Pfizer Central Research, a division of Pfizer Inc. (NYSE: PFE), a biopharmaceutical company, from 1987 to 1993, and Abbott Laboratories (NYSE: ABT), a health care company, from 1985 to 1987. Dr. Rosen serves on the board of directors of IDEAYA Biosciences, Inc. (Nasdaq: IDYA) and on the boards of various private and non-profit entities including, Epiodyne, Inc., Simcha Therapeutics Holding Company, LLC, Sonoma Biotherapeutics, Inc., the Berkeley Board of Visitors, the Berkeley Foundation, the California Life Sciences Association and the Salk Institute.  Dr. Rosen previously served on the board of directors of PACT Pharma, Inc. from December 2016 until October 2022. Dr. Rosen holds a B.S. in Chemistry from the University of Michigan and a Ph.D. in Chemistry from the University of California, Berkeley. We believe that Dr. Rosen should serve as a director based on his position as one of our founders and as our Chief Executive Officer, his extensive experience in general management and business development and his experience in the field of biosciences. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_28"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Independence of The Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under the NYSE listing standards, a majority of the members of a listed company&#8217;s board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the board of directors. The Board consults with counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of the NYSE, as in effect from time to time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with these considerations, after a review of all relevant identified transactions or relationships between each director, or any of his or her family members, and us, including our senior management and independent auditors, the Board has affirmatively determined that the following seven directors are independent directors within the meaning of the applicable NYSE listing standards: Ms. Falberg, Dr. Kaneko, Dr. Lacey, Ms. Lambert, Mr. Machado, Dr. Perlman and Dr. Ribas. In making this determination, the Board found that none of these directors had a material or other disqualifying relationship with us. Dr. Rosen is not independent by virtue of being one of our executive officers, and Dr. Berger, Dr. Higgins and Ms. Mercier are not independent by virtue of their relationship with Gilead.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws and Corporate Governance Guidelines provide the Board with the flexibility to combine or separate the positions of Chairman of the Board and Chief Executive Officer. Dr. Rosen, our Chief Executive Officer, currently serves as our Chairman of the Board and Dr. Kaneko serves as our lead independent director. As lead independent director, Dr. Kaneko presides over periodic meetings of our independent directors, serves as a liaison between our Chief Executive Officer and the independent directors and performs such additional duties as the Board may otherwise determine and delegate. We believe that our current leadership structure is appropriate as it allows the Board to benefit from Dr. Rosen&#8217;s in-depth knowledge of our business in formulating and implementing strategic initiatives, provides a unified leadership to confront challenges facing our business, and enhances our ability to communicate our message and strategy clearly and consistently to stockholders. We will continue to periodically review our leadership structure and may make changes in the future if appropriate.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the Board in Risk Oversight</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the key functions of the Board is informed oversight of our risk management process. In particular, the Board is responsible for monitoring and assessing strategic risk exposure. Our executive officers are responsible for the day-to-day management of the material risks we face. The Board administers its oversight function directly as a whole, as well as through various standing committees that address risks inherent in their respective areas of oversight. Our Audit Committee oversees the management of risks associated with our financial reporting, accounting, auditing and cybersecurity matters; the Compensation Committee of the Board (the "Compensation Committee") oversees the management of risks associated with our compensation policies and programs; the Nominating and Corporate Governance Committee of the Board (the "Nominating and Corporate Governance Committee") oversees the management of risks associated with director independence, conflicts of interest, composition and organization of the Board and director succession planning; and the Science Committee of the Board (the "Science Committee") oversees the management of risks associated with our research and development strategy. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meetings of The Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board met eight times during the last fiscal year. As required under applicable NYSE listing standards, in fiscal year 2024, our independent directors met in regularly scheduled executive sessions at which only independent directors were present. All of our directors attended at least 75% of the aggregate number of meetings of the Board and committees on which they served, held during the portion of the last fiscal year for which they were directors or committee members, respectively.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Regarding Committees of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Board had four standing committees: an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and a Science Committee. The following </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">table provides membership and meeting information for each of the committees during our 2024 fiscal year (Dr. Rosen and Ms. Mercier did not serve on any committees in 2024):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating<br/>and Corporate<br/>Governance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Science </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kathryn Falberg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Linda Higgins, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Lacey, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick Machado, J.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merdad Parsey, M.D. Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antoni Ribas, M.D. Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicole Lambert</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total meetings during 2024 fiscal year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:5pt">Committee Chairperson</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. With regards to our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, the Board has determined that each member of such committees meets the applicable NYSE rules and regulations regarding &#8220;independence.&#8221; </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is established by the Board in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), to oversee our corporate accounting and financial reporting processes and audits of its financial statements. For this purpose, the Audit Committee performs several functions. The Audit Committee assists the Board with: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">oversight of the integrity of our consolidated financial statements; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our compliance with legal and regulatory requirements; the qualifications, independence and performance of the independent registered public accounting firm; and </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the design and implementation of our financial risk assessment and risk management. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, our Audit Committee is responsible for reviewing and discussing with our management the adequacy and effectiveness of our disclosure controls and procedures. The Audit Committee also discusses with our management and independent registered public accounting firm the annual audit plan and scope of audit activities, scope and timing of the annual audit of our consolidated financial statements, and the results of the audit, quarterly reviews of our consolidated financial statements and, as appropriate, initiates inquiries into certain aspects of our financial affairs. Our Audit Committee is responsible for establishing and overseeing procedures for the receipt, retention and treatment of any complaints regarding accounting, internal accounting controls or auditing matters, as well as for the confidential and anonymous submissions by our employees of concerns regarding questionable accounting or auditing matters. In addition, our Audit Committee has direct responsibility for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm. Our Audit Committee has sole authority to approve the hiring and discharging of our independent registered public accounting firm, all audit engagement terms and fees and all permissible non-audit engagements with the independent auditor. Our Audit Committee reviews and oversees all related person transactions in accordance with our policies and procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee is currently composed of the three following directors: Ms. Falberg, Dr. Kaneko and Dr. Perlman. Each member of our Audit Committee is independent under the rules and regulations of the SEC and the listing standards of the NYSE applicable to audit committee members. Ms. Falberg is the chair of the Audit Committee. The Board has determined that each of Ms. Falberg and Dr. Kaneko qualify as an audit committee financial expert within the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">meaning of SEC regulations and meet the financial sophistication requirements of the NYSE. The Board has adopted a written Audit Committee charter that is available to stockholders on our website at www.arcusbio.com.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Report of the Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2024 with management of the company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the company&#8217;s annual report on Form 10&#8209;K for the fiscal year ended December 31, 2024. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kathryn Falberg (Chair) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material provided under &#8220;Report of the Audit Committee&#8221; in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee is currently composed of three directors: Dr. Kaneko, Dr. Lacey and Ms. Lambert. Ms. Falberg served as a member of the Compensation Committee during the fiscal year ended December 31, 2024 but was replaced by Ms. Lambert in March 2025. Each member of the Compensation Committee is independent (as independence is currently defined in NYSE Listed Company Manual Section 303A.02 as applied to compensation committee members). Dr. Kaneko is the chair of the Compensation Committee. The Board has adopted a written Compensation Committee charter that is available to stockholders on our website at www.arcusbio.com. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee acts on behalf of the Board to review, adopt and oversee our compensation strategy, policies, plans and programs, including: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establishment of corporate and individual performance objectives relevant to the compensation of our directors, officers and employees and evaluation of performance in light of these stated objectives; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and approval of the compensation and other terms of employment or service, including severance and change-in-control arrangements, of our Chief Executive Officer and the other executive officers and directors; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">administration of our equity administration policy, equity compensation plans, pension and profit-sharing plans, deferred compensation plans and other similar plan and programs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee Processes and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Typically, the Compensation Committee meets at least annually and with greater frequency if necessary. The Compensation Committee meets regularly in executive session. However, from time to time, various members of management and other employees as well as outside advisors or consultants may be invited by the Compensation Committee to make presentations, to provide financial or other background information or advice or to otherwise participate in Compensation Committee meetings. The Chief Executive Officer may not participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his compensation. The charter of the Compensation Committee grants the Compensation Committee full access to all books, records, facilities and personnel of Arcus. In addition, under the charter, the Compensation Committee has the authority to obtain, at the expense of Arcus, advice and assistance from compensation consultants and internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of the work of any consultants or advisers engaged for the purpose of advising the Compensation Committee. In particular, the Compensation Committee has the sole authority to retain, in its sole discretion, compensation consultants to assist in its evaluation of executive and director compensation, including the authority to approve the consultant&#8217;s reasonable fees and other retention terms. Under the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Compensation Committee, other than in-house legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the SEC and NYSE, that bear upon the adviser&#8217;s independence; however, there is no requirement that any adviser be independent. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has engaged Radford, Inc. (&#8220;Radford&#8221;), a nationally-recognized compensation consulting firm, to assist the Compensation Committee in developing appropriate incentive plans for our directors and executives on an annual basis, to provide the Compensation Committee with advice and ongoing recommendations regarding material executive compensation decisions, and to review compensation proposals of management. The Compensation Committee reviewed the independence of Radford, taking into consideration the six factors prescribed by the SEC and NYSE. Based on this assessment, the Compensation Committee determined that the engagement of Radford does not raise any conflicts of interest. In addition, the Compensation Committee evaluated the independence of its other outside advisors to the Compensation Committee, including outside legal counsel, considering the same independence factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its charter, the Compensation Committee may form, and delegate authority to, subcommittees as appropriate. In 2018, the Compensation Committee formed an Equity Committee, currently composed of Dr. Jaen, to which it delegated authority to grant, without any further action required by the Compensation Committee, equity awards to employees who are not officers of Arcus. The purpose of this delegation of authority is to enhance the flexibility of equity administration within Arcus and to facilitate the timely grant of equity awards to non-management employees, including any annual grants to continuing employees, within specified limits approved by the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The specific determinations of the Compensation Committee with respect to executive compensation for fiscal year 2024 are described in greater detail in the &#8220;Executive Compensation&#8221; section of this proxy statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee of the Board of Directors of Arcus Biosciences, Inc. has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy statement. Based on this review and discussion, the Compensation Committee has recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement and incorporated into Arcus Biosciences, Inc.&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D. (Chair)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Lacey, M.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicole Lambert</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material provided under "Compensation Committee Report" in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any of our filings under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee is responsible for identifying, reviewing and evaluating candidates to serve as our directors (consistent with criteria approved by the Board), reviewing and evaluating incumbent directors, recommending to the Board for selection candidates for election to the Board, making recommendations to the Board regarding the membership of the committees of the Board, assessing the performance of the Board, and recommending to the Board a set of corporate governance principles for us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee is composed of three directors: Dr. Lacey, Ms. Lambert and Mr. Machado. Dr. Lacey is the chair of the Nominating and Corporate Governance Committee. All members of the Nominating and Corporate Governance Committee are independent (as independence is currently defined in NYSE Listed Company Manual Section 303A.02). The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to stockholders on our website, www.arcusbio.com.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee considers several factors in evaluating potential candidates for the Board. The director qualifications that the Nominating and Corporate Governance Committee has developed to date focus on what the Nominating and Corporate Governance Committee believes to be essential competencies to effectively serve on the Board, including possessing relevant expertise upon which to be able to offer advice and guidance to management, demonstrated excellence in his or her field, having the ability to exercise sound business judgment, having the commitment to rigorously represent the long-term interests of our stockholders, and having </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sufficient time to devote to our affairs. The Nominating and Corporate Governance Committee identifies potential candidates by using its network of contacts as well as solicits additional potential candidates from the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee does not have a formal policy with regard to the consideration of diversity in identifying director nominees, but the Nominating and Corporate Governance Committee strives to nominate directors with a variety of individual backgrounds and complementary skills so that, as a group, the Board will possess the appropriate talent, skills and expertise to oversee our business and operations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Corporate Secretary at 3928 Point Eden Way, Hayward, CA 94545 at least 120 days prior to the anniversary date of the mailing of the proxy statement for the last annual meeting of stockholders and must include the following information: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">name and address of the nominating stockholder;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a representation that the nominating stockholder is a record holder; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a representation that the nominating stockholder intends to appear in person or by proxy at the annual meeting to nominate the person or persons specified; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">information regarding each nominee that would be required to be included in a proxy statement;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a description of any arrangements or understandings between the nominating stockholder and the nominee; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the consent of each nominee to serve as a director, if elected. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee will evaluate candidates recommended by a stockholder in the same manner as candidates identified by any other person, including members of the Board. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Science Committee </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Science Committee is responsible for overseeing, on behalf of the Board, our research and development strategy, including with respect to our clinical programs and the capabilities of our product candidates. Among other responsibilities, the Science Committee:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">advises the Board on the direction of any progress made towards our research and development strategy;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">monitors the status, progress and outcomes of our key clinical trials; and </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">reviews the potential effect of developments in the competitive scientific landscape and emerging science trends on our clinical programs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Science Committee is currently composed of five directors: Dr. Berger, Dr. Higgins, Dr. Lacey, Dr. Perlman and Dr. Ribas. Dr. Parsey served as a member of the Science Committee during the fiscal year ended December 31, 2024 but was replaced by Dr. Berger in February 2025 in connection with Dr. Parsey's departure from our Board. Dr. Perlman is the chair of the Science Committee. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder Communications with The Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders and any interested party may direct correspondence to the Board or an individual director, including Dr. Kaneko, our lead independent director, to our Corporate Secretary at our principal executive offices at 3928 Point Eden Way, Hayward, CA 94545. The Corporate Secretary will review all correspondence and will forward the communications on to the relevant individual director or the whole Board; however, the Corporate Secretary generally will not forward communications that are primarily solicitations for products or services, matters of a personal nature that are not relevant for stockholders, matters that are of a type that render them improper or irrelevant to the functioning of the Board, or requests for general information about Arcus.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct and Ethics</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted the Arcus Biosciences, Inc. Code of Conduct and Ethics that applies to all officers, directors and employees. The Code of Conduct and Ethics is available on our website at www.arcusbio.com. If we make any substantive amendments to the Code of Conduct and Ethics or grant any waiver from a provision of the Code to any executive officer </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or director, Arcus will promptly disclose the nature of the amendment or waiver on its website or in a Current Report on Form 8-K. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance Guidelines </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board adopted Corporate Governance Guidelines to document the governance practices we follow and to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and management with those of Arcus&#8217;s stockholders. The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to Board composition and selection, Board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning and Board committees and compensation. The Corporate Governance Guidelines, as well as the charters for each committee of the Board, may be viewed at www.arcusbio.com.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clawback Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a Compensation Clawback Policy which is administered by our Compensation Committee. Under this policy, our Compensation Committee is required to recoup applicable excess incentive-based compensation received by our executive officers in the event of a covered financial restatement. This policy is designed to comply with the Dodd-Frank Wall Street Reform, Consumer Protection Act and requirements of NYSE Listed Company Manual Section 303A.14.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_527"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Administration Policy</span></div><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiDiscTextBlock" id="f-5" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee has adopted an Equity Administration Policy which implements a framework for a consistent process for granting, pricing and administering equity-based awards. The <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiCnsdrdFlag" format="ixt:fixed-true" id="f-6">policy</ix:nonNumeric> establishes the terms of all equity-based awards issued by the Company to officers, employees and consultants under our equity plans. The policy establishes the terms for such grants including the grant effective date, pricing and vesting. <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMethodTextBlock" id="f-7" escape="true">For example, all equity awards will have a grant effective date of the <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgPredtrmndFlag" format="ixt:fixed-true" id="f-8">next 8th or the 23rd of a calendar month</ix:nonNumeric> (whichever occurs first) following approval by the Compensation Committee. If such day is not a trading day, the effective date of such grant will be the next trading day thereafter.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, we did not grant stock options, stock appreciation rights, or similar option&#8208;like instruments to our named executive officers during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form 8-K that discloses material nonpublic information. <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="f-9" escape="true">Our Compensation Committee does not take material nonpublic information into account when determining the timing or terms of awards, and we have <ix:nonNumeric contextRef="c-1" name="ecd:MnpiDiscTimedForCompValFlag" format="ixt:fixed-false" id="f-10">not timed</ix:nonNumeric> the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ix:nonNumeric></span></div></ix:nonNumeric><div id="i3be39c5b0a4e4bb6bffeea39d605508e_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider Trading Policy </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-11">adopted</ix:nonNumeric> an Insider Trading Policy governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees that is designed to promote compliance with insider trading laws, rules and regulations, as well as procedures designed to further the foregoing purposes. A copy of our Insider Trading Policy is filed as an exhibit to our Annual Report on Form 10-K for our fiscal year ended December 31, 2024. In addition, it is our intent to comply with applicable laws and regulations relating to insider trading.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insider Trading Policy also provides that directors, officers and employees should not (i) engage in any short sales, (ii) acquire, sell, or trade in any interest or position relating to the future price of our securities, such as a put or call option or other derivative contracts or transactions, nor (iii) borrow from a brokerage firm, bank or similar entity in order to purchase our securities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 2</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has selected Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst &amp; Young LLP has audited our financial statements since 2016. Representatives of Ernst &amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee, in its discretion, may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in our best interests and the best interests of our stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of a majority of the shares present or represented by proxy and cast on the matter at the Annual Meeting will be required to ratify the selection of Ernst &amp; Young LLP. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Accountant Fees and Services </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents aggregate fees billed to us for the fiscal years end December 31, 2024 and 2023, by Ernst &amp; Young LLP (in thousands):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,570&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,239&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-Related Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Fees</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,306&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of the aggregate fees billed for professional services rendered for the audit of our annual financial statements included in our Annual Reports on Form 10-K; review of our interim financial statements included in our quarterly reports on Form 10-Q; consultation on technical accounting matters; assistance with registration statements filed with the SEC; and the issuance of comfort letters and consents.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of fees billed for professional services rendered for tax compliance and studies of our research and development tax credits.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of fees billed in the indicated year for an annual subscription to Ernst &amp; Young LLP's online resource library.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All fees described above were pre-approved by the Audit Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our engagement of Ernst &amp; Young LLP, we entered into an engagement agreement with Ernst &amp; Young LLP that sets forth the terms by which Ernst &amp; Young LLP will perform audit services for us. The terms of such agreement are subject to alternative dispute resolution procedures.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Approval Policies and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee must pre-approve audit and non-audit services rendered by our independent registered public accounting firm, Ernst &amp; Young. Pre-approval may also be given as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be delegated to one or more of the Audit Committee&#8217;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting. The Audit Committee has approved all services by Ernst &amp; Young prior to performance of the services.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AVOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ROPOSAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 3</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY VOTE ON EXECUTIVE COMPENSATION </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Section 14A of the Exchange Act, our stockholders are entitled to cast an advisory vote at the Annual Meeting to approve the compensation of our named executive officers as disclosed in this Proxy Statement. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this Proxy Statement. Our stockholders have recommended, and the Board has approved, a frequency of each year for advisory votes on executive compensation. Accordingly, the next advisory vote on executive compensation will be at our 2026 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation of our named executive officers subject to the vote is disclosed in the &#8220;Compensation Discussion and Analysis,&#8221; compensation tables, and related narrative disclosure contained in this Proxy Statement. Our executive compensation program is focused on pay-for-performance with a goal of providing competitive overall compensation that attracts and retains top performers and aligns their interests with those of our stockholders. Approximately 96% of the votes cast on the say-on-pay proposal at our 2024 annual meeting of stockholders voted in support of the compensation paid to our named executive officers for 2023. We are again requesting your non-binding vote on the following resolution:</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the compensation paid to the named executive officers of Arcus Biosciences, Inc., as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vote is an advisory vote only and is not binding on us or the Board, the Compensation Committee and the Board value your opinions and will consider the outcome of the vote in establishing compensation philosophy and making future compensation decisions. Your vote will serve as an additional tool to guide the Compensation Committee and Board in continuing to improve the alignment of our executive compensation programs with business objectives and performance and with the interests of our stockholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required; Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority of shares cast is required for approval of this proposal. Votes &#8220;For&#8221; and &#8220;Against&#8221; will affect the outcome. Abstentions and broker non-votes are not considered to be votes cast and therefore will have no effect.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">HE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OARD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">IRECTORS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ECOMMENDS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">AVOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">ROPOSAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 3.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as to the beneficial ownership of our common stock as of March 1, 2025, for:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">each named executive officer;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">each of our directors; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">all executive officers and directors as a group.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares beneficially owned, subject to community property laws where applicable. Common stock (i) subject to options that are currently exercisable or exercisable within 60 days of March 1, 2025 and (ii) underlying restricted stock units that are scheduled to vest within 60 days of March 1, 2025, are deemed to be outstanding and to be beneficially owned by the person holding any such options or restricted stock units for the purpose of computing the beneficial ownership of that person (including for the purpose of computing beneficial ownership of all current directors and officers), but are not treated as outstanding for the purpose of computing the beneficial ownership of any other person.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Percentages of beneficial ownership of our common stock in the table is based on 105,841,422 shares of common stock issued and outstanding on March 1, 2025.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Name of Beneficial Owners</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares<br/>Owned</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares<br/>That May Be Acquired Within 60<br/>Days</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Shares<br/>Beneficially<br/>Owned</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Percentage<br/>of<br/>Beneficial<br/>Ownership </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">5% Stockholders (other than directors and named executive officers):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Gilead Sciences, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,424,760</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,575,464</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40,000,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">BlackRock, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,732,399</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,732,399</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">The Vanguard Group, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,161,943</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,161,943</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Directors and Named Executive Officers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,571,357</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,019,732</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,591,089</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Robert C. Goeltz II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22,763</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">489,957</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">512,720</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,444,741</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">785,632</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,230,373</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">102,657</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,703,356</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,806,013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Dimitry Nuyten, M.D., Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,268</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,268</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Dietmar Berger, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Kathryn Falberg </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">149,006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">99,400</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">248,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Linda Higgins, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">930,555</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64,400</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">994,955</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">David Lacey, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">49,252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">106,025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">155,277</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Nicole Lambert</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Patrick Machado, J.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">114,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">131,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Johanna Mercier</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">92,325</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Antoni Ribas, M.D., Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,503</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">120,025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">150,528</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">All current directors and executive officers</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">as a group (16 persons) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,413,795</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,300,374</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,714,169</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:6pt">Represents beneficial ownership of less than one percent of the outstanding common stock. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Based on Schedule 13D filed with the SEC on March 5, 2025 by Gilead. The number of shares that may be acquired within 60 days is the number of shares that may be acquired pursuant to the terms of the Third Amended and Restated Common Stock Purchase Agreement, dated January 29, 2024 between Gilead and us, which number is the maximum that will cause Gilead&#8217;s beneficial ownership to be 35.0% subsequent to the issuance of such shares. The principal business address of Gilead is 333 Lakeside Drive, Foster City, California 94404.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Based on Schedule 13G/A filed with the SEC on November 8, 2024 by BlackRock, Inc. Blackrock, Inc. has sole dispositive power with respect to all of these shares and sole voting power with respect to 9,732,399 of these shares. Blackrock Fund Advisors may also be deemed to beneficially own 5% or more of our outstanding shares of common stock. The principal business address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Based on a Schedule 13F-HR filed with the SEC on February 11, 2025, reporting that as of December 31, 2024, The Vanguard Group, Inc. had the sole dispositive power with respect to 5,226,631 of these shares, the shared power to dispose of 60,857 of these shares and the shared power to vote and to dispose of 101,728 of these shares. This number is also adjusted to reflect 772,727 shares of our common stack that such beneficial owner and/or its affiliates purchased in the underwritten equity offering that we closed in February 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Shares owned includes 632,974 shares of common stock held in family trusts in which Dr. Rosen has no pecuniary interest but retains voting and dispositive power.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Shares owned includes 1,188,233 shares of common stock held by trusts.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Dr. Nuyten departed the Company in January 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Shares owned includes 102,106 shares of common stock held by trusts.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Shares owned consists of (a) 505,050 shares of common stock held by Kaneko Capital, LLC, (b) 252,524 shares of common stock held by Kaneko Investments, LLC, and (c) 152,981 shares of common stock held by trusts.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Shares owned includes 8,553 shares of common stock held by trusts.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:8.02pt">Consists of the number of shares of common stock beneficially owned by all executive officers and directors as of March 1, 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our executive officers as of April 1, 2025:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:41.692%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NAME</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POSITION HELD WITH THE COMPANY</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer, Director and Chairman</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard Markus, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Medical Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carolyn Tang</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General Counsel</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a biography of Dr. Rosen, see &#8220;Proposal 1 &#8211; Election of Directors.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Robert C. Goeltz II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer since August 2020. Mr. Goeltz joined us from UNITY Biotechnology, Inc. (Nasdaq: UBX), a healthcare company focused on age-associated diseases, where he served as Chief Financial Officer and Senior Vice President from September 2017 to July 2020, in which position he was responsible for investor and public relations, accounting, financial planning and analysis, information systems, real estate, insurance, procurement and facilities. Prior to Unity, Mr. Goeltz was Chief Financial Officer and Senior Vice President at CytomX Therapeutics, Inc. (Nasdaq: CTMX), a biotechnology company focused on cancer therapeutics, from May 2015 to May 2017, in which position he was responsible for investor relations, finance, real estate, insurance, procurement, facilities and information systems. Prior to that, Mr. Goeltz served as Chief Financial Officer of Onyx Pharmaceuticals, Inc. after its acquisition by Amgen Inc., from October 2013 until May 2015. Previously, Mr. Goeltz held roles of increasing responsibility at Amgen Inc., including in Business Development, Commercial Finance, R&amp;D Finance and Corporate Accounting from 2004 to 2013. He began his career working in the audit practice of Ernst &amp; Young LLP. Mr. Goeltz received a B.B.A. in Business from Emory University and an M.B.A. from the UCLA Anderson School of Management. He is also a Certified Public Accountant (inactive).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Juan Carlos Jaen, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our co-founder and has served as our President since May 2015. Dr. Jaen also served as a member of the Board from April 2015 until January 2024. Previously, Dr. Jaen co-founded (with Dr. Rosen) and served as the President and Head of Research and Development at Flexus Biosciences, Inc. from October 2013 to April 2015, when it was acquired by Bristol-Myers Squibb. Prior to that, Dr. Jaen served as Senior Vice President of Drug Discovery and as the Chief Scientific Officer of ChemoCentryx, Inc., a biopharmaceutical company, from 2007 to September 2013. From 2004 to 2006, Dr. Jaen was Vice President of Chemistry at Amgen Inc. (Nasdaq: AMGN) and from 1996 to 2004, Dr. Jaen held positions as Director of Medicinal Chemistry and Vice President of Chemistry at Tularik, Inc. Prior to that, Dr. Jaen held several positions in drug discovery and program management, from 1983 to 1996, at the Parke-Davis Pharmaceutical Research division of Warner-Lambert Company, a pharmaceutical company. Dr. Jaen also serves on the board of directors of multiple private entities including the Bella Charitable Foundation, Breakpoint Therapeutics GmbH, Hexagon Bio, Inc., R2M Pharma, Inc. and Shasqi, Inc. Dr. Jaen previously served on the board of directors of PACT Pharma, Inc. from October 2016 until October 2022. Dr. Jaen holds a B.S. in Chemistry from the Universidad Complutense de Madrid and a Ph.D. in Organic Chemistry from the University of Michigan.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jennifer Jarrett</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Operating Officer since October 2020. She also served as a member of the Board from January 2019 until January 2024. Prior to joining us, Ms. Jarrett served as Vice President, Corporate Development and Capital Markets at Uber, Inc. (NYSE: UBER), a technology company providing a platform for mobility, delivery and freight services, from January 2019 to October 2020 and prior to that, served as our Chief Operating and Financial Officer from June 2018 to January 2019, and as our Chief Business Officer and Chief Financial Officer from March 2017 to June 2018. From April 2016 to September 2016, Ms. Jarrett was the Chief Financial Officer of Medivation, Inc., a biopharmaceutical company, which was acquired by Pfizer Inc. Prior to that, Ms. Jarrett spent 20 years in investment banking, most recently as Managing Director at Citigroup from July 2010 to April 2016, where she was responsible for managing their west coast life sciences investment banking practice. Before that, Ms. Jarrett was a Director and Managing Director at Credit Suisse from 2000 to 2010, and an associate at Donaldson, Lufkin &amp; Jenrette from 1998 to 2000. During her tenure as an investment banker, Ms. Jarrett covered biotechnology and pharmaceutical companies, primarily in the San Francisco Bay Area. She currently serves on the board of directors of Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), Sagimet (Nasdaq: SGMT), Zura Bio Ltd (Nasdaq: ZURA), Cajal Neuroscience and LifeMine Therapeutics and previously served on the boards of directors of Arena Pharmaceuticals, Inc. from July 2017 until its acquisition by Pfizer in March 2022, Audentes Therapeutics from July 2017 until its acquisition by Astellas Pharma Inc. in January 2020, Radius Health, Inc. from May 2022 until its acquisition by Gurnet Point Capital and Patient Square Capital in August 2022 and Consonance-HFW Acquisition Corp. from December 2020 until its business combination with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surrozen Operating, Inc. in August 2021. Ms. Jarrett holds a B.A. in Economics, cum laude, from Dartmouth College and an M.B.A. from Stanford Graduate School of Business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Richard Markus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">joined us in January 2025 to serve as our Chief Medical Officer. Dr. Markus was most recently the Chief Executive Officer of Dantari, Inc. from February 2019 until August 2024, a biotechnology company that developed a novel platform for next generation antibody-drug conjugates. Prior to Dantari, Dr. Markus  served as Vice President, Global Development at Amgen where he led the R&amp;D activities for the Biosimilar Business Unit and held multiple roles from 2006 to 2019 including as Clinical Development Medical Director and served as pre-launch Medical Affairs Lead for denosumab (XGEVA&#174;), for patients with bone metastases from prostate cancer, breast cancer and other solid tumors. Prior to Amgen, Dr. Markus was Sr. Medical Director at Corus Pharma, where he led the phase 2 and phase 3 development of Cayston&#174;. Dr. Markus received his B.S. degree in Cybernetics from UCLA and his M.D. and Ph.D. at the University of Southern California.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Carolyn Tang</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our General Counsel since September 2019, after joining Arcus in 2017. From 2015 to 2017, Ms. Tang was Director of Securities and Transactions at Medivation, Inc., a biopharmaceutical company, where she was responsible for securities, corporate governance and strategic transactions until the company&#8217;s acquisition by Pfizer, Inc. From 2004 to 2015, Ms. Tang was at InterMune, Inc., a biotechnology company focused on pulmonology and orphan fibrotic diseases, ultimately having responsibility for the company&#8217;s global intellectual property portfolio and transactions, and supporting the company&#8217;s corporate and securities activities until its acquisition by Roche Holdings, Inc. Ms. Tang received her law degree from Santa Clara University School of Law and her B.A. in Molecular and Cell Biology, with an emphasis in Neurobiology, from the University of California at Berkeley.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Discussion and Analysis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Compensation Discussion and Analysis provides an overview of the material components of our executive compensation program for the year ended December 31, 2024, for named executive officers, whose compensation is set forth in the Summary Compensation Table and other compensation tables contained in this Proxy Statement. For the year ended December 31, 2024, our &#8220;named executive officers&#8221; are:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Terry Rosen, Ph.D., our Chief Executive Officer;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Robert C. Goeltz, our Chief Financial Officer;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Juan C. Jaen, Ph.D., our President;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Jennifer Jarrett, our Chief Operating Officer; and </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Dimitry S.A. Nuyten, M.D., Ph.D., our former Chief Medical Officer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Nuyten ceased serving as our Chief Medical Officer on January 31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis is intended to enhance your understanding of the information provided in the compensation tables below and to provide additional context regarding our overall executive compensation program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company focused on creating best-in-class therapies. Using our robust and highly efficient drug discovery capability, we have created a significant portfolio of investigational products which are in clinical development, with our most advanced molecule, an anti-TIGIT antibody, now in multiple Phase 3 registrational studies targeting lung and gastrointestinal ("GI") cancers. Our deep portfolio of novel small molecules and enabling antibodies allows us to create highly differentiated therapies, which we are developing to treat multiple large indications. We expect our clinical-stage portfolio to continue to expand and to include molecules targeting immuno-oncology, cancer cell-intrinsic and immunological pathways. Our vision is to create, develop and commercialize highly differentiated therapies that have a meaningful impact on patients.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Say-on-Pay Vote</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our 2024 annual meeting of stockholders, approximately 96% of the votes cast on the say-on-pay proposal voted in support of the compensation paid to our named executive officers for 2023. While this vote was only advisory and not binding, the Compensation Committee believes that the 2024 stockholder vote generally endorsed our compensation philosophy and the decisions made for 2023. As such, we did not make any significant changes to our core compensation philosophies and practices in 2024. We hold a say-on-pay vote on an annual basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Business Highlights </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes key highlights of our corporate performance during our fiscal year ended on December 31, 2024:</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.46pt">Advanced our late-stage programs developing domvanalimab and zimberelimab towards potential commercialization by completing enrollment for STAR-221 several months ahead of schedule. </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Generated and presented compelling data from ARC-20, our Phase 1 study evaluating casdatifan across multiple cohorts. The strength of this data supports further development of casdatifan, and we hope to leverage the interest generated by ARC-20 as we initiate PEAK-1, our Phase 3 study evaluating casdatifan and cabozantinib in second-line, post-immunotherapy (IO) patients with clear cell renal cell carcinoma (ccRCC).</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.75pt">Entered into a clinical collaboration with AstraZeneca to efficiently evaluate casdatifan in combination with volrustomig, AstraZeneca&#8217;s investigational PD-1/CTLA-4 bispecific antibody, in IO-naive patients with ccRCC.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Successfully initiated PRISM-1, our Phase 3 study in metastatic pancreatic cancer evaluating quemliclustat with gemcitabine and nab-paclitaxel (the standard-of-care chemotherapies used for advanced pancreatic cancer) against gemcitabine and nab-paclitaxel. Taiho also exercised its option for quemliclustat for the Taiho Territory and opted to participate in PRISM-1. As a result, Taiho will reimburse us for their portion of the global study costs and operationalize the Japanese sites for the study.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Advanced our early-stage clinical programs by initiating the first expansion cohort evaluation for AB598 with and without zimberelimab and chemotherapy in gastric cancers.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Realized multiple funding opportunities including a $320 million follow-on investment by Gilead in January 2024 and a term loan facility with Hercules that can potentially provide up to $250 million in additional non-dilutive capital. As a result, we ended the year with a cash runway into mid-2027.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Philosophy and Objectives</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goals of our executive compensation program are to align our executive officers&#8217; compensation with our corporate objectives and the interests of our stockholders. To do this, we focus on the following principles to guide decisions regarding executive compensation:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Competitive Total Compensation Package</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for qualified employees, including executive officers, both in the San Francisco Bay Area (where our principal offices are located) and in the pharmaceutical and biotechnology industries, where competition for talented employees is fierce. We strive to offer a market-competitive compensation package that enables us to attract and retain superior executive officers and other employees with outstanding skills and values who contribute to our long-term success. </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Pay-for-Performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We structure our executive compensation program so that executives are appropriately incentivized to achieve our annual corporate goals and longer-term business strategies and objectives. The annual bonus and equity awards for our executive officers are determined based on an assessment of the company's performance and such executive officer&#8217;s contribution to the achievement of the company's goals and objectives.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Alignment with Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use equity-based awards to align executive incentives with the creation of stockholder value. For our executive officers, our equity awards are predominately weighted towards options as we believe that options provide a strong alignment with our stockholders&#8217; interests because their entire value depends on future stock price appreciation; to a lesser extent we also grant restricted stock units (&#8220;RSUs&#8221;) as we believe that RSUs also promote retention and allow us to deliver value while using fewer authorized shares.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Flexibility, Simplicity and Parity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation program is intended to be flexible so that we can adapt to rapid changes in the competitive environment for executives in the biotechnology industry and simple in design to facilitate communication, understanding and administration. We also strive to provide internal parity for similarly situated executives within the company.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Avoidance of Excessive Perquisites</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In general, we do not offer our executive officers any enhanced benefits or perquisites as compared to our overall employee population. However, from time-to-time, we may provide a perquisite if appropriate and also determined by our Compensation Committee to be aligned with the overall interests of the company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Executive Compensation Process</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee oversees the compensation policies, plans, and programs for all of our employees generally, but only reviews and specifically approves the compensation for our executive officers. In making its executive compensation determinations, our Compensation Committee considers evaluations of performance and recommendations from our Chief Executive Officer (except with respect to his own performance and compensation). The Compensation Committee considers our Chief Executive Officer&#8217;s input in executive sessions and can accept, reject or modify these recommendations in its discretion. The Compensation Committee may consult with compensation consultants, legal counsel and other advisors in designing our compensation program, including in evaluating the competitiveness of individual compensation packages.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A key objective of our executive compensation program is to ensure that the overall compensation packages we offer our executive officers remain competitive with the packages offered by companies with which we compete for executive talent. Accordingly, our Compensation Committee, with the assistance of its compensation consultant, Radford, has developed a peer group of companies to serve as a reference for our Compensation Committee when designing and evaluating our executive compensation program to the market. The Compensation Committee annually reviews the composition of the peer group to account for changes in both our business and the businesses of the companies in the peer group, considering: </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Industry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: biopharmaceutical companies, with a therapeutic focus on oncology; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Stage of Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: clinical-stage companies, with an emphasis on companies in late-stage clinical development; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Market Capitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: market capitalization of between $500.0 million to $5.0 billion;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Headcount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: headcount between 150 and 1,500 employees, with such outer range representing approximately 3 times our size at the time of review; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt;text-decoration:underline">Geography</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: geographically situated in a biotechnology hub within the U.S., with a preference for those located in Northern California.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this review, the Compensation Committee approved the <span id="icc2494da21244caaac1fc3f4262a3d24_22505"></span>peer group set forth below to help set executive compensation for our fiscal year 2024, which differed from the prior year peer group as BridgeBio Pharma, Inc., Day One Biopharmaceuticals, Inc. and ImmunityBio, Inc. were added and Apellis Pharmaceuticals, Inc., Fate Therapeutics Inc., ImmunoGen, Inc. and Revance Therapeutics Inc. were removed. The changes to our peer group from the prior year are largely due to changes in stage of development and market capitalization.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agios Pharmaceuticals Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alector, Inc.  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allogene Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrowhead Pharmaceutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BridgeBio Pharma, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cytokinetics, Incorporated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Day One Biopharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denali Therapeutics Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ImmunityBio, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intella Therapeutics Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iovance Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kura Oncology, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mirati Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prothena Corporation Plc</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REGENXBIO Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SpringWorks Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Syndax Pharmaceuticals Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xencor Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Elements of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program generally consists of three principal components:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">base salary; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">short-term incentives in the form of an annual cash bonus opportunity; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">long-term incentives in the form of equity incentive awards (stock options and RSUs). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our pay-for-performance philosophy, a substantial portion of executive compensation is variable and at risk. However, we do not have any formal policies for allocating compensation among salary, cash bonus opportunity and equity incentives, or among cash and non-cash compensation. Instead, the Compensation Committee uses its judgment to establish a total compensation program for each executive officer that it believes is appropriate to achieve the goals of our executive compensation program and our corporate objectives. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Base salary is intended to provide financial security through a fixed amount of cash compensation to compensate our executive officers for performing their day-to-day duties and responsibilities. We believe this balances against the impact of having the remainder of their compensation at risk in the form of annual cash bonuses and equity-based incentive compensation. The Compensation Committee establishes base salary amounts based on a number of factors, including the scope of the executive officer&#8217;s responsibilities, experience, achievements, leadership, teamwork and value to us, and the committee's review of market data from peer companies provided by our compensation consultant, Radford. The Compensation Committee reviews the base salary of each of our executive officers on at least an annual basis and may make discretionary adjustments from time to time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024, Dr. Rosen received a base salary of $725,000 (an increase of $75,000 from the prior year), Mr. Goeltz received a base salary of $510,000 (an increase of $20,000 from the prior year), Dr. Jaen received $625,000 (an increase of $50,000 from the prior year), Ms. Jarrett received $625,000 (an increase of $50,000 from the prior year) and Dr. Nuyten received $585,000 (an increase of $23,000 from the prior year).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Bonus </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash bonus is intended to motivate and reward our executive officers for attaining rigorous annual corporate performance goals that relate to our key business objectives. The Compensation Committee generally reviews annually the target bonus amounts, calculated as a percentage of base salary, which are determined based on the scope of the executive officer&#8217;s responsibilities, experience, achievements, leadership, teamwork and value to us and after referencing market data </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from peer companies provided by our compensation consultant, Radford, generally referencing the 50th to 75th percentile. The Compensation Committee determines actual bonus amounts earned after the end of the year based on our overall performance and each individual&#8217;s achievement and contributions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our annual corporate performance goals are typically established around the beginning of each year. Management prepares a set of goals covering corporate, development and financial objectives and key activities, which is then reviewed and, following any modification the Compensation Committee deems appropriate, approved by our Compensation Committee. For 2024, our Compensation Committee approved corporate performance goals, which included: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">maintaining timelines associated with our Phase 3 studies STAR-121 and STAR-221;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">initiating a Phase 3 study for quemliclustat in pancreatic cancer; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">generating data supportive of our development plans for casdatifan;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">advancing our early-stage clinical portfolio, which includes AB801 and AB598, through dose escalation and potentially into expansion cohorts; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">securing funding to support a significant cash runway that extends through mid-2027.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not disclose the specific portions or weighting of these goals, because they include highly sensitive and competitive data, and therefore, we believe that such disclosure would result in competitive harm to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee does not use a formula to calculate any individual&#8217;s performance. Rather, it evaluates the totality of the company&#8217;s achievements relative to its corporate goals, overall progress and performance and contribution towards the creation of long-term stockholder value, and each individual's contributions. Achievements considered by the Compensation Committee include the &#8220;2024 Business Highlights&#8221; discussed above and the 2024 bonuses approved by the Compensation Committee for each named executive officer are set forth below: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name and Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024 Bonus Target</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(%)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024 Bonus Target</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Bonus Payout for 2024 Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D., Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">616,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">615,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Robert C. Goeltz, II, Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">229,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">230,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D., President</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jennifer Jarrett, Chief Operating Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dimitry Nuyten, M.D., Ph.D., former Chief Medical Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">263,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Dr. Nuyten terminated employment with us on January 31, 2025. The 2024 bonus payout reported here was made pursuant to our Severance Benefits Plan. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:120%">Severance and Change in Control Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">below for more information. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee considered our 2024 achievements, particularly the acceleration of enrollment for STAR-221 and the overall progress of our clinical development pipeline, which the Committee considered critical to the company&#8217;s success. In recognition of Dr. Rosen&#8217;s leadership of the company, the Compensation Committee awarded him a bonus in the amount set forth in the table above. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Mr. Goeltz, key performance highlights included ongoing, real-time assessment of our budget and cash forecast throughout 2024, which allowed us to efficiently assess strategic decisions around clinical programs with a high degree of confidence. As part of this effort, Mr. Goeltz led a strategic planning exercise to align our broad portfolio of molecules and clinical trials against a scenario analysis, including timing and other critical variables, with the corresponding capital requirements. The results of the exercise enabled us to do a holistic evaluation of our plans and support our fund-raising strategy and efforts in 2024, leading to transactions that extended our cash runway in which Mr. Goeltz further played a seminal role in their tactical execution. Mr. Goeltz's leadership, strategic planning and foresight have been and continue to be critical to ensuring that we optimize the financial components and opportunities associated with our relationships with our multiple collaboration partners.  Given the breadth of our portfolio of programs and the number of late-stage molecules and programs, these analyses were essential in creating operational plans that were prudent and efficient but also leveraged the opportunities inherent in the pipeline. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Dr. Jaen, key performance highlights included continued productivity of our discovery platform, including the advancement of new programs that are applicable to inflammatory disease and are central to the inflammation collaboration that we forged with Gilead in 2023. Dr. Jaen also led our translational efforts, which continued to generate data across our late-stage programs and are particularly important in linking the biology and mechanism of our molecules to their clinical activity.  In the casdatifan program, his team generated data that established unambiguous differentiation from our major competitor in this field.  Dr. Jaen continues to play the central role in bringing mechanism of action </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">perspectives to decision making affecting our selections of combinations, settings and trial design across our portfolio of programs.  Dr. Jaen also led our CMC efforts, which are unusually substantial and complicated for a company at our stage, given the number of late-stage trials that we have ongoing, as well as integrating the efforts and needs of our collaboration partners to optimize efficiency and cost.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Ms. Jarrett, key performance highlights included continued leadership of our corporate governance framework to enable the most efficient planning, decision-making and execution of our clinical development plan and integration of these efforts with our partners including Gilead, Taiho and AstraZeneca. These efforts were evident in the advancement of our clinical programs involving casdatifan, domvanalimab and quemliclustat, all in or near Phase 3 registrational trials.  Ms. Jarrett&#8217;s leadership and efforts on the corporate development and the medical affairs fronts, both strategic and tactical, led to a key new collaboration with AstraZeneca around our HIF-2a inhibitor casdatifan and to data disclosures that generated strong investigator enthusiasm that will facilitate enrollment in our broad clinical program for this molecule. She has also led our early preparatory efforts to be ready to launch and commercialize our initial product candidates, particularly in working with Gilead to prepare for the potential launch of the domvanalimab/zimberelimab combination therapy.  She also was central in negotiating the Gilead equity investment in January 2024 and Hercules term loan facility that extended our cash runway into mid-2027.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentives </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that equity grants provide our executives with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executives and our stockholders. Therefore, equity awards represent the largest at-risk component of our executive compensation program. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our 2024 annual equity awards, the Compensation Committee approved awards of $7.5 million, $3.0 million, $3.0 million and $2.1 million for Dr. Rosen, Dr. Jaen, Ms. Jarrett and Mr. Goeltz, respectively. These awards were approved at the Compensation Committee's meeting in the first quarter of 2024 following completion of our annual performance review process. We do not time the grant of our equity awards to be in advance of the announcement of any material information. In determining the aggregate value of the equity awards granted to our executive officers, the Compensation Committee considers a number of factors, including corporate and individual performance, current equity holdings and their retention value and total ownership, historical value of our stock, internal equity amongst executives and market data provided by Radford. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our 2024 annual equity awards, our Compensation Committee determined that the appropriate mix for equity grants to our executive officers be split, with approximately 67% of the value delivered in the form of stock options and 33% of the value delivered in the form of RSUs. The Compensation Committee believes that this equity mix helps to ensure long-term performance and strong alignment with our stockholders&#8217; interests because their value predominantly depends on future stock price appreciation. Including RSUs also promotes retention and allows us to deliver value while using fewer authorized shares. In sizing the  equity grants, our Compensation Committee approves a value. To mitigate the impact of stock price volatility on the number of options and RSUs to be granted, the number of each type of award to be granted is determined based on a 30-day average stock price. For the grant date fair value of the stock options and RSUs we granted, please see the Summary Compensation Table and 2024 Grants of Plan-Based Awards Table below.  </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers are eligible to participate in our health and welfare plans to the same extent as are all full-time employees generally. We have established a 401(k) tax-deferred savings plan, which permits participants, including our executive officers, to make contributions by salary deduction pursuant to Section 401(k) of the Internal Revenue Code of 1986, as amended. We are responsible for administrative costs of the 401(k) plan. For the 2024 plan year, we matched 100% of the participant&#8217;s salary deferrals up to 6% of their salary and a maximum of $5,000 per participant for the plan year. In addition, we provided a health and wellness and mobile device management stipend of $600 per quarter for each eligible employee. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Arrangements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an offer letter with each of our named executive officers.  Each offer letter includes the named executive officer&#8217;s initial base salary, target bonus opportunity and equity award.  Each offer letter also includes severance benefits, which have been superseded by our severance program described below under the heading &#8220;Severance and Change in Control Benefits&#8221;. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax and Accounting Treatment of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section 162(m) of the Internal Revenue Code (&#8220;Section 162(m)&#8221;), compensation paid to each of our &#8220;covered employees&#8221; that exceeds $1 million per taxable year is generally non-deductible. For these purposes, a &#8220;covered employee&#8221; means anyone who served as our principal executive officer at any time during the year, anyone who served as </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our principal financial officer at any time during the year, and any employee who is among the three highest compensated executive officers for the taxable year (other than the principal executive officer and principal financial officer), regardless of whether the executive officer is serving at the end of the taxable year and regardless of whether the executive officer&#8217;s compensation is subject to disclosure for the last completed fiscal year under the applicable SEC rules. In addition, once an individual becomes a covered employee, that individual will remain a covered employee for all future years, including following any termination of employment. Although our Compensation Committee will continue to consider tax implications as one factor in determining executive compensation, our Compensation Committee also looks at other factors in making its decisions and retains the flexibility to provide compensation for the our named executive officers in a manner consistent with the goals of our executive compensation program and the best interests of the company and its stockholders, which may include providing for compensation that is not deductible by us due to the deduction limit under Section 162(m).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to considering the income tax consequences, our Compensation Committee considers the accounting consequences of its decisions, including the impact of expenses being recognized in connection with stock awards, in determining the size and form of different stock awards. </span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows compensation awarded to or paid to, or earned by, our named executive officers for the fiscal years ended December 31, 2024, 2023 and 2022: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:19.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Bonus<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-Equity Incentive Plan </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">All Other<br/>Compensation<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>($)</span></td></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Chief Executive Officer</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#160;and Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">725,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,544,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,380,960&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">615,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,544&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,279,504&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,327,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,582,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">550,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,120,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">350,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,146,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,145,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,048,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">510,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">339,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">934,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">230,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,023,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">490,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">748,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,120,458&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">220,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,587,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">470,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">511,965&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,396,675&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">270,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,653,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">President</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">625,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">617,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,752,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">315,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,324,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">575,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,008,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,852,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,750,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">550,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,032,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,793,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">370,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,756,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Chief Operating Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">625,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">617,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,752,816&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">315,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,319,110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">575,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,008,516&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,852,338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">300,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,744,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">550,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,032,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,793,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">370,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,750,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Dimitry Nuyten, M.D., Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Chief Medical Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">585,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">432,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,227,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">261,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,506,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">562,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">748,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,120,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,692,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,105,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,114,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">160,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,605,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The amount represents the aggregate grant date fair value of restricted stock units on the date of grant, computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining fair values for restricted stock unit awards are described in Note 8 to our financial statements included in our Annual Report. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The amount represents the aggregate grant date fair value of stock options computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining fair values for option awards are described in Note 8 to our financial statements included in our Annual Report. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Dr. Nuyten terminated employment with us on January 31, 2025.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The amount includes $7,144 life insurance premiums paid by the company for the executive's benefit and $5,000 in 401(k) matching contributions.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The amount includes $250,000 severance payment and $5,000 in 401(k) matching contributions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Grants of Plan-Based Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows certain additional information regarding grants of plan-based awards to our named executive officers for the 2024 fiscal year:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Future Payouts Under Non-Equity Incentive Plan Awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Stock Awards: </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares of Stock or Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Option </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards: Number of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities Underlying </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise or Base Price of <br/>Option Award</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant-Date Fair Value of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock and Option Award </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Award Type</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ per share)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Option</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">405,900&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,380,960&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,544,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">616,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Option</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">86,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">934,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">339,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bonus</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">229,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Juan Carlos Jaen,</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ph.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Option</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">162,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,752,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">617,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Option</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">162,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,752,816&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">617,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bonus</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dimitry Nuyten,</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">M.D., Ph.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Option</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">113,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,227,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">432,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">263,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Reflects the target award each named executive officer was eligible to receive. Actual amounts paid in early 2025 are presented in the Summary Compensation Table above. There were no threshold or maximum amounts established. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Each restricted stock unit award vests as to 25% of the restricted stock units comprising the grant on each anniversary of December 15, 2024, subject to continued service.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"> Each stock option vests as to 1/48th of the total number of shares underlying the stock option on each monthly anniversary of January 1, 2024, subject to continued service.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Represents the grant-date fair value of each equity award, calculated in accordance with FASB ASC Topic 718. The valuation assumptions used in determining fair values for equity awards are described in Note 8 to our financial statements included in our Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at 2024 Fiscal Year End </span></div><div style="margin-top:6pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows certain information regarding outstanding equity awards of our named executive officers as of December 31, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Grant<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Number of Securities Underlying<br/>Unexercised Options</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Option<br/>Exercise<br/>Price<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Option<br/>Expiration<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Number of<br/>Shares or Units<br/>That Have Not<br/>Yet Vested<br/>(#)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Market Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares or Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">That Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Yet Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">($)</span></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Exercisable<br/>(#)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Unexercisable<br/>(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" rowspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/16/2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100,175&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10.36&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/17/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">183,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/16/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/19/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">161,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/18/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">137,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/7/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">205,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">223,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">93,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">312,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">223,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">786,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,116,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="8" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8/3/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8/2/2030</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/19/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73,438&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/18/2031</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">45,573&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,927&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/7/2032</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2033</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2034</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">57,699&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">253,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">245,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Juan Carlos Jaen,<br/>Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/16/2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/15/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/17/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/16/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/19/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">113,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/18/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">91,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/7/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">89,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">96,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">125,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">116,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">340,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">446,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/15/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">181,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/14/2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/4/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">107,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/3/2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/8/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">161,114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/7/2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/14/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/13/2029</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/6/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/5/2029</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/4/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6/3/2030</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10/1/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">900,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9/30/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">91,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/7/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">89,077&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">96,823&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2033</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">125,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2034</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3/8/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">116,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">340,981&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">446,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" rowspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Dimitry Nuyten,<br/>M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">99,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">70,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8/22/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">87,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/22/2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">316,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">253,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">312,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">For the purpose of determining market value, we assumed a stock price of $14.89, the closing sale price per share of our common stock on December 31, 2024, the last business day of our last fiscal year.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The shares subject to this option vest in 48 substantially equal monthly installments commencing on January 1 of the year of grant provided the officer remains in our continuous service through each vesting date. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The shares subject to this option are fully vested.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The shares subject to this option vest in 48 substantially equal monthly installments commencing on August 1, 2022, provided the officer remains in our continuous service through each vesting date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The shares subject to this RSU award vest in four equal annual installments commencing December 15 of the year of grant, provided the officer remains in our continuous service through each vesting date. Accordingly, the number of shares in the table reflect only those shares subject to the RSU award that remain unvested.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The shares subject to this RSU award vest in four equal annual installments commencing September 15, 2023, provided the officer remains in our continuous service through each vesting date. Accordingly, the number of shares in the table reflect only those shares subject to the RSU award that remain unvested.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Option Exercises and Stock Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no exercises of stock options by the named executive officers during the year ended December 31, 2024. The below table describes the number of shares acquired upon vesting of RSUs for the named executive officers during the year ended December 31, 2024.</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of shares acquired on vesting<br/>(#)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value realized on vesting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99,743</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,626,117&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,855</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">781,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129,262</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,220,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dimitry Nuyten, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,125</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">439,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The amount represents the closing market price of our common stock on the vesting date multiplied by the number of shares of common stock that vested on that date.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severance and Change in Control Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides the potential payments that each of our named executive officers would have received under our severance benefits plan (i) in the event of termination without cause or (ii) in the event of termination without cause or by the named executive officer for good reason in connection with a change in control. The amounts below assume that the triggering event occurred on December 31, 2024 and that when discretionary, the Company elects to pay consideration for the named executive officer's bonus.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in Control</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Not in Connection with a Change in Control</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash Severance<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Health Benefits<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity Acceleration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash Severance<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Health Benefits<br/>($)</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,450,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">616,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">67,195&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,127,498&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,260,943&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">725,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">616,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,598&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,374,848&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Robert C. Goeltz, II</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,020,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">229,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">95,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">556,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,901,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">510,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">229,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">47,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">787,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Juan Carlos Jaen, Ph.D.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">67,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">904,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,533,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">625,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">971,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jennifer Jarrett</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">904,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,521,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">625,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">312,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">965,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dimitry Nuyten, M.D., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,170,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">263,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">62,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">882,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,377,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">585,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">263,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">879,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The value of the equity acceleration would be equal to the shares multiplied by (i) in the case of options, the excess of the then current stock price over the exercise price of the options and (ii) in the case of RSUs, the then current stock price. For the purposes of this table, we have calculated the value of the acceleration using a stock price of $14.89, the closing sale price per share of our common stock on December 31, 2024, the last business day of our last fiscal year.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Dr. Nuyten&#8217;s employment with us was involuntarily terminated on January 31, 2025.  In exchange for a release of claims, pursuant to our severance program, we paid Dr. Nuyten a lump sum of $585,000, which was 12 months of his base salary and a lump sum of $250,000 in lieu of his 2024 bonus and will make payments for COBRA healthcare premiums for a total 12 months from the date of his termination. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the severance program approved by the Compensation Committee, in the event that a named executive officer is terminated without cause, the named executive officers would be entitled to received: (a) a cash lump-sum payment equal to 12 months (the "Severance Period") of the eligible employee's base salary; and (b) continued Company-paid coverage under our benefit plans, subject to timely COBRA election, for the Severance Period (or until the expiration of the eligible employee's continuation coverage under COBRA or the eligible employee secures employment with similar benefits). We may, but are not required to (as determined in our sole discretion), pay the officer a lump-sum cash amount equal to their prorated annual target bonus. In the event such termination occurs within twelve months following a change in control, (a) the Severance Period will be increased to twenty-four months, (b) the officer will be entitled to 100% of their target annual bonus for the year of termination and (c) all of the officer's then outstanding equity awards will vest. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all events, in order to receive the payments and benefits, the officer will be required to, among other things, execute and not revoke a general release of claims against the company and certain related parties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cause means the employee&#8217;s:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">unauthorized use or disclosure of our confidential information or trade secrets, which use or disclosure causes material harm to us;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">material breach of any agreement with us;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">material failure to comply with our written policies or rules;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony under the laws of the United States or any State; </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">gross negligence or willful misconduct;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">continuing failure to perform assigned duties after receiving written notification of the failure from us or the Board; or</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">failure to cooperate in good faith with a governmental or internal investigation of us or our directors, officers or employees, if we have requested such cooperation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Good reason means a resignation of employment within 12 months after one of the following conditions has come into existence without the officer&#8217;s consent, which remains uncured more than 30 days after delivery of notice to us of such condition within 90 days following our receipt of the officer's notice of the initial existence of such condition:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a reduction in the officer&#8217;s annual base salary by more than 10%, other than a general reduction that is part of a cost-reduction program that affects all similarly situated employees in substantially the same proportions;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a relocation of the officer&#8217;s principal workplace by more than 25 miles from its location prior to a change in control; or</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a material reduction of responsibilities, authority or duties, provided that neither a mere change in title alone nor reassignment following a change in control to a position that is similar to the position held prior to the change in control shall constitute a material reduction in job responsibilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in control means certain mergers or consolidations of us with or into another entity; a sale, conveyance or other disposition of all or substantially all of our assets, property or business; or the acquisition by any person or persons acting as a group of beneficial ownership (or a right to acquire beneficial ownership) of shares representing a majority of the voting power of the then-outstanding shares of our capital stock.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Pay Ratio</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under SEC rules, we are required to calculate and disclose the ratio of our median employee&#8217;s annual total compensation to the annual total compensation of Dr. Rosen, our Chief Executive Officer. For the fiscal year ended December 31, 2024, the total compensation for Dr. Rosen was $7,279,504 as reported in the Summary Compensation Table, whereas the total compensation for our median employee was $243,173 resulting in a pay ratio of approximately 29.9 to 1.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified median employee by use of a &#8220;consistently applied compensation measure&#8221; (CACM) that closely approximates the annual target total direct compensation of our employees. Specifically, we identified the median employee by aggregating, for each employee (other than Dr. Rosen) as of November&#160;15, 2024: (i) annual base pay, (ii) annual target cash incentive opportunity, and (iii) the grant date fair value for equity awards granted in 2024. After applying our CACM methodology, we identified the median employee. Once the median employee was identified, we calculated the median employee&#8217;s annual total compensation in accordance with the requirements of the Summary Compensation Table.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules, based on our internal records and the methodology described above. The SEC rules for identifying the median compensated employee allow companies to adopt a variety of methodologies, to apply certain exclusions and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices. Accordingly, the pay ratio reported by other companies may not be comparable to the pay ratio reported above, as other companies have different employee populations and compensation practices and may use different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios. Neither the Compensation Committee nor management uses the CEO Pay Ratio measure in making compensation decisions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay versus Performance</span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-12" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses additional compensation information of (i) our Chief Executive Officer and (ii) all other named executive officers (the "Other NEOs"), including &#8220;compensation actually paid&#8221; during the specified years alongside total shareholder return ("TSR") and net income metrics:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of initial fixed $100 investment based on:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary compensation table total for CEO<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation actually paid to CEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average summary compensation table <br/>total for Other NEOs<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Compensation actually paid to Other </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total shareholder return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer group total shareholder return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ millions) </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">7,279,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">4,803,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">2,793,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">1,696,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-17">147.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-18">95.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-19">283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-20">10,120,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-21">7,480,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">4,193,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">2,953,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-24">194.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-25">94.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-26">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-27">9,048,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-28">2,065,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-29">4,191,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">2,394,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-31">204.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-32">87.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-33">267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">9,483,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">14,577,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-36">5,939,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">7,091,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-38">400.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-39">117.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-40">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-41">5,685,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-42">12,015,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-43">5,363,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-44">10,455,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-45">257.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-46">148.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-47">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-48" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Our Chief Executive Officer for each of the years presented was <ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-49"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-50"><ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-51">Dr. Rosen</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>. Our Other NEOs for 2024, 2023 and 2022 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett and Dimitry Nuyten. Our Other NEOs for 2021 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett, Carolyn Tang and William Grossman. Our Other NEOs for 2020 were Jennifer Jarrett and William Grossman.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-52" continuedAt="f-52-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Fair value or change in fair value, as applicable, of equity awards in the "compensation actually paid" columns was determined by reference to (i) for RSU awards, closing price on applicable year-end dates or, in the case of vesting dates, the actual vesting price and (ii) for stock options, the fair value estimated using a binomial lattice model as of the applicable year-end or vesting date(s). Key inputs included the contractual terms of each agreement such as vesting date, maturity date, and exercise price, while additional key inputs included the closing stock price, volatility, dividend rates, risk free rates, and an early-exercise factor which were all determined as of the revaluation date.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-53" continuedAt="f-53-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The adjustments made to the summary compensation table total for Dr. Rosen for each year presented above to determine compensation actually paid to Dr. Rosen in such year are shown in the tables below:</span></ix:nonNumeric></div><ix:continuation id="f-53-1"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary compensation table total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">7,279,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">10,120,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">9,048,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-57">9,483,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-58">5,685,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, value of stock &amp; option awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-59">5,924,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">8,909,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">8,292,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">8,548,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">5,356,475</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus year-end value of awards granted in fiscal year that are unvested and outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-64">4,156,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-65">5,634,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-66">3,788,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-67">7,142,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-68">7,893,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change in fair value of prior year awards that are outstanding and unvested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-69">1,390,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-70">573,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-71">5,490,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-72">3,923,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-73">1,828,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus FMV as of the vesting date of awards granted this year and that vested this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-74">1,363,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-75">1,648,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-76">1,608,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-77">1,783,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-78">1,108,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-79">679,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-80">439,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-81">2,728,104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-82">794,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-83">856,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-84">2,476,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-85">2,640,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-86">11,113,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-87">5,094,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-88">6,329,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Compensation actually paid to CEO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-89">4,803,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-90">7,480,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-91">2,065,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-92">14,577,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-93">12,015,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-94" continuedAt="f-94-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The adjustments made to the average summary compensation table total for Other NEOs for each year presented above to determine average compensation actually paid to Other NEOs in such year are shown in the tables below:</span></ix:nonNumeric></div><ix:continuation id="f-94-1"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary compensation table total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-95">2,793,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-96">4,193,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-97">4,191,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-98">5,939,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-99">5,363,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, value of stock &amp; option awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-100">1,918,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-101">3,364,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-102">3,444,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-103">5,298,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-104">4,864,788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus year-end value of awards granted in fiscal year that are unvested and outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-105">1,345,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-106">2,127,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-107">1,848,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-108">3,797,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-109">6,969,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change in fair value of prior year awards that are outstanding and unvested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-110">591,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-111">367,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-112">4,050,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-113">2,678,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-114">1,656,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus FMV as of the vesting date of awards granted this year and that vested this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-115">441,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-116">622,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-117">528,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-118">1,094,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-119">509,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-120">374,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-121">257,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-122">1,467,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-123">678,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-124">820,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, prior year fair value of prior year awards that failed to vest this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-128">1,827,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus adjustments for stock modification</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-133">29,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-135">1,097,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-136">1,240,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-137">6,585,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-138">1,152,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-139">5,091,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Compensation actually paid to Other NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-140">1,696,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-141">2,953,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-142">2,394,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-143">7,091,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-144">10,455,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:PeerGroupIssuersFnTextBlock" id="f-145" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-146" escape="true">TSR figures assume an initial investment in our common stock of $100 on December 31, 2019.</ix:nonNumeric> The peer group referenced for purpose of the TSR comparison is the group of companies included in the S&amp;P Biotechnology Index, which is the industry peer group used for purposes of Item 201(e) of Regulation S-K. The separate peer group used by the Compensation Committee for purposes of determining compensation paid to our executive officers is described on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:none" href="#icc2494da21244caaac1fc3f4262a3d24_22505">26</a>.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">R<ix:continuation id="f-52-1">eflects after-tax net income attributable to stockholders prepared in accordance with GAAP for each of the years shown.</ix:continuation></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Analysis of the Information Presented in the Pay versus Performance Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above under &#8220;Compensation Discussion and Analysis,&#8221; our executive compensation program is built around a pay-for-performance framework. While we utilize various performance measures to align executive compensation with company performance, these measures are focused on the clinical development of our investigational products and, as such, are non-financial in nature. Moreover, we generally seek to incentivize long-term performance, and therefore do not specifically align the company&#8217;s performance measures with compensation that is actually paid (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year. As a result, we do not have a financial performance measure as described in Item 402(v)(2)(vi) of Regulation S-K to link compensation actually paid to our performance. The most important performance measures that we use to link executive compensation actually paid to our named executive officers, for the most recently completed fiscal year, to company performance are as follows:</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Expansion of our co-development programs with our strategic partners;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Initiation of new registrational trials;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Demonstrating proof of concept for investigational products;</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Nomination of new development candidates; and</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Efficient utilization of our resources in the advancement and execution of our clinical programs and pipeline.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-147" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-148" continuedAt="f-148-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years: </span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:center"><img src="rcus-20250422_g1.jpg" alt="4027" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/></div></ix:nonNumeric><ix:continuation id="f-148-1"><div style="margin-top:6pt;text-align:center"><img src="rcus-20250422_g2.jpg" alt="4029" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All information provided above under the &#8220;Pay Versus Performance&#8221; heading will not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent we specifically incorporate such information by reference.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the Compensation Committee currently consists of Dr. Kaneko, Dr. Lacey and Ms. Lambert. None of the members of our Compensation Committee has at any time during the past three years been one of our officers or employees. None of our executive officers currently serve or in the prior three years has served as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on the Board or Compensation Committee. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION OF DIRECTORS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Compensation Program for Non-Employee Directors, we pay each of our non-employee directors annual cash retainers, paid quarterly in arrears, as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Prior to<br/>June 6, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Subsequent to<br/>June 6, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retainer for each non-employee member of the Board:</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for Lead Independent Director:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for Chair of Audit Committee:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for Chair of Compensation Committee:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for Chair of Science Committee:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for Chair of Nominating and Corporate Governance Committee:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for non-Chair members of Audit Committee:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for non-Chair members of Compensation Committee:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for non-Chair members of Science Committee:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional retainer for non-Chair members of Nominating and Corporate Governance Committee:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Compensation Program for Non-Employee Directors, we automatically grant an initial equity award having a grant date fair value of approximately $750,000 on the date the person becomes a director of the company. Further, we automatically grant an annual equity award having a grant date fair value of approximately $400,000 on the date of our annual meeting of stockholders. Initial and annual equity awards will be split between stock options and RSUs, with approximately 2/3 of the value delivered through stock options and the remaining 1/3 through RSUs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted as part of an initial or annual equity award will have an exercise price equal to the Fair Market Value (as defined in our 2018 Equity Incentive Plan) on the date of grant. Subject to the director&#8217;s continuous service on the Board, initial option awards shall vest and become exercisable in substantially equal monthly installments over 36 months and initial RSU awards shall vest in three substantially equal annual installments. Subject to the director&#8217;s continuous service on the Board, annual option and RSU awards will vest and become exercisable in full on the earlier of (i) the date that is 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. Initial and annual equity awards will become fully vested and exercisable in the event that we are subject to a change in control. The foregoing notwithstanding, a new director who has received an initial equity award will not in the same calendar year receive an annual equity award. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Compensation for Fiscal 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information about the compensation of the non-employee members of the Board who served as a director during the year ended December 31, 2024. We did not pay any compensation for service as a director to Dr. Rosen, Dr. Jaen, Ms. Jarrett, Dr. Higgins, Ms. Mercier or Dr. Parsey in the year ended December 31, 2024.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fees Earned or<br/>Paid in Cash<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kathryn Falberg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,037&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">474,609&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">498,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Lacey, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicole Lambert</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">456,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick Machado, J.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">451,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">484,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antoni Ribas, M.D. Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">473,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:20.02pt">The amount represents the aggregate grant date fair value of restricted stock units granted during the fiscal year computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining such amounts are described in Note 8 to our financial statements included in our Annual Report. </span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:20.02pt">The amounts in this column reflect the aggregate grant date fair value of each option award granted during the fiscal year computed in accordance with FASB ASC Topic 718. The valuation assumptions used in determining such amounts are described in Note 8 to our financial statements included in our Annual Report.  The below table summarizes the options to purchase shares of our common stock and the unvested restricted stock units held by our non-employee directors at December 31, 2024:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares Subject to Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares Subject to Restricted Stock Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kathryn Falberg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yasunori Kaneko, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Lacey, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nicole Lambert</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick Machado, J.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Perlman, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antoni Ribas, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:20.02pt">Consists of cash compensation for service on our advisory boards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY COMPENSATION PLAN INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides certain information regarding our equity compensation plans in effect as of December 31, 2024 (in millions, except per share amounts):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity Compensation Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities to be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issued Upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Warrants or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rights (a)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Warrants or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rights </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ per share) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Remaining<br/>Available for<br/>Future Issuance<br/>Under Equity<br/>Compensation<br/>Plans<br/>(Excluding<br/>Securities<br/>reflected in<br/>Column (a))<br/>(c)<br/>(#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Approved by Stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18.82&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not Approved by Stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9.0</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Excludes 0.3 million shares, the maximum number of shares that could be purchased in the ongoing offering period under our 2018 Equity Incentive Plan (2018 Plan) as of December 31, 2024.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The weighted-average exercise price excludes shares subject to outstanding restricted stock units, which have no exercise price. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The number of shares remaining available for future issuance includes shares available under our 2018 ESPP and shares available under our 2018 Employee Stock Purchase Plan (2018 ESPP). As of December 31, 2024, a total of 2.7 million shares remained available for future issuance under the 2018 ESPP, of which approximately 0.3 million shares are subject to purchase during the current purchase period. The maximum number of shares subject to purchase rights under the 2018 ESPP is a function of stock price and total employee contributions as of the purchase date. As such, we cannot reasonably determine the number of shares subject to purchase rights as of December 31, 2024, and such shares are not reflected in the amount subject to rights outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Represents shares of our common stock issuable pursuant to the 2020 Inducement Plan (2020 Plan). The Board adopted the 2020 Plan in January 2020, as subsequently amended, pursuant to which we reserved a total of 9.0 million shares of our common stock for issuance under the 2020 Plan. The only persons eligible to receive grants of Awards under the 2020 Plan are individuals who satisfy the standards for inducement grants under NYSE Listed Company Manual Rule 303A.08; that is, generally, a person not previously an employee or director of Arcus, or following a bona fide period of non-employment, as an inducement material to the individual's entering into employment with us. An &#8220;Award&#8221; is any right to receive Arcus common stock pursuant to the 2020 Plan, consisting of non-statutory stock options, stock appreciation rights, restricted stock awards, RSUs, or any other stock award.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock reserved for issuance under the 2018 Plan automatically increases on January 1 of each year during the term of the 2018 Plan by the lesser of (i) 3.6 million shares, (ii) 4% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year or (iii) a number of shares determined by the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock reserved for issuance under the 2018 ESPP automatically increases on January 1 of each year during the term of the 2018 ESPP by the lesser of (i) 1.1 million shares, (ii) 1% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or (iii) a  number of shares determined by the Board.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PERSON TRANSACTIONS</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_136"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee has the primary responsibility for the review, approval and oversight of any &#8220;related party transaction,&#8221; which is any transaction, arrangement or relationship (or series of similar transactions, arrangements, or relationships) in which we are, were or will be a participant and the amount involved exceeds $120,000, and in which the related person has, had or will have a direct or indirect material interest. We have adopted a written related party transaction policy under which our management is required to submit any related person transaction not previously approved or ratified by our Audit Committee to our Audit Committee. In approving or rejecting the proposed transactions, our Audit Committee will take into account all of the relevant facts and circumstances available.</span></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Related-Person Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of transactions since January 1, 2024, to which we have been a party in which the amount involved exceeded $120,000 and in which any of our executive officers, directors or beneficial holders of more than 5% of our capital stock had or will have a direct or indirect material interest, other than compensation arrangements which are elsewhere in this proxy statement:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Relationship and transactions with Gilead Sciences, Inc.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Gilead, a beneficial holder of more than 5% of our capital stock, are parties to the following agreements: </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt;text-decoration:underline">Option, License and Collaboration Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In 2020, we entered into an Option, License and Collaboration Agreement with Gilead (as amended the "Gilead Collaboration Agreement"). The Gilead Collaboration Agreement provides Gilead with an exclusive license to our anti-PD-1 program (including zimberelimab) and time-limited exclusive option rights to our clinical programs, which they have exercised for our anti-TIGIT program (including domvanalimab), adenosine receptor antagonist program (including etrumadenant) and CD73 program (including quemliclustat). For each program that Gilead has exercised its option, the two companies will co-develop and equally share global development costs for such optioned program, subject to opt-outs applicable to certain programs, expense caps on our spending, true-up adjustments, our right to conduct certain independent activities and certain other exceptions. For each optioned program, provided we have not exercised our opt-out rights (if applicable), we have an option to co-promote in the United States with equal sharing of related profits and losses. Gilead has the right to exclusively commercialize any optioned programs outside of the U.S., subject to the rights of our existing partners to any territories, and Gilead will pay to us tiered royalties as a percentage of revenues ranging from the high teens to the low twenties. Further, with respect to domvanalimab, we remain eligible to receive up to $500 million in milestone payments. During the year ended December 31, 2024, we have recorded $137 million in gross cost-sharing payments from Gilead under the Gilead Collaboration Agreement. During the year ended December 31, 2024, we have incurred $100 million due to Gilead pursuant to our cost-sharing obligations. </span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt;text-decoration:underline">Common Stock Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In 2020, we entered into a Common Stock Purchase Agreement with Gilead (as amended, the "Purchase Agreement"). Under the Purchase Agreement, Gilead has the right, at its option, to purchase additional shares from us, up to a maximum ownership of 35% of our then-outstanding voting common stock, from time to time until July 2025, at a purchase price per share equal to the greater of a 20% premium to market (based on a trailing five-day average closing price) at the time Gilead exercises such option, and the $33.54 initial purchase price per share. Since January 1, 2024, Gilead has purchased 15.2 million shares for an aggregate purchase price of $320 million under the Purchase Agreement.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt;text-decoration:underline">Investor Rights Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In 2020, we entered into an Investor Rights Agreement with Gilead (as amended, the "Investor Rights Agreement"). The Investor Rights Agreement provides Gilead with registration rights, pro rata participation rights in certain future financings and the right to designate three individuals, which they have exercised, to be appointed to our board of directors. Gilead&#8217;s current director designees are Dr. Berger, Dr. Higgins and Ms. Mercier. Pursuant to the Investor Rights Agreement, we established a Science Committee and Drs. Berger and Higgins are members of our Science Committee.</span></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt;text-decoration:underline">Participation in Our Underwritten Equity Offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2025, we sold through an underwritten offering, 13.6 million shares of our common stock at a price of $11.00 per share, for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:90pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">total gross proceeds of approximately $150 million, before deducting underwriting discounts, commissions and offering expenses. Gilead acquired shares in this offering from the underwriters for an aggregate purchase price of $15 million. As of February 19, 2025, Gilead owned approximately 29.7% of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information about our collaboration with Gilead, including the Gilead Collaboration Agreement, Purchase Agreement and Investor Rights Agreement, please refer to the information disclosed in our Annual Report under &#8220;License and Collaborations&#8212;Gilead Collaboration.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment of Relatives of Executive Officer</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A son of Terry Rosen, Ph.D., our Chief Executive Officer and member of the Board, has been employed by us since February 2016, currently in the capacity of Research Fellow. In 2024, he earned approximately $247,000 in annual salary and other cash compensation. In 2024, he was also granted (i) an option to purchase 1,388 shares of common stock with an exercise price of $15.44 per share and (ii) 2,112 restricted stock units. The grant date fair value of the option award and restricted stock unit award, computed in accordance with FASB ASC Topic 718 were $14,981 and $32,609, respectively. He also received other benefits consistent with other employees serving in the same capacity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another son of Dr. Rosen has been employed by us since November 2020, currently in the capacity of Senior Scientist. In 2024, he earned approximately $206,473 in annual salary and other cash compensation. In 2024, he was also granted (i) an option to purchase 800 shares of common stock with an exercise price of $15.44 per share and (ii) 1,200 restricted stock units. The grant date fair value of the option award and restricted stock unit award, computed in accordance with FASB ASC Topic 718, were $8,635 and $18,528, respectively. He also received other benefits consistent with other employees serving in the same capacity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A daughter-in-law of Dr. Rosen has been employed by us since March 2024 as a Senior Bioinformatics Scientist, in our bioinformatics department. In 2024, she earned approximately 136,383 in annual salary and other cash compensation. In connection with her hiring, she was granted an option to purchase 3,200 shares of common stock with an exercise price of $16.97 per share and 1,600 restricted stock units. The grant date fair value of the option award and restricted stock unit award, computed in accordance with FASB ASC Topic 718 were approximately $37,997 and $27,152, respectively. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSEHOLDING OF PROXY MATERIALS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This year, a number of brokers with account holders who are our stockholders may be &#8220;householding&#8221; our proxy materials. A single Notice of Internet Availability of Proxy Materials may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or us. To notify us, please direct your written request to Arcus Biosciences, Inc., Attention: General Counsel, 3928 Point Eden Way, Hayward, CA 94545, or at (510) 694-6200. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.</span></div></div></div><div id="i3be39c5b0a4e4bb6bffeea39d605508e_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote, to the extent permitted by SEC rules, on such matters in accordance with their best judgment.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Order of the Board of Directors</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Terry Rosen</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Terry Rosen, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman of the Board</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 22, 2025</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A copy of Arcus Biosciences, Inc.&#8217;s Annual Report is available without charge upon written request to: Corporate Secretary, Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, CA 94545.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.</span></div></div></div><div id="if7c69a670761483ea22f4e972c1b72cf"></div><div><img src="rcus-20250422_g3.jpg" alt="null001.jpg" style="height:1820px;margin-bottom:5pt;vertical-align:text-bottom;width:1406px"/></div><div><span style="color:#FFFFFF;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLYTHIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. V70333-P28711 !! !! !! !! ! !! ! !! 2. To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp;amp; Young LLP as the independent registered public  accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025. 3. To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.  Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give  full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full  corporate or partnership name by authorized officer. 1. Election of Directors. ARCUS BIOSCIENCES, INC. The Board of Directors recommends you vote FOR  the following proposals:  Nominees: For Withhold 1a. Yasunori Kaneko, M.D. 1b. Patrick Machado, J.D. 1c. Andrew Perlman, M.D., Ph.D. 1d. Antoni Ribas, M.D., Ph.D. For Against Abstain ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD, CA 94545 SCAN TO  VIEW MATERIALS &amp;amp; VOTEw VOTE BY INTERNET  Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information  up until 11:59 p.m. Eastern Time on June 9, 2025. Have your proxy card in hand when  you access the website and follow the instructions to obtain your records and to create an  electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/RCUS2025 You may attend the meeting via the Internet and vote during the meeting. Have the information  that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m.  Eastern Time on June 9, 2025. Have your proxy card in hand when you call and then follow  the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have  provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood,  NY 11717. </span></div><div id="i7a356fc07c704e33bb919eaa3b4d995e"></div><hr style="page-break-after:always"/><div><img src="rcus-20250422_g4.jpg" alt="null002.jpg" style="height:1820px;margin-bottom:5pt;vertical-align:text-bottom;width:1406px"/></div><div><span style="color:#FFFFFF;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%">V70334-P28711 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:  The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. ARCUS BIOSCIENCES, INC. Annual Meeting of Stockholders June 10, 2025 8:30 AM PDT This proxy is solicited by the Board of Directors The stockholder(s) hereby appoint(s) Terry Rosen, Ph.D. and Juan Carlos Jaen, Ph.D., or either of them, as proxies, each  with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on  the reverse side of this ballot, all of the shares of Common Stock of Arcus Biosciences, Inc. that the stockholder(s) is/ are entitled to vote at the Annual Meeting of Stockholders to be held at 8:30 AM PDT on June 10, 2025, virtually at  www.virtualshareholdermeeting.com/RCUS2025 and any adjournment or postponement thereof.  This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this  proxy will be voted in accordance with the Board of Directors' recommendations. Continued and to be signed on reverse side </span></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>rcus-20250422.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:82caba53-fe79-45a6-b4b8-8a6bfaea78ec,g:80351a8a-ce6d-4070-8aef-aa80c9a7e4f9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rcus="http://arcusbio.com/20250422" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://arcusbio.com/20250422">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rcus-20250422_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rcus-20250422_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rcus-20250422_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://arcusbio.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rcus_PlusAdjForStockModificationMember" abstract="true" name="PlusAdjForStockModificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>rcus-20250422_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:82caba53-fe79-45a6-b4b8-8a6bfaea78ec,g:80351a8a-ce6d-4070-8aef-aa80c9a7e4f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_rcus_PlusAdjForStockModificationMember_806421c2-57b7-422c-b90b-56db5ab15ebe" xlink:href="rcus-20250422.xsd#rcus_PlusAdjForStockModificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_rcus_PlusAdjForStockModificationMember_806421c2-57b7-422c-b90b-56db5ab15ebe" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rcus-20250422_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:82caba53-fe79-45a6-b4b8-8a6bfaea78ec,g:80351a8a-ce6d-4070-8aef-aa80c9a7e4f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_rcus_PlusAdjForStockModificationMember_label_en-US" xlink:label="lab_rcus_PlusAdjForStockModificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plus Adj for Stock Modification [Member]</link:label>
    <link:label id="lab_rcus_PlusAdjForStockModificationMember_documentation_en-US" xlink:label="lab_rcus_PlusAdjForStockModificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plus Adj for stock modification.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rcus_PlusAdjForStockModificationMember" xlink:href="rcus-20250422.xsd#rcus_PlusAdjForStockModificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rcus_PlusAdjForStockModificationMember" xlink:to="lab_rcus_PlusAdjForStockModificationMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rcus-20250422_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:82caba53-fe79-45a6-b4b8-8a6bfaea78ec,g:80351a8a-ce6d-4070-8aef-aa80c9a7e4f9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_rcus_PlusAdjForStockModificationMember" xlink:href="rcus-20250422.xsd#rcus_PlusAdjForStockModificationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_rcus_PlusAdjForStockModificationMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>rcus-20250422_g1.jpg
<TEXT>
begin 644 rcus-20250422_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^"H_B+\(_B!I7B'0Y69!J6F7:R1HZ@%D?'*. 02K8(R,CF@#IJ*X3X)_M.?
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M>YT3Q#8FVO4B?;(F&#I*C8.UT=4=200&09!Z4 >._LJ_L/?LC6?[*'P]T4?
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M7OPE_8[\7^.-/T+1_'?C2#4/&VI:CJ"6T-MHMFZLXD=R%7>[93)Y>WQ7)_\
M!)_XZ_#7X*?$3]H#]E[POXUT_7O"?A/5+OQAX*O-%OX[J&?2F4><D<B$J=B_
M900#@.\F<'-?1WB;_@GWX'^)G[:>H_M9_&W5M,\9::WA*+0O#W@?6_#$4UKI
M85E=IR\LCK,Q<SD#REV^>>3@&LS5O^":/PST_P#:_P##7[4?PAOM'\%Z?IOA
MVYT7Q-X(T;PI%'9Z];S),C%C%)&L38E&3Y;Y\F/TH \N_8<\5_\ !13]LCPW
MHO[9,W[4^B:#X8U?Q5*B?#)?!UO+;?V1#=&&91=_ZY9_DDV$YR54E@K%1YW_
M ,$OOA?^TW;_ +?/QXFO_P!J&*>'PYXSLT^(L/\ PAEHO_"82,+\1N"#FPV.
M';$7#;\'@"O:OV??^":'QV_9J\4V'A+X9?MVZ_:?";3?%4>MP^ E\-P?:90L
MZRFS>_W^8(7*XD"A5D#."F6)KJ/ 7[ _Q$^$G[:_BC]ISX6?M+W&E^%O'6IQ
M:AXT\"2>&H9CJ$T<<@11=N^Z)!)*\F40-ABI+#D 'C'P-_;?_:>\9?\ !*_X
MP_M(^(_B6+CQIX5\1ZI:Z#K(T6R3[+%$MH8U\E81$^WS7Y=&)SSG K?^*_[2
M_P 1)_V8_@AXX\:_\% M(^$D_B_P%9:AXANHO!,6JZOKM[+:V[EK>V1"(HPS
MN6:.,8+*HX.!1O/^",GCR'1?'GP=\(?MN:[H?PL\9ZG=:J/!=IX<B=HKV0#R
M_-G,H:6%&2(M&OE^:L:JVTC?7:^,O^"97CFUU;X-_$3X'_M*)X:\:?"3P+!X
M5BUG4/",=_:ZC:I 86E%L\P$,A$DIQN?AP,C;N(!\T:C^UK\4_VF/^"6G[2G
MAGXI_$*+QC)X'UZTT_1O& T/^S9=6L6OX?*EDMMB>4Q$9;:RAP'"MEE)/6:;
M#-<?MQ_L/6]M=M!(_P #'6.=%4M&QT*X 8!@02.N""..:]@T+_@D[J&F_ 7X
MT_!O6_VE[O5[_P",VKVVIZCXEO?"T:RVERDPGE=HHYU6;S)-YPIC"A@.<9/;
MV/\ P3Y2R^._P-^-@^+1;_A2_@@^'AIG]A8_MC-B]KY_F>?_ */]_?LVR=,;
MN] 'S)'_ ,%,_P!I/X:_L8?%[PA\4?&L=[\=/ OQ%C\)Z/?QZ-:H;I[J4BWG
M6W2(1.0D%XRCRR&$<9.=Q-?>>F:?XZTG]G*'3/BAKXU7Q+!X,$?B'4E@CB6Z
MO1:8GD"1*J*&DW$!0  >*^%?B_\ LN^%_C3_ ,%V]%N_#FC7K:9H6B:?XI\?
M,ULPM3J-HA%J ?NN6!L<@]FDZ_-7Z*^(-)&O:#?:&T_E"]LY8#*%SLWH5SCO
MC/2@#\1?@M%HWQU_X)L1?LJ_"O\ 8U\3>+?B;J?BHR:=XWLO""?8]-C%Y'(S
M-J)Y7]TKQ%6(0"0[B, '[?\ VF_B!X_^ .F> _@[XN_X*9Z9\+9-*^'.G6UU
MIFD^ SX@UC5M1AB:.:\D 1Y$@8QC;A07(DSTKZ!_8,_9&'[$?[/%G\!1\0#X
MF^R:E=79U;^ROL6_SGW;?*\V7&.F=QS[5P_QM_8(^*7B7]K6?]KK]G?]IK_A
M M=UCPNN@>(8[OPG#JH>V#(1);^;(HB?]W%U!Y3.<%E(!\I>,_\ @H;^TAX]
M_P""0#?'K5?$6D3^,-*^)\>@7.LW'AFRN(KZ) )5F:UN(6A1R'49$:D;,@*2
M:]P^-WQH_;$_:%_X*&ZM^QE^S'\=K+X::7X$\&P:WKFM2>&X-2EU"YE$#I$4
MF_Y9XN85PI7&)&._Y5#[O_@CE:R_L1:K^QC;_M%W'E:C\1&\41^);GPN))8P
M45!;O"+E0[87)E#*"3]P=*[/]HG_ ()Y?$3QU^U G[6G[,_[4-Y\,/%5_H"Z
M+XGEC\.0ZE'?VHV@,J2NJJX5(QR&&8HV4HRDD \W_P""(D?BZ*3X_P 7Q GL
MY=>7XPW@UN73E86[W@W^<8@W(C,FXKGG&,UH_$:X?QW_ ,%V? .@:L2UIX+^
M$=UJ&FP/RHN9VN8GD /<I(@_[9CTKV']A+]AJW_8BT[QKIEO\6M0\7#Q?XE.
MKM>:M9".ZB8IM82R"1O/D9LLTF$R2?EKR_\ :P\(Z_\ "3_@J3\"_P!J?3]%
MN[G0_$=A<^!_$4UI;LXM99/.-H\A4':&DN!ECP%MSG'% 'G/[$GP_P# O[47
M_!3W]I?XD?'_ ,,V'B+4_!.O1:+X6T_7;5+F&TLQ/=P"2.*0%01':188#CSG
M/5R3[!_P40\1?"W]@O\ 8'^(E]\%_!^E^%KGQA<O96-GHUNMM%)J5]&MO).B
M+A4=;>)Y/E &8<XR2:3X\?\ !-#Q;KO[1]]^UC^R5^T[J?PH\8ZY:B#Q*(-%
MCU"RU, *-[0NZJ&.Q"P8.I90P"MEC5UK_@E[XT^)H^'UO^T5^UQJ_P 0;3PI
MXYG\4^([#Q!X=1H==N&CMXXK5$\_9:6L:P-^Z"R*WVF;INP #YA_8<USX'_L
M8_\ !0OX?_#CX._&/PYXE\/?$[X966C^*9O#^NPWD-OXCA3)9O*9MIDEB 3/
M7[6_IFK/B_XH_"7X9_\ !5_]H<_%C]F?7/BG%JFAZ;:Z=X>T+P@FKN9OL5F?
MG5_]4K#Y=X!//0]*^LOVK/\ @EQ\&/CEHWAFZ^!]EX;^$WB?PKXHM]9T[Q-X
M;\$VQ=C$"1$\<+P;AO\ +<$O\ICZ<FNM^$?[&'_"K?VT/B3^U\WQ)^WM\0M,
ML[0^'QH_E"P,$4*%_/\ .;S=WDYQL7&[&3C) /B[PG^RE\3_ (0_\$)OBAX.
M^/?AZ?2+^_U*7Q+I.A7S'SM)@26R:*)@23&[-;R.4Z@388!BPK[N_9,\3^)?
MBC^Q7\//%$NM26FLZU\.--D?4S&LC1W3V48,^UP0QW_/A@0>^:\O_P""Q&L^
M*YOV*]2^$WP_\/WFI^(/B'KVF^'-(M;*!G.^6X65RVT?*ACA="QP 7&:^@/@
MS\.K/X0?"#PK\)]/F$D'ACPY9:5%*!C>MO D0;\=F?QH _/>S_X*;_M,:#_P
M3T\86_BKQ8DWQZT#XICP+:W*Z3:"1[N2?>DGV81"$D11W42_N\%H02"3DZW[
M0_[<'QHT?]J8?L?^)OVM+OX;6O@7P+ITOBOQIHGPX;7+WQ!K<MM;RMB""W=;
M>$B8/\J(N59>C*%]7\1?\$C_  =K_P"WNG[9_P#PMJ:'26\1VGB"\\ +H>89
M]3MX"L=P;CSP ?.)FYB)RSJ" V1TWQY_8+^(_B#]IB7]KS]EC]H^3X<>,]3T
M--)\2I=^&X=4LM5MTV!"T<CKL<+'&,_-GRDQM^8L ?,_BG_@I7^V'IW_  36
MA^.*:NEEXWT+XP0^&;C6Y_#201>(+ 0&<3&WN(@(A*&56**C#8<;"2!VO[4W
MQ!_X*2?LA?LW:+K7Q(^/1UB?Q!X\CD\;>./"O@B"Y;P=H[PQ[X88"H25%D$V
M)I #PJY5G%>M?'G_ ()]_%?]IO\ 96M/@#\;?VLYM9U^'QC#KUQXP?P9!$K+
M&KJMI':0S1JB .<-O)SDD'.!ZM^TI\+OV@OB/IVE7'[/'[1B_#_4M.FF-Y]J
M\,0:K:ZG%(JCRY8Y64H5(W*ZG/)&#G@ ^0/V@?VS_C#\*O\ @G%8_'#X"?MM
M6WQ&U&Y^)-KI]MXU7PA9VL\5E)"S-8W-K)&RI,K+DNR(Y5T.!G)]J_:,_:-^
M,G@+_@I-\"O@#X4\7BU\)>,M,U>7Q)I/]GV[_;'AMYGB/FO&98]K(I^1E!QS
MD5REO_P1V\&7/[&WBO\ 9F\1?&*[NM>\7>+O^$HOO&$&B1P10:F,!?*LD<(L
M(7<NP.#^\8@J JK>^%W_  3,^+FE_M(?#S]JCX\?MHZOX\\2^!X[N"2WO/#<
M<%M/;26KP110A)1Y+(9)'>5A(TQ*Y"E=Q /+/V</VO\ ]H#X@?MBW_P[_:._
M:\N/AIXFM?'CVFF_!_5O %NNGZOI(D 2*"_<!S-(-P20MN<[2F\-@?0'_!7S
M_E'#\4?^P5:?^E]M7*^)/^";WQQ^,'Q:\'>)?VD_VQW\8^%O /B==;\/:2G@
M:ULM0>1) \<,UY&^YD&U0Q"Y<#/RMAA[G^U[^ST/VK/V</%/[/I\7?V#_P )
M+:10_P!KBP^U?9MD\<V?*\R/?GR\8WCKGMB@#\P_"FMZW^PI\-OB5^RSXKNY
M?^$$^-WP&N_%7@"ZF8^7;:H^C,]Q; G@%L/'@DD^7;=Y*].U?]M;QW^S_P#L
M??LM_ 7X>?$0>"7\<^%(YO$'CA?#;ZO/I-A B _9[1(Y#+(Y9A]P[=HZ9++]
M/?M<?\$T?!'[6?[+/@_]GK7/'+:7JW@>SLX="\7QZ0)G3RK=()0T!E7,<JH"
M4$@PRH<G;@Y'C[_@F!_;7P=^$'ASX=?'J^\,^/?@K9+!X6\=V^AQS+-\B"59
MK1Y,%'* A2[!06!WAB" >$>!_P!I']ISX]_"G]H3]GC3_P!H>^U_3/#W@HZM
MX3^*^I_#8Z?-?6(BW7NG36L\42[W0O"LNW>OSR M\NWU3_@AOX,^,FC_ +&?
MA[Q=XO\ C.FL>$M5L[@>%?" \/06YT)H]1NUG)ND_>7/FOE\/]S.!Q7M'PC_
M &>?VAX_"WB[PW^U9^U,WQ"A\5:,=,BLM.\)6VD0:9"\<J2F/RBS2.XD'S-T
MV#BL3]@#]C3XL?L5^$+WX6^)_P!I:3QKX2M04\(Z(_AB&Q_LE7FEFF9I5=WF
M+O+T8X7!Q@'  /(/V@O^4\/P(_[)IJG_ *3ZO7E.G_M%?\%-/C;\,?CS\5O!
M'[4^D>'='^#'BO7)+.W_ .$0LY;S4X+0-+]C9S$$CBCACRKE6>1Y&#D@*5^R
M?B#^Q>GCO]N_P)^VT?B0;4^"?#5UI'_",_V1O^V>='=IYOVCSAY>/M9.WRVS
MLZC/'-?"G_@G6GPQ^"GQR^#O_"WS?#XSZEK5W_:/]@>5_8XU"W>'9Y?GM]H\
MO?NSNCW8QA>M 'BWCC]OG]ISXR?#C]FSX4_!/Q-IGA'QO\;M/DN/$'BQ]*2Z
M33(K8!9G@@ERA+E97"MT"!006WKT'[4/QN_;9_8E^ F@?"W5/CCHWCKXA_$+
MXE0>'_!GC:]\-Q68L+&:.,>9<6Z Q-,DQ90?F4JX9MQ&VM_QG_P2C?4_@5\(
M_!?@']H2]\.^/?@R)/\ A%_'MKH*,LWF2!W66T:4C:2JX!D8#Y@0P<K6C\0O
M^":WCSX\?L\O\.?VA_VN==\2^.K?QA'XDT'Q]#HD-H-&NDA2)(8+.-PBP *6
M**R;G;>-IH XWPQ\6OVROV0/VZOAQ^S;^T%^T7!\5?"WQ3L+L6VH3^%K?3+K
M2[V%&8[!!G<A;RQ\S$;9#A5*9;Q6R_:C_P""G/Q6_9Z^+W[1GA7]J31]$TCX
M1^,=1MX-/'A"SDN]72*2-C!(YB$<<44+IL(5FD8N'/"L/JGX)_\ !/OXGV/[
M1NC_ +4_[7/[4-Q\3_%'A;3);'PE;P^&8-*L]-6175YC'"Q$LA5WYPN"V26V
MIMC^'G_!,]/ 7[+7Q?\ V:1\:3=_\+6\0ZCJG]M?\([L_LO[5'$@C\G[0?/V
M>5G=O3=NZ+CD ^?KS]K;_@H;\/[GX!_M6_$7XU^';WPC\8/$VGZ=>?#C2?#<
M<4&GVEUL*,MP^Z9Y3&6<G< C@+\Z$BI_VA/^"@GQ1\:?M8?$WX1Z#^U?>?"'
M0?AR(['0DTCX:3>()M=U/:V][EX[:;R(ED0KM^4,K*0&(8CZ#^(G_!-Y/'WP
M+^!_P6_X7(;3_A3.M:5?_P!I?\(]YG]L?8HPA3R_M ^S[\9SNDV],-UJK\0?
M^"?OQCT#]H[Q1^TE^Q[^U4WPYO\ QW' /&.C:AX2@U:TO)HAA;B,2.OEL,LV
M,$[G?Y@&*T =Q_P3J_:"^)7[3?[)?AOXJ?&'PVVF>)96N+35XS9-;K/)!,T8
MG6-@-H=0K$#@,6 P !7N%<O\&/!WCWP!\--,\)_%#XJ7'C;7[42G4O%%SI<5
MDU\[S/(#Y$/R1*JL(U5<X5!R3FNHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y3_ &QO%FM1_'2S
M\-_&;XR>)/AG\.;#3]-U7PIXMT/0+:XL)]>BNIF==2NKBVG2V2(+;-'&_E))
MN<F0E0H[']JOQM\<?!-S\-/%7P^^+-A:>'K_ ,?^&=*UBWM=&BFGUI+W4(X9
MLSNS)% 8FR!$F\LV1(H&&T_VA?AC^T_\1_%!\#_#_P"*NDZ;X%\4Z1=6/B87
M_A2&[N=*0P[,VSFXC#M-O8?O(I5C*D\@A:SOC!^R-\1_%?@7P#\*?A!\:-&\
M,>&_A]/HESIMOK?@R;5KJ>XTJ1'MB\R7]L/+(BC#ILW'#$.,@  YO]I7]HC4
M;?\ :-N?@@WQ,\<>$]!\.>"[;7=:O_AYX)EU?4+J:YN+B-%=Q97:6MO#':L[
M,45I&E4!L*RGZ"^&GB#1/%GP[T+Q-X;\9GQ'I]_H]M/9>(&$8;4HVB4K<$1H
MB N#N(5%4%B JC@>8>-/V<_C9=?$%/B_\,/CIHF@^)]6\%VOAWQE<W?@I[NT
MOA \LD=Y:P?;4:VF1[BXVK)).FV158/LR?0_@M\*?#GP+^$GAOX-^$))Y-,\
M,Z-;Z=9RW3AI9$B0)O<@ ;FQN. !DG  XH Z>BBB@ K.U*V\32W1?2]2MHHM
MHPDL)8Y[\UHT4 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
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MM/TW0)OAY/-(;&\DM'N$DN1J:!I3]D0)((E5=QS&W% 'E'BWXW_'T_"CQ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\
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MF>NG=7*?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRBPA*_\ +%"/G;^-AM^ZI+]W^WI^U-\/?V#O@G:?L(?LCS"SUK[!L\0:O;R
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\
MGQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T_
M_GQA_P"_0H_L[3_^?&'_ +]"@"/3];TG57:/3K^.9D&6"'H*M4R*VMH"3!;H
MA/4H@&:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ((;?\I7/@W_ -AV[_\ 3?=5\GU]8?\ !#;_ )2N?!O_ +#MW_Z;[JN',_\
MD6U_\$O_ $EET_XB]3^H2LSQGX7L/&OA:^\+:D/W5[;M'NQG8W57'N& (^E:
M=%?A2;3NCV=SP[]E;Q1?^'-=U;X.>(SY<]O.\MJC'HZG;*@]<X##Z,>]>XUX
M-^TEH=_\._B+I'QG\.Q8WSHMV!P#,@X!]GC!4_[I]:]MT#6[#Q+HEIX@TN7?
M;WENLT3=\,,X/N.A]ZWKI2M477\R(:>Z7****YRPHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN?VA?^B@_P#E)M/_ (U1_P -<_M"_P#10?\ RDVG_P :KS>BOY+_ -=.,?\
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M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
M"#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\
M(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?
M\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/
MI'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _
M-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>
M_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!
M;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^
M!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!
ML45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L451TK0++1Y'DM99V+K@^;
M,6'ZU>H **** "BBB@ HHHH **** "BBB@#XA_;[^*^O_"CXN75KX:_X*!^-
M]/\ $&M+!_PCOP:\ >"+#5]1W"!%^564NBR,K2;I2OWR%W  5Z%_P38\+_M^
M:=H'B3Q9^V_XVFNHM7DM6\(Z!J1M'O\ 38E\XRM<-:Q(@:0-#\F6*[#D*<@_
M.?[='AOX'^,OVQ]?O?"?_!/_ %CXB^(7UW2?#WBCQ7#\6+G0$N-4GT])K>RA
MB1]KD6D4>Y\*H90&Y(9OJK_@GS\'?V8?"?PBMOC7^S1X-UK1;/Q[IMM/?6FN
M:_>7LT30F5?)87$T@1HW>5"4P&(ZD 4 >_4444 %%%% !1110 4444 %%%%
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M&^M/_P!O$HHHK^.3]K"OMC]D;_DWKP_];O\ ]*YJ^)Z^V/V1O^3>O#_UN_\
MTKFK]P\ ?^2QK_\ 8/+_ -.4C\X\4/\ DGZ?_7V/_I,STBO.OV@/C7!\,]&_
ML;1)5?6[V,_9TZ_9T/'FL/7LH[GGH,';^+OQ3TCX5>&&U:[VRWDV4T^SW<RO
MZGT4<$G\.I%>;_ 3X6:OXWUUOC5\3-UQ+/+YNG0SK_K&[2D=E' 0>P/0#/\
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M(@X ;'E-D#ID>M 'L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF[SI2W1M,Z9Z=:_'ROV3A;_D0T?^WO\ TJ1Y6)_CO^N@4445] 8'VQ_P;O\
M_*6[X9_]>>N_^F:]K]/6ZGZU^7G_  ;X6$.I?\%8_AK9W#NJ/::YDQN5/&C7
MIZBOU#;J?K7\*_2^_P"1ME/^"K_Z5 _<?!S^'C?6G_[>)1117\<G[6%?87[/
M?C/0_ /[*^C^)O$%QL@@%WM0?>E<W<VU%'=C_P#7/ -?'\4;S2"*)268X %>
MR_!7X=^*?BR=-\%SW<D6BZ*K-=S(3M3?(SD+G@R-N('H!G'!S_0'T>\MQ=7B
M3$XUP?L8TG!RZ<TIP:CZM1;\NNZO^7>*>+H0RBCA^9>T<U)+K91DF_2[7])G
M9_#SPAX@_:/\>2_$CQY&R:+:R[(+7)VR8.1"G^R.K-W)]2<?0D44<$:PPQJB
M(H5$48"@= !VK!TSX:^&M&L(M+TP74-O @6**.Y8!15C_A!](_Y^;W_P+:OZ
MQJU/:/39;'X=&/*C8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK(HV*_(
M/_@[7_Y)E\%/^P]K7_HFTK]9/^$'TC_GYO?_  +:OR-_X.P=!L]&^&GP7:UE
MG8R:[K(;SIBW2&TZ9KW^&/\ D>T?5_\ I+,,1_!9^*M%%%?LIY05]8?\$-O^
M4KGP;_[#MW_Z;[JOD^OJO_@B)9Q:A_P51^#UG,SA7URZ!,;;3_R#[KH:X<S_
M .1;7_P2_P#2673_ (B]3^HFBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:
MOPD]DV**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ .>_:%^'_ /PG_P .
M+J&U@WWVGYNK+ Y8J#N3_@2Y&/7'I6;^RW\0/^$O^'JZ'>S[KW12+=\GEH2/
MW;?D"O\ P#WKL_\ A!](_P"?F]_\"VKPC5-&M?@=^T!';7$DT6A:N00ZRE=D
M4AP<D?W)!G_='O732_>4G3ZK5$2]V5SZ/HK&_P"$(TC_ )^KS_P+:E_X0?2/
M^?F]_P# MJYBS8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'
MTC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?
MF]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^
M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_
M  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH
MV**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A
M!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\
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M#Z<U7]IGX!Z'\2(OA%JWQ5TB#Q%-?162:;)/R+J10\=NSXV+,ZLI6(L'8,N
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M-'OTMT22ZENI)V1<%V%S(@)]2%51] *^,=4U*349]YR$7A%]/_KU]G?LC?\
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M4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#\YOVSO$GPGT_]KKQY#^VU\9?C)X4LHK;3
MO^%.Q> YKV*RG@-FAGD@-M&RM=_:O,#>80.%&<8Q]C_L2ZO\7=>_9,\ :Q\>
M(KQ?%MQX<@?6/[1B\NY9L'8TRGE96CV,X/(8MG!S7R=^W?\ M$?![P#^T!XO
M\.:O_P %7/'GPXUZSM;<IX&TGP;<WEI82M8PO&%D2V*N) 5E(\S@RD$KCCZK
M_84\7^-/'W['_P //&GQ$;6'UO4_#,%QJ4NONK74TC9/F.51!AQAE^4'8RYR
M<D@'K%%%% !1110 5QG[0?[/GP@_:H^$&K_ ;X\^$?[>\)Z]]G_M72OM]Q:^
M?Y%Q'<1?O;>2.5=LL,;?*PSMP<@D'LZXG]HKQ=XA\"?!O6/%?A34/LM_:_9_
ML]QY2/MW7$2-\K@J<JQ'([UQYCF<,ER^MF$[\M&,JCY?BM!.3Y=5KIIJM>J.
MG!X2>/Q=/#0M>I)15]KR=E??3771GS1_Q#Y?\$A/^C1O_+^U_P#^3Z/^(?+_
M ()"?]&C?^7]K_\ \GU4_P"&N?VA?^B@_P#E)M/_ (U1_P -<_M"_P#10?\
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MYSBOFC]BOX\7_P 0_C;X4@U'_@K_ *?\2YM2MIY9OAW%\.++37OV-G+(4$B
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M,D<QURZV/(N0/^)?==17#F?_ "+:_P#@E_Z2RZ?\1>I^O'BK_D9]2_Z_YO\
MT,U0J]XF#CQ)J D(+?;I=Q'<[S5&O\9,5_O53_$_S/[4H?P(^B_(****P-3[
M*_8P_P"2%6?_ %_W/_H=>K5XO^R#;>)I?@I:/I>IVT4/VVXPDL!8YW\\UZA]
MB\;_ /0;LO\ P&/^-?W_ ,!?\D5EW_7FG_Z2C^7.)_\ DHL7_P!?)?FSS_\
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M'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&OP(]LV**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
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M)M^SE^S[X4^"4NOC5)?#VE+;SWZP>4LTI9G<HF3L3<S!5S\JA1VH [ZBBB@
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M+\@HHHK U/LK]C#_ )(59_\ 7_<_^AUZM7E/[&'_ "0JS_Z_[G_T.O5J_O\
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MSFMADF-Q7W;X!\3:%XQ\%:7XG\,ZG'>6%[91R6MU%G;(N,9&>>H- &O1110
M445G:EK.H6-T8+?P]<W*[0?-B88^G- &C16/_P )+J__ $*%[_WTM'_"2ZO_
M -"A>_\ ?2T ?CE_P=P_\A[X#?\ 7GXE_P#0],K\<*_8/_@[+U*[U'7?@2;K
M2)K39:>)-OG$'=EM,Z8_SS7X^5^R<+?\B&C_ -O?^E2/*Q/\=_UT"BBBOH#
M^V/^#=__ )2W?#/_ *\]=_\ 3->U^GK=3]:_+S_@WPNIK/\ X*Q_#6XM[)[A
MUM-<Q%&1EO\ B37H[U^H;=3]:_A7Z7W_ "-LI_P5?_2H'[CX.?P\;ZT__;Q*
M***_CD_:PK[8_9&_Y-Z\/_6[_P#2N:OB>OL7]E77-1L_@-H5M!X;N;A%-UB:
M-EPW^E2GO^7X5^X> /\ R6-?_L'E_P"G*1^<>*'_ "3]/_K['_TF9ZW16/\
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M7N?#)B.OI\;!XF-ZK7$3"W^SB5_*!V%Q+C_ED5S\U 'V=1110 4444 %%%%
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M_P $-O\ E*Y\&_\ L.W?_IONJ^3Z^L/^"&W_ "E<^#?_ &';O_TWW5<.9_\
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M6/\ X"_/_ SZ5[12JP]G-Q"+YE<****S*"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+7]>'X,;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q7Y!_P#!VO\ \DR^"G_8>UK_ -$VE?K)_P )+J__
M $*%[_WTM?D;_P '8.J7FH_#3X+K=:-/:!==UG:9B/F_<VG3%>_PQ_R/:/J_
M_2688C^"S\5:***_93R@KZP_X(;?\I7/@W_V';O_ --]U7R?7U7_ ,$1+B6T
M_P""J/P>N(;5YV77+K$4?5O^)?==*X<S_P"1;7_P2_\ 2673_B+U/UX\5?\
M(SZE_P!?\W_H9JA5[Q,Q?Q)J#LI4F^E)4]OG-4:_QDQ7^]5/\3_,_M2A_ CZ
M+\@HHHK U/LK]C#_ )(59_\ 7_<_^AUZM7B_[(.M:A9?!2TM[?P]<W*B]N#Y
ML3#!^?WKU#_A)=7_ .A0O?\ OI:_O_@+_DBLN_Z\T_\ TE'\N<3_ /)18O\
MZ^2_-FQ16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+7UIX1L45C_P#"2ZO_
M -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!XS\<M/O/A!\9M,^+>B0-]FOI=UTB<
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MT._![,V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EKX$[38HK'_ .$EU?\
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M-%(@;)Y:$_ZL_@ 5_P" #UKTVHJ0=.;B^@T[JX4445 PHHHH **** "BBB@
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M^A$?=DT>D45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU7,6:5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M&'H0#VJQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\
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M?\%+/@@DBA@?B-IN01D']Z*_:OXGJJ_$KQ"JJ !KEV  .G[YZ_,;X3?LT/\
MLL_\%TOA=X%TZQ,.A:A\2M-U3PT0N%^Q33DB,?\ 7-P\7_;,'O7Z=?%'_DIG
MB+_L.W?_ *.>OX^^EM6AB,'E56&SYW^"/V/P@36+Q2?:/YLPJ***_B<_=0KZ
MW_8>M+6?X-W#S6T;G^W)QED!/^KBKY(KZ[_89_Y(S<?]AV?_ -%Q5^P^!O\
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M_/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\
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MH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_
M +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J
M/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,
M?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\
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M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
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M 1W5G:7T#6M]:QS1.,/'*@96^H/!KC/$G[.WPB\3;I)O"D=G*W_+73F,)'_
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MZV>3[9IEVEU?DO#//!:"[**JQB5E5TWMLWM6O\7_ (#?M ?M)>*/$G[0EO\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
MGYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^
M?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_
M ,"VK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W
M_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ
MV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH
M_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH
M Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X
M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M!Y?EMOVX--;]K[X(R_#BQ^)^BW^O:O9ZCJ,^GVVG:)X0U&\U(7D)83V\EE#
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M HHHH **** "BBB@ HHHH *;+%%/&89XE=&&&5UR#^%.HH   !@# '04444
M%%%% !1110 4444 %%%% !1110 4444 -EBBGC,,\2NC##*ZY!_"G  # & .
M@HHH **** "BBB@ HHHH **** "BBB@ HHHH *;+%%/&89XE=&&&5UR#^%.H
MH   !@# '04V:&&XC,-Q$KHWWD=<@_@:=10   # %%%% !1110 4444 %%%%
M !1110 4444 -EBBGC,,\2NC##*ZY!_"G  # & .@HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>rcus-20250422_g2.jpg
<TEXT>
begin 644 rcus-20250422_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!^=W[&/@'P-^U%_P5*_:2^(?Q
M_P##5AXBU'P1J\.C>%=.URU2XAM;037, DCBD!4$);1X;'!G<]7)/IW[<OQ$
MN_V'O"?@_P""7[$O@OPYX.\4?&OXEQ6%O?Q:6@L["YF%O;RW@@QY?F'_ $9<
M;2N S%2W72^/G_!-'Q5XB_:/O/VL_P!DW]IK4_A1XSUFT%OXD-OHL>H6>I@!
M5W-"[JH8A$+!@ZED# *V6,?C_P#X)A>*/BY\ [/P-\6/VNO%&N_$+2?&O_"4
MZ%\2;FP17TR]$448A@M!)MCM@(5<1*ZXD^<$9*D YCX=_%[]L']E7]O_ ,$?
MLD?M!_M!P?%/PU\2M!N[K3-9G\,6^F7>F7<$<TC+M@)W(?)"_,S<2 C;L.[P
M/1OVL?\ @I_\3/V1/'_[7FB?M2Z-I>F?##Q=<V*Z2O@^S>YUH)- 769_*"1Q
MQQ7$80*N7P^X@A6KZZ^ O[ /Q&T#]H^S_:S_ &K_ -IBX^)WC/1-'DTSPOY7
MAN#2K/2H9 ZNXBA8AY&620;L+_K&SN(4KF^ /^"7R>!?V)_B3^QV/C>;H?$+
MQ'=ZK_PD7_"-[/L'G_9?W?D?:3YNW[-][S$SOZ#'(!XFO[5'_!0;X;_$/]G;
MX^_%/XU^'M3\(?'?7-.M+GX>Z3X;CAM]'M;X6YA*7#YFED$=P)"Q88=-OSH:
MZ,?$_P#X*%_M-_MG?'']FGX+?M.:3X(T'P-=V<VG:A<^$[:\NH/,@_=VD9V+
M^[DDW-)+(7=-B[."RGV/XC?\$[D\?^!/V?/!/_"WC:#X$:CHUT+G^P/,_MP6
M$5O'MV^>/LWF?9\YS+MW8PV.?F;P?^SE^T3\7O\ @I'^TMJ'P+_:+UKX6ZC!
M<:;"=2BT)+RUU*VG@(=&24J!(NP-'*AW(2V,;L@ J6W_  5P_:#_ .'=WA_Q
MGJ.JZ?9_$?4_B?)X(OO%DFC">*U2**.>34!:Q(5DE$<T2^6J%6;<0AX2N_\
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M[5-?BEHOQ/\  'P[T+X??\%*!\6_#]Y\5;WXV:CK7C3PI9:["^HIHMVY0P-
M&WJBI#,!P"%OAG@#'ZZ?MF_L[Z[^U=^SIX@^ .A?$P^$CXA6"*[UE=*^V,L"
M3)(\0C\V+[X383N^ZQX.:XGXB?\ !,7]E#QG^S=>_ '1/A)X4T:\E\,II=AX
MPMO"=J=0MIXXU6.[,BJLDC[T5W^<%_F!;YB: . _:Z_:2_:!^(_[7OPY_8B_
M9/\ BS8^"U\6^$I/$^M>.QI$6H2+8GS_ "DMXI?D.X6[$G@GS$(90K;O"/\
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M^"A]M\:+'QCXVM=#\8:"GPT72[&TBGGCA\VUNA$!)L+MC8^244L&!(%_6?\
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MND:"NIW%V7&I1H$MFXDVNRN<_="ENU/_ &)OAO\ %WX6V'[1_P"U?H6AVWP
M\)^+YX9/ ]KX\TL6\.EQQRREKN:R) C 67$:?=+R[5W*HW?5?Q"_8Q3QY^W9
MX"_;7/Q'-J?!'AN[TK_A&O[(W_;?.CNT\W[1YP\O;]J)V^6V=G49XZ7]L+]F
M?0OVO_V=/$?[/?B'Q'<Z1!KT4)CU.UB$C6TT,\<\;E"0)%WQKN7(RI(!4X(
M/B?]G']NWXIV/[=/P[^"VD?MQ'XW^$_'4%Y%K<EY\.AHG]G7,<$DD<EL_E)Y
MBDJOW69=NX$9*M3;'_@H-\9O@Y\!?VK/BF9=*O-6\)_&"?0_!P30+2V2W\V[
M>!9)OL\2&Y9$&_?*79B@#,037M/P]_X)K_&B'XW?"WXZ?&_]KX>*;OX5PRVF
MCZ-9^!H+&U:S-MY*HICFRLF<,TC!]P55"KC)M6__  2D\':A\*_CC\*/&GQ4
MN-1M/C)XSE\1PW-MHPMY-"G-PUQ"JYF<3['(R?W>]01A=V0 ?,'Q]\"_MF^$
M/CW^R5JO[4O[0^F^/[?7?B?I=_9K%X>AL;C2+Q[BR::V#0@+/#AEVN0IRIPJ
MC&?M/_@J;XQU7P)_P3X^*FO:-*\<\GAHV.]#@A+J:.U?I_L3-7DOA_\ X)1_
M&O6?&/PO\<_'?]NO5O%]Q\)_$NGWGAO3W\)106BV-K(CFW*I,&,\GE1 W+EV
M"I@A^"/H[]LCX+W/[0_[+'CWX,:<JF]U[PU<P::'("_:U7S+?)/0>:D>3Z4
M? 7[=B7/@O\ X)3_ +,_P-T;59-,\/\ C*7P]%XGNK=MJO')9K<NK'IM,TAF
MY[Q ]J^_O"O['/[+'@AO#<_A'X!>%M.N?",BR>'[^RT>**YM'5"F[SE D<D,
M=VYCN)RV3S7SK^S[\ ?!7_!0W_@E-X*^!_QPTK5M&OM!L(M+$KVQAO-)O].+
MVL4RK*N#F$#((P4E89!Y'0?"7]@_]M+P9JNEQ^/_ /@IAXDU_1?#D$BZ#I47
MA6.V,LOD/'"]Y*)S)=)&S*YB=COV#YUZT ?$O[:^O_!3]L/XR?M)?%;QI\9_
M#ND:I\/M*M/#_P )=.U+7X8)[R6QN#->-;QLX:0NT4Z1E1R;L 9(KU?_ (*.
M?'^+]I__ ((I^!?C2]RLM[JFN:5'K.T_=OX4N(+GCL#-&Y _ND'O7U-^RI_P
M3!_9M_9Z^#%G\-OB!X \*?$36TN[FYU3Q;XB\&6K7%[)+*S#B7SF153:@'F-
MRI;C<17EEW_P1CE?]D?Q'^Q_I_[34L6@ZG\0U\3:%<3>$?-?28PA0VF/M@\X
M$;#ORGS*QV?,< 'GOP^\&3_M4?\ !1SX6?'C]FC]DOQ-\,O"/@73IG\7>)]<
M\)+HB:JS1R*L*1IQ.2K"/();;*VX!44GTO\ 8WN'\"_\%=OVG/A3I!VZ9JEC
MH^O2Q+]U;I[>"1VQV+->R9]<#TK[8MXA;P) &SL0+GUP*^./^"<'A/7_ (B_
MM5_M#?MEZ]HEW:67B?Q='H'A5KVW:)[BRL%\LSA7 .QU6VP>F48=N #?_:P_
M:2^-G[.7[>GP3TNY\8A?A3\1&GT#5M(;3K<B+5RQ6"?[08_-3<T]N-N_9B&3
MCJ:\2\3_ /!3']H?P[\-?VC_ -J71]=MM1\(>&_&MOX/^$NDSZ7 +:.[#^7<
M7CR(BRS+L,<P5W8$R;<*.GU=^WA^QOIO[;GP6M_A?)XZE\+:IIFO6NKZ%XDM
M[#[3)87,.X;@@DC)RCNO#K@E6YVXKCO#?_!,#X4:=_P3^;]@KQ'XINK^TF$E
MQ=^*;:R6WN)-0-R;A;L1EG VL$386.8TVEN<T ?/W[-O[;_Q\T_]J'X9> Q^
MT[JWQET'QVDEKXUMKWX57&B#PW>F-6CEMYFM8?,B+DC^(!8G)"EE(Z/]C3XM
M_P#!0K]JWX_^-[Z?]H32K#P+\,OBS?V-QI+>'+7[5K5JLQ5=/,B1KY<<<2?+
M+S(6F.XMM4K[?^SW^S'^VQ\,_%N@?\+9_;U/BWPGX=A:&/P]!\/K2RFU.,0-
M%%]HNA(\GR95N,EB@+,3DUM?L@_L9G]E&7XE30_$Q]:;XA>-[SQ"KII M6TW
MS\XA&99!*5S]_"Y_NB@#Y?\ V$?VO?CW\8/VCT\*?M*?M@W/@_QQ%X@NX=3^
M!NM_#ZWM;:XM C^7%:7A ?S%.'!+%V"$8=?F/9?L^_M@_M$>./@!^UEXX\4?
M$ 76J?#/7/$\'@BY_LFT3^S8K2TGDMUVI$%FV,BG,H<MCYB172Z3_P $Y/C?
MXU^/?@+XO?M2?M@?\)Y9_#+4#>^%;2V\#6NF7<TV49#<W,3DR!6CC)7'S%2?
ME+-GG_%/_!([QY=?$/XEK\.?VS-=\*_#SXKZC<:CXL\&Z?H,3RS3S>8SQK<M
M)E82TC;E55+QGRF)&& !YC\4/VY_VO+/]C']GWXKZI\3=5\/Z)XS6\;XJ?%+
M1/!MO?W&F[)MD %NL8BA5QORRH"?+^7D%7^U?V-/&+^//V?=&\3-^T;9?%9;
MB2?R?&MGH\=@;N/S6V)+;Q\1RQKA&!"ME<E02:\QTK]B#]I+X5_L]^ O@?\
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MVKOA/X3\,?\ !02'XV:3XZ\5Q:+XMTI_AHND6ECYTL<*36MP(E$@#2,0$?\
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MJBNK-E-XD8@(0" #B?V._P!LCXSW7[:?A_X!G]HO6?C-X+\5^'[J:\\1:O\
M#&?P_+H6IPQ2S%1OMX@\+K%@ [@#*H&"OSS_ /!+;XL_\%!?VO[NS^//Q3_:
M)TH>!O#7B'4=(O\ PY#X:M4NM><0NPDDDBC00B)IK<+LQN$3;ADDO] _L^?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ\,?]!J#_OJOG[_@JSXI\/77_!-KXW6UOJT3R/\ #?5%10>2?(:OHW^SM/\
M^?&'_OT*^?/^"KUC91_\$UOC@Z6<2D?#;5""(P"/W#5UX#_?J7^*/YHF?P,_
ME4HHHK]Y/%"I+6UNKZZCL;&VDFFFD"0PQ(69V)P% '))/  J_P"#?!OBKXA>
M*+'P3X'\/W6JZMJ5PL%AI]E"7EFD/8 ?B2>@ ). *_2W]G_]E+]GK_@EI\+X
M_P!J#]KS5[/4?'+QG^Q]+@VS&SF*Y%O9H3B6XY^:<X5!T*KEWX,=CZ6"BE;F
MG+X8K=_\#S*C!R/V8_8[\8^&[7]E?X=:!>ZFL%]I'@?2;#4[2=&22WN8;*))
M(V4C((92/PKTK_A,?#'_ $&H/^^J^6?A7K_BGX9>%?!7QPBTSS]$\9^&-/U*
MXM&(94^T6R3- 3C&]-YVM@9 _P!X5]2>&]3\+^+=#M_$6@K;SVMU'OB<1#\0
M1V(/!'8BOQ3%4W&JY=&W_P ,>O"5U8=_PF/AC_H-0?\ ?5'_  F/AC_H-0?]
M]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*Y2RG_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U
M!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_
M *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
MPF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
M *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?
M^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^
M?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_
ML[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[
M]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8
M?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\
M8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^S
MM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5
M7/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^@U!_
MWU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!
M_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/
MAC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\
M)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_W
MU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_
MWU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z
M#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )
MCX8_Z#4'_?5/MO%'A^\G6UM=5B>1SA$4\DU9_L[3_P#GQA_[]"E2QLHV#QV<
M2L.A6, B@"6BBB@ KR_]H#]JOP-\!K^P\,S:/J_B#Q#>R6D[^'_#NB7M_<VV
MF/>1P7.HRK:03-'##&TLF6 \TPF-#N/'J%?,7[8?B7X/?#KXLGXG:3^U=!\,
MOB?:^$5M+>VU*T2ZL_$-@LTTL-K):2KFZ(F,NW[*ZSKYK#D,!0![/\6/VB/A
M!\$?A&_QS^)?BT:=X92"&87WV.:5Y%E *;840RL2#N*A<JH9B %8BA\2_P!J
M?X._"J33+7Q!J&KWMWJVEOJEKIWAWPS?:I=+8)MWW<D-I#(\4*[U!=PH).T9
M.17RY^U7?_M+_%W]G35OC+\5_P!G>6#2K/\ 9]U*ZM].AUFWA71]:OM)N%O[
MN:"=A*6@@8PQ( 659K@'+,,=;X&^-/A'X&_M'K\2OVE]2L_ UAXE^!N@P:#<
MZ_J,0A,MC=W[7-G',#LDG*W-M*(D)=@XP"5( ![;XM_;!^ WA31] UJ+Q)J&
MNIXGT<ZOHL'A+P_>:O//IRA"UX8K.*1T@'F("[@#+!1EN*[KP3XU\*?$?PAI
MGCWP-KMOJ>CZQ91W>F:A:MF.>%U#*X[\@]#@CH0#7P]^QYXJ\-_LE^+O#/B?
M]IG6;?P3I?B'X'VR^'KKQ-(+2.)X]:U.\DT\&3 %P+>^LV\C[YVX"DH0/H__
M ()\^&M<\*?L?^#M-\0Z/<:=-/%>WT-A=PF.6WMKJ^N+FWC=#RC+#+&"IP5Q
M@@8H ]FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0HI1D(.3T /HFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4^V\4
M>'[R=;6UU6)Y'.$13R35G^SM/_Y\8?\ OT*5+&RC8/'9Q*PZ%8P"* ):***
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\
M_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U26?A+3;&Z2[A
MN+HM&V5#W+$?B* -2BBB@ HHK*\8>-O"_@'2X-:\7:LMG;7.J66G02-&S[[J
M[N8[6WC 0$Y>::-,XP-V20 2 #5HJ*ZO[&Q\L7M[%#YL@CB\V0+O<]%&>I]J
M+N^LK"-9;Z\BA5W"*TT@4%CT49[GTH EHJ*\OK+3XA-?WD4",X0/-(%!8\ 9
M/<^E2T %%%% 'P_^VMK7BG2OV@M6\7Z3^W?^SMX5U+PW:Q2>'/#WCS0=,FUO
M2&^RI)L\^9S/'YKEI5VKG;*N%;C/H'_!-O7OVK_BW\/]+_:/^-_QD\/ZWH7C
M+PVES::+I_@Q-.N[>ZWJN^696/FJJI(@X^8,K#'2O#/VE/C#\&=%_P""A&N:
M5\?/ O[/::%#KFG:+?#QGX1LKC798Y]%^TPZS)<S<O#%,D=N4)&$"K\I*,?L
M+]B?XK:E\;_V4/ ?Q3U?PW8:1<ZOX?B>73])MC#:1;"8P8(V)*1,$#(I)PK*
M,G&: /4:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK
MR[]H7]M/]E_]E>2WLOCI\7].T6_O(1+9Z0B275].A8JKK;0*\I4LK*&V[<J1
MG@X\X\,_\%>/V"]?UJ#0M5^+EWX=FNG"VDOBGPW?:?!+[^=+"(T&,'+LO!H
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MO*/VB?@G-XJA_P"%@>"XFCUNQ >5(.&N57D$8_Y:+C@]2!CL*[__ (0?2/\
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
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MGBE'\2> O#MGH@^(^O:3)=ZG=Z=JES>36DHTUFA@BE5UC'5<3,20"44 ]O\
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M?AN>YUV\^R:;;+?@2-<&5HEB=3S"[2*R*LFTLRE5!(Q5OQ3^UK^S3X(\73>
M_%OQJT#3]8MM1CL;NPN;T*]M/(D3HLO:(,)XL,^%)< '.0 #T2BN(\<?M)?
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MQ^S]X+^)'@+PS_8FBZSX9L[K2]&$2H+"!H5V6X5 % 0?(-H PHQQ0!VU%%%
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M *^S_*!^ >)?_)1K_!'\Y&Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
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M_L3;_P#]*UK\EJ_5[_@ZVAUB'X^_"8:Q>0S,?!]]L,4>W ^U+7Y0U^S\,_\
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M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:
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M[54_9]\)?#/X9?"S2/A%\*O&)UC2O#%C'9VLL^L+>SQQ#=L6213V *KP  H
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M?/G_  5A_P"4:GQQ_P"R:ZI_Z(:NO ?[]2_Q1_-$S^!G\IU%%%?O)XH4444
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M*?"&H>'M,U'[)<7=N8XKG)_=G(YXYII)O4#6HKP?_AE?XG?]%8_\B3_XT?\
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M .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V*^?/^"L/_ "C4^./_ &375/\
MT0U>U_\ "2ZO_P!"A>_]]+7S_P#\%5M?U.X_X)N_&V"7PO=Q*_PXU0-([+A1
MY#<FNO ?[]2_Q1_-$S^!G\L=%%%?O)XH4444 ?TC^,/^3=/@7_V2+1O_ $DA
MKC*ZOQ#>W%W^SM\$!/I\D'E_";1E4R$?./LD/S#':N4K_)7Q;_Y./F/^-?\
MI,3^LN"/^24PO^%_^E,****_.3ZH]=_8F_Y+?'_V"KC_ -EK[#KXT_8YO)['
MXRQSVUA)<M_9DX\J(C/\//-?6?\ PDNK_P#0H7O_ 'TM?V-X%?\ )$2_Z^S_
M "@?@'B7_P E&O\ !'\Y&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM?LQ
M^?&Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
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MP43PEK%SQ-J-UHS0,TA[_:]/.]@/64*/48JIKO\ P1L_9?\ CCI<OBC]C_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M%GA7XK>,=#TC_@L/X9^&D4%A&(_AO??#K3[V>Q+64;;&NF)N#YQ;S00A9!,
MH.T5[E_P3131T_8)^%0T&PU*VMCX0MV6'5G#3!CDN<@#*%BQ3@?NRE 'N5%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%_\ 9(M&_P#22&N,KL_&'_)NGP+_ .R1:-_Z20UQE?Y*^+?_ "<?,?\ &O\
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M](?\/!?^J1_^5_\ ^T4?\/!?^J1_^5__ .T5\WT5\U_Q&#Q%_P"@[_RE1_\
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MZ^CF*>(-8+A#T_<6U?B=7[#PG_R(J7K+_P!*9Y6)_C,****^C,#ZM_X(>_\
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MI^RI=6>@V,;Z#I/Q7T&.XU:U46Z2-'++))A%>7>Z\!=CJ2#R3]$?L4?%>_\
MCC^RAX#^+&J-9?:=;\/0SW":=IIM((G&4:..$N^Q4*E1AB#MR."* /4:***
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M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
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M6*A0[<'.: /9**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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M&/\ H-0?]]4?\)CX8_Z#4'_?5?Z4G\@FE16;_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'
M_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;
M_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-
M0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_
MWU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9
MO_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\
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M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\
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MCX9\->'_  9X<L/"'A/1[?3M+TNSCM-.L+2()%;P1J$2-%' 55  'H*O444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_
M  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8
MHH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A
M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
MX0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_
M )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC
M_GYO?_ MJDL_"6FV-TEW#<71:-LJ'N6(_$5J44 %%%% !7S%^V'XE^#WPZ^+
M)^)VD_M70?#+XGVOA%;2WMM2M$NK/Q#8+--+#:R6DJYNB)C+M^RNLZ^:PY#
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M,C[D) CW2'"*S#OOC+_R2#Q7_P!BW??^D[UXY^Q3\*/&?B+]C[P?X?\ B_\
M$>V\4>%/$?PHTNS3PT_AR*V%O;3:?$IB:9'+3#RF,>2!GKUH ]4\8_M _"CP
M'XGOO!WB3Q%,FHZ;X;&NWUM::9<7+16)G\A'Q#&^7DERL<0S)(4?:IVG&+X,
M_:_^ OC3PSXK\4KXHO=%B\"Q++XOM/%.AW>E7>DQ-&TL<DUO=Q1RA'169&"D
M/@@9((KQ7]BW7_!G[-G[*7C;]IGXW>.[W4'L-;U#3=:\0WT.^X;3M#N9=(L;
M=53[S%+;=CJTUU(Q.6)KSC7_ !5X,^._[/'QB^/6@?$3PYXC\:^*;KPUK&O^
M#/!^N0:G+H/AS2M2MY4M)!;LYEF^S_:WF9?E:25D7*HI(!]8>$?VOO@?XPLM
M>NH-5UK39O#6F1ZEJNFZ_P"$]0L+U;*3<([F.VN($FGC<HRJ8U;+#;C=Q5KX
M7_M3_!CXL)XB31-<O]*N?"4,<_B73_%FAW>C7.FV\B/)'<2Q7L<3+"R(["3&
MW"MDC!KQB?\ :1^!VK?M6:O^U/X6^(NG:OX!\!?!*[M_%?BG1)A=VD=Q/J-O
M<06PDBR))UCMYB8E)9?.4$ N 7_L?_&#X&?%WQ3\0_VG/%7QD\$W&M>)-"MY
M-1\,67B6TNQX8\,V2R^4EX4=E\PF>66=R?+1I!&"0FY@#WCX+_'KX5?M"^'K
M_P 5_"'Q1_:^G:=J\NF7-V+.:%?M$:H[!?-12Z[9$(=<JP8$$BNPKYF_X)\_
M'#X-?$3Q9\8= \!?%3P_K-]=?%;5-7MK/3-7AGEET]H+&-;I51B3"7^42#Y<
M\9S7TS0 4444 %%%% !1110 4444 >??%7]ISX7?![QA8?#_ ,30>);_ %O4
MM-EU"VTOPOX+U+6)OLL<B1O,ZV,$I1 \B+EL<L/45-IW[27P>O[3Q3=S^)9]
M/_X0G2;?4_%,.L:7<64NG6D]J;J.:2.>-6P8E?.!E7CD1@'1E'DWQD\-?$;Q
M1_P4(\-67PS^)D?A6]3X-:L\U_)H<=^)8O[6T\&+RY'4+EBK;LY^7'>LK]LK
MX(V?BWX[_!FUU?Q#/CQMJ9\*>/TM[=4C\0:;:02ZS'#*O.Q?M%@R84_ZJ\G3
M.&H ]-\8_MP_L]^ (=/O_%NK^(+/3[ZRLKN?6'\&:F;'3(KL*;<WMR+<Q69?
M>ORRLK+N&X*.:T?BW^UQ\#_@GXAG\,>.=;U0W5AIR:CK1T?PW?:A'H]D[.JW
M-[):PR+:Q$H^&D*Y",WW5)'B_P"W=^T7\"_&OBM_V$_&GQB\,^$['4;>UN_B
M1K/B'6X++[-I1=9%L;42LIEN;D(%+#*PQ,SM\S1J<[Q?\:/A)\'_ (G_ +15
MO\4?%=A:'QWH&EZCX%M9Y5+^);)M#2S6"P7K=O\ :8Y5\N+<V9E.,-F@#W/X
MJ_MC_ 7X,7D<7CK7=66S^R075YK>F^%[^]TW3[><XAFN;RWA>"!'/0NXX.XX
M7FI?C'^UU\$?@/J/V'XCZIK4,,5K%=:CJ>G^%-0O;'3;>1BD<UU=6\#PVZ,P
M."[C@9QCFOF;XM?&3X>Z%\ _A]_P3?\ BS\7/#W@[5;OX::+;_%+6O$NM06G
M]FZ<EK#'/;0>:P\Z\N#')&H7(B0O(_/EJ_8?ML?M._ /Q#I]E^Q5!\;/"OAF
MP\9^&X;CQ-XGU;7;>WMK#PW, NVU:5@+BYN8PT<87<$1FE<X"*X!]9P3PW,*
M7-M,LD<BAHY$8%64C(((Z@TZL[PC<>&KSPII=WX,O;:YT>73H'TFXLYA)#+;
M&-3$Z."0R%-I# G((-:- !1110 4444 %%%% !7*_&'XS^ O@5X3B\9_$.\O
MH[2XU*VT^UBTS2+F_N+FZN)!'##'!;1O)([N0 %4Y)KJJ\#_ ."AMEK.I?#7
MP+I_AW6AIM_/\9?"B66HM:B<6LIU*(+*8V(#[3@[20#C% '=>%/VG?A9XKUS
M0?#(3Q'H^H^)Y[V'0K'Q1X.U'29;N2TB2:956\@C((CDW+G&\))MW>6^VIKG
M[77P6T;3+[4[2ZU_638>(KO0WM?#?A'4=2GEO;4*;E(X[:!V=(BVUY0/+#*R
M;MP(KSK]M3P5\0/"_P"Q1XE\?^*?B>-7\9?#LMXN\*^)K?1(K,VEY9@R1KY*
MLRLK)YL+Y)W1SN"*7XG?&;X8_P#!.K]F/P9\-M*UG3$UG5(!I?A:3Q/J:6EM
M=7[+YMSJ%]<.0L<8=WGF;.YV?:@+NHH ]%G_ &OO@$/A;X>^,&D^+[G5M(\6
MW!M_#$.B:+=WE[J<ZB0O#%:11-.73RI=ZE!Y?EMOVX--;]K[X(R_#BQ^)^BW
M^O:O9ZCJ,^GVVG:)X0U&\U(7D)83V\EE# UQ#)&48.)$7;CG&1GYT\%WOP(^
M .I?L\^-M*^.6AZ]\/\ 08?%NF:]\1$U.$Z8->U#R+IIIIU8Q6XDE2]50S +
MYJIGD9L^%?VMO _[-7PF^(7QI>_TXP_%#XU:E)\+O[9OEL;#4E:UM+?[9)<2
M86*S\VVN)VF_B0@H':1 P!]#0?M:?!34_A3I'QE\+ZIK&O:/KUQ);Z3%X>\+
MW]]>SSQF021&UAA::-D,4@?>B["A#8.*Z;X3?%KP#\</ EG\2?AIKAO])O7E
MCCE>VD@DCDBD:*6*2*55DBD21&1D=0P*G(KY^^&7C#X _"']D;1_#GA/]N[P
MSH[:CK=Y)?\ Q/M+K3Y[*[UF:9[R]4-<;[:+<\[%8W.X)M R02>E_P"":M])
M=?LWSVD<$5U9V?C/6HM/\5012HGBN(WLDAUD+*S$?:)))&.&*$@E,(5  /H"
MBBB@ HHHH **** "BBB@"MK.KZ=X?T>[U[5[CR;2QMI+BZEVEMD:*69L $G
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MY>61G&3N5B_+C/UG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 -EBBGC,,\2NC##*ZY!_"G
M  # & .@HHH ;+%'-&8IHU=&&&5AD$?2E5550JJ  ,  =*6B@ HHHH ****
M"BBB@ HHHH **** "BBB@!L4,,">7!$J+DG:BX&3UIU%% !1110 4444 %%%
M% !1110 4444 %%%% !37AAD=9)(E9D.49ER5/MZ4ZB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ;+%%/&89XE=&&&5UR#^%.  & , =!110 V:&&X
MC,-Q$KHWWD=<@_@:<  , 444 %%%% !1110 4444 %%%% !1110 4444 -BA
MA@3RX(E1<D[47 R>M.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>rcus-20250422_g3.jpg
<TEXT>
begin 644 rcus-20250422_g3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI&940NQ"JHR2>@% "T5SEMX^\(WEW%:VWB/3)9Y7$<<:7"DLQ. !
M[YKHZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+//F_92QQUV @O\ ^.AJ\<^*G_)P&B?[]E_Z,KZ1=%DC:-U#(P(96&00>QH
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MM7V!#_J(_P#='\J\V^.'_(DVO_7_ !_^@O7I,/\ J(_]T?RH ?1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)-K_ -?\?_H+UZ3#_J(_]T?RKS;XX?\ (DVO_7_'_P"@O7I,/^HC_P!T?RH
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M['KCB@#U634[")]DE[;(V <-*H//([U95E=%=&#*PR"#D$5X/JVGP2?%KQ+
MMKX9>.*&U5$UN0HB@1( (\=_7\*]NTM432;)(Q;A%@0*+8YB VC&P_W?3VH
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MX6L;M0UI%;W-Y$K?=>==BJ?<JK,1]:V/#6@S:'/KDDTT<@U'4I+U F?E5E4
M'/?Y:7Q-X;7Q!;VSPW;V.I64OGV=Y&NXQ/C!R#PRD<%3U% &[U&#7#^ 0+76
M/%VEVP TZSU3_1E4?*A=%=U'L&)X[9JR\?Q GM_LOG:!;,1M-]'YKL/]H1$
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M_:VPM//T&]91M6^F\V)S[M$JD$_1@/I0!UP 48  'H*X_1O^2K>*?^O&P_\
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MQU;6]&GTHQ:C#!&T=X)-R^4&'&WUW&MW1AX@#3?VX=,(P/*^Q"3WSNW?ATH
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ME:/AGX;Z5H5U_:=])+J^M.=SW]Z=S!O]@'.W]3[UV=% !1110 4444 %%%%
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MWOC'3<:OV]O+"!YEY-/C/^L5!GI_=4=,?J?; !8HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS@)PN,@Y]Z9:Z#>6R62!H%>"5G,\,CQ[4:3>T8C'# @!>3QZ<<]'10 4444
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M21V-Q>&226:.3,SJV\@;DX&6&2,X!K2TUM3M/%TVHRM?M LDLL2 @I)"8L)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW+%.&$<4:$'Z[#^=1CPU<R6L\4UQ&%:TN;6&/+2"%91&  S<L 8R>?[V.@H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[,H,R,GS*2Q7&!U((YQQ@@]"*M7&J1Q6%_=11/-]C#;E7 WE5!(!/'?'U!H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !16?>ZJMI=K;):7-S(8C*X@"G8H.,G+ G/. ,DX
M-3PZA9W$"3Q7,31/MVMN'.X!E'U((./<4 6:*SQKFFL/,6_M&@QDS"X3:#G
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M]<=JM0S17$0EAE26-NCHP8'MU% #Z*I7FI+;7$=M';3W5PZE_*AVY"CC<2Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH QKG3]2;5;JYM;FWA6X@CA\QD+/&%+G('
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MGVZ?#*VS!WYSQM^[C'S4Z?PO)-#<6RS1QV[N[1XR6&Z$0C/^ZFX=>>#7344
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&[/&&:-HR?X6QD?D2*?110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA#AA(0% ]_F7([;E]:J6/BF"72K>XNXI8II8(I @3 E+X'R9/3<<<XXYZ<T
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M'_PBUD+A)EFN!M:-BN5(8I*95R2N0-Q/ (S2MX6L"F$:5'^TO<!_D8J6&TJ
MRD;<8 &.,"MNB@#)U?2/[2LK6R 7RDE1G<MM(1?O  #!W+E".!AC]*27P[:3
MNXEEG:V9Y)!;;@$5Y%8.PP-W.]SC.,L3CIC7HH RK?0HH;M+N2ZN;B='5P\I
M7^%'0<*H'21OQJ.^T,ZAJ=Q++<RQVLUJEO)%&1^\ 9RP;(/!# 9!!Z]*V:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 45C7GB?3M/N=4@NC+$VFV@O9
M2RC#Q'=RG/."I';G%9]SX\TZV,[&RU*2"T1&O9XX 4M-RAL/SG(!!.T-CO0!
MU-%<TWC.V76GTO\ LO4VD6(S^:L<9C,.2/,!WYVY'IGVJ]X?U^/Q%8K>P6%[
M;6\B))$]RBKYJL,@KM8]O7'44 :]%<?;_$;2KFWGF6QU,+%;/=J# N98D<([
M)ACG:3R#@^F:W-,U^QUB[N8+!FG2W6-GN% \LEUW!0<\G:03Z;A0!J45QX^)
M6@GPY?:WMNQ!9W'V:2(Q#S6;CE1GD8.<YZ ^E:5SXOTNTU32-.E,HGU1-\)"
M?*@(^7><\;CP.N2* -ZBL*'Q;IT^KIIB+/Y[7DMD"4&WS(XQ(W.>FT\>];M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDP @/(>.0I9>/3/I0!KT5E7&HWDFI26.G6T,KP(KS2SRE%7=G:HPI).!D],
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA((FC1M\BL" KG/W1G.!U(!XQ6S10 V/?Y:>85,F!N*C SWQ[4ZBB@ HHHH
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M!I45F3^(=)M91'-?1)F-9=YSL"-G:Q;[H!P>2>U3RZI9PWD=HTQ,[A2$1&?
M)P"V =H)!P3@<&@"Y1110 4444 %%%% !114-W'/+9SQVLX@N'C98IBF\1L1
MPVWO@\X[T 345QO_  C_ (Y_Z'FV_P#!*G_Q='_"/^.?^AYMO_!*G_Q= '94
M5"T<YLC&LX%P8]HFV9 ;'WMOUYQ7)_\ "/\ CG_H>;;_ ,$J?_%T =E17&_\
M(_XY_P"AYMO_  2I_P#%UUD$<Z64<<TXEN%C"O,$VAFQRVWMD\XH FHKC?\
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M>C'.>/IB@#8HKG];TOQ)>WRRZ1XDATVW$85H7T]9R6R<MN+#M@8]JS?^$?\
M'/\ T/-M_P""5/\ XN@#LJ*Q-!T[7[&2<ZSK\6J*P C5+%;?RSSDY#'.>/RI
MNNZ;XAOKF)]&\11:9"J8>-[!9]S9ZY+#'':@#=HKC?\ A'_'/_0\VW_@E3_X
MNM70M-\0V-S*^L^(HM3A9,)&E@L&UL]<ACGCM0!NT5B:]IVOWTD)T;7XM+50
M1(KV*W&\]CDL,8YK(_X1_P <_P#0\VW_ ()4_P#BZ .RHKG]#TOQ)97KRZQX
MDBU*W,9584T]8"&R,-N#'L",>]6->L-<OA!_8NN1Z64W>:7LEN/,SC'5AC'/
MUS0!L45QO_"/^.?^AYMO_!*G_P 76AHVE>)[/4!+JOB>'4;7:08$TU83GL=P
M8]/3% '145DZ[8ZS?0PKHVLQZ9(K$R.]H+C>.PP6&*P_^$?\<_\ 0\VW_@E3
M_P"+H [*BN:TG2/%5IJ4<VI^*H;^T4'?;KIBPEN#CY@YQ@X/3M6CKEGJU[:1
MQZ/JR:9.)-S2O:B<,N#\NTD8YP<^U &I17&_\(_XY_Z'FV_\$J?_ !=6],T;
MQ9;:C#-J'BV"]M%)\RW72TB+C!_B#G'.#T[4 =/16=K5IJEY8B+2=433;G>"
M9WMA.-O.1M)'MS[5SW_"/^.?^AYMO_!*G_Q= '945RUAHOB^"_@EO?%\%U;(
MX,D"Z4D9D7TW!SCZUM:Q;:C=Z<\.EZBFGW1(*W#VXF &>1M)'7ZT 7Z*XW_A
M'_'/_0\VW_@E3_XNIK30_&45[!)=>,K>XMTD5I81I"(9%!Y7=OXR.,]J .LH
MJGJMO?76FRPZ;?+8W;8\NX:$2A.03\I(SD9'7O7,_P#"/^.?^AYMO_!*G_Q=
M '945R,&A>-4N(WF\:V\L2N"\8T=%W#/(SOXSZUTFHPW=QI\T5A=K9W3+B.=
MHA($/KM)&?SH M45QO\ PC_CG_H>;;_P2I_\72KH'C@.I;QQ;LH/(_L9!D?]
M]T =C14%[%<36,\5I<BVN70B*8Q[Q&V.&VDC./2N4_X1_P <_P#0\VW_ ()4
M_P#BZ .RHKC?^$?\<_\ 0\VW_@E3_P"+KK)XYWLI8X9Q%<-&528IN"MCAMO?
M!YQ0!-17&_\ "/\ CG_H>;;_ ,$J?_%T?\(_XY_Z'FV_\$J?_%T =E14*QSB
MR$;3@W'E[3-LX+8^]M^O.*Y/_A'_ !S_ -#S;?\ @E3_ .+H [*BN-_X1_QS
M_P!#S;?^"5/_ (NNLM(YXK*&.YG$]PL:K),$V!V Y;;VR><4 345QO\ 8'CG
M_H>;;_P2I_\ %T?\(_XY_P"AYMO_  2I_P#%T =E6%H6C7&F2W#7#1ND2BVL
ME4_=MU)90<]#\P4^R*:U;"*Z@L((KVZ%U<H@$LZQB,2-W.T$X^E<O)H/C9I7
M:/QO;HA8E5_L9#@>F=_- %Y=%O8M*LI%\F34X;K[;,"Y"22,&#J&QG 5R%./
MX5J*;2+N>RNTN]*M+UK^X:>6%[DJL1V*B#=MR?E49('!Z9JI_P (_P".?^AY
MMO\ P2I_\773Z9!>6VG0PZA>+>W:@^9<+"(@YSUV@G'&!UH P+_0K^ZTFPT]
MX+>>YMH(U34GF*M%* ,R!<9)R 0,\]#BK5WI=S>>(;2]%E;P-;2Y^V"<EWCV
MD;-NWOGG)XZC)JE<Z%XTDNIGM_&EO#"SDQQ'2$8HN>!G?S@<9J+_ (1_QS_T
M/-M_X)4_^+H TKGPTMQ=V'FSW%Q;PM*TAFN&W_,H  (QQQTI)["_.M6JK8VY
MTFS"?9HDFV!6Q@NR[?X1PJ]._7&W4TFWO[738H=3OUO[M2=]PL A#<G'R@G&
M!@=>U8-[HGC&:^GEM/&,%M;/(6BA.DHYC7/"[MXS@=Z $M?#U[#KZWQA@6?[
M5)++?B=B\L+9VQF/&.!L'7 V9'-;>EV4UO+>W5T5-S=3ECM.0L:_+&H_X",G
M_:9JY[_A'_'/_0\VW_@E3_XNNBT:UU*ST\1:KJ2:C=;B3.EN(01V&T$]/K0!
M%8:=/;:+=6CE/,EFNG7!XQ)*[K^C#-6],MWL]*L[:3'F0P)&VT\9"@'%8.HZ
M-XNN-0FEL?%T%I:LV8X&TI)"@]-Q<9_*JO\ PC_CG_H>;;_P2I_\70!V5%9N
MB6FJV5BT6KZJFI7!D+"9+80 +@87:">^3GWK+U71_%=UJ4TVF^+(+&T;'EV[
M:6LI3@ _.7&<G)Z=Z .FHKC?^$?\<_\ 0\VW_@E3_P"+K=T*RU>QMI$UC6(]
M3F9\I(EH(-JXZ8!.>>] &K17-ZOI/BF[U%YM+\4PZ?:D +;OIJS%3CD[BPSD
M^U4?^$?\<_\ 0\VW_@E3_P"+H [*BLC0K#6K&.8:SK4>J.Q!C9+,6^P=Q@,<
MYJKK6E>)KR_\W2?$T.G6VP#R'TY9SNYR=Q8>W'M0!T-%<;_PC_CG_H>;;_P2
MI_\ %ULZ#I^NV)N/[:UV/5 ^WRMEDMOY>,YZ,<YR/ICWH V:*P-<TSQ'>WD<
MFC^(XM,@$85HGT]9RS9/S;BPQQ@8]JS/^$?\<_\ 0\VW_@E3_P"+H [*N2U;
M3[QO%TFIQVSW-M;6EN3;$869@\QRIZ&1,@@'CYNQVL-'0M-\06,TS:SX@BU2
M-E C1+%;?8>YR&.:-=TWQ!?3Q-HWB"+3(U4B1'L%N-YSUR6&* *5G(Z^*KV9
MI=3ABN7A:.-;)C%(/*499C&2I!X(W+C'-9=K;W<G@^2P674VNE6/]Q-9%%B(
ME'W#Y8W8Z]6X%6_^$?\ '/\ T/-M_P""5/\ XNM30],\1V5W))K'B.+4X#'M
M2)-/6 JV1\VX,<\9&/>@#0TW3A8?:':XDN)[F7S999 HR0JJ,    !0*P+BP
MNY=$N842>*5];2561,LJ?:4;> 01@ $Y((P*T]>T_7;YH#HNO1Z6$#>:'LEN
M/,SC'5AC'/US6/\ \(_XY_Z'FV_\$J?_ != !=Z7?1ZU<,TEW>JS::1-)&O1
M+B0L!L51A003Z9K0T1GM]4:RLA=MI2PLVVYMGC^SN&7:B,P!92"YQSMVCG!
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M;+;(6+LY  XXX/>O0?BA97-UX=L+B&UDNX+'4[>[N[>-=S2PH3N 7OU!Q[4
M;&C>,] U^[:TTZ_WW(3S/)DB>)V3^\H< D>XIL'C?PY<Z!=:[#J:/IMJ_ESS
M"-_D;(&"N-W\0[=ZY6ZU6S\9>/\ PO<>'_,N(]-,TUY>"%T6)&3 C)8#))[5
MYQ<Z9?:/\)XKVTM97M]9B>UOHE4Y25+AFBEQ[J&4_P# : /?6\0Z6MQJ=O\
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M?3K2*Y<LS3)"JNQ8Y8E@,\GDTL.D:;;7CWD&GVL5RY8O,D*J[$G))(&3D]:
M..A%M;^'[>R5;H/J-U,D[VZR22"".5]Q^7+ 8VID=-XJW97S:PNC6-_+,L>)
MXKH,&B::>+:%5@<$!E+2;3U &>*ZR*TMH'#16\4; , 50 @$[B/Q/)]ZCGTV
MQNHYHY[.WE29@\JO&"'8  $YZD  9]A0!C:A'-INJZ-;Z3;Q%3Y_[EYFC3&T
M'J%;\L5/X>N)VM]3DO=D;I>R[@)2ZH !T8@<?@*T[?3K*U6);>T@B$6[R]B
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M9QV-GX@FLXRL\.HP10YE8 *1;G;GG ))[=S7:PVMO;-,T$$<33/YDI1 I=\
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MW_VX:?:B[SN\\1+OSC&<XSG'&: .1TR.677T$\9B@N+Z^0SBX9OM(#2 0LG
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M^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\
M0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#X
MW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^
MASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\
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M^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\
M0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#X
MW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^
MASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\
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M^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\
M0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#X
MW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^
MASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\
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M^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\
M0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#X
MW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^
MASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\
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M^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\ \;H ]DHKQO\ X0OXO?\
M0YVG_?Y__C='_"%_%[_H<[3_ +_/_P#&Z /9**\;_P"$+^+W_0YVG_?Y_P#X
MW1_PA?Q>_P"ASM/^_P __P ;H ]DHKQO_A"_B]_T.=I_W^?_ .-T?\(7\7O^
MASM/^_S_ /QN@#V2BO&_^$+^+W_0YVG_ '^?_P"-T?\ "%_%[_H<[3_O\_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O&OV@E5--T"Y4
M8GCNG"..H& ?Y@?E7LM>.?M"?\@+1/\ K[;_ -!H ]B'*@TM(OW1]*6@ HHH
MH **** "L/QI_P B+X@_[!MQ_P"BVK<K#\:?\B+X@_[!MQ_Z+:@#D_@;_P D
MU@_Z^9?YUZ17F_P-_P"2:P?]?,O\Z](H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBJ&MZ?+JNAWVGPW36LMS \23J"3&2,;A
M@CI]10!?HKQO_A2VO_\ 10;_ /[]2?\ QVC_ (4MK_\ T4&__P"_4G_QV@#V
M2BO&_P#A2VO_ /10;_\ []2?_':/^%+:_P#]%!O_ /OU)_\ ': /9**\;_X4
MMK__ $4&_P#^_4G_ ,=KE/B!X)UWP-H,.IMXQO[T27*P>7\\>,JS9SYA_N_K
M0!]'T52T<LVAZ>68LQMHR23R3M%7: "O'/VA/^0%HG_7VW_H->QUXY^T)_R
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MGUN^U&'5GAF.U)DCXCB)[ J,CZUZO<VMO>0F&Z@BGB)!*2H&7(]C4@
MZ 4 >6:OX,\0^)+;Q1J$UI;Z==ZE!;16]EYXDW&%P^YW QDXP/3O70>'M-UZ
M3QUJ&OZMI\-C#<V$4$<27 E92K$D,0!ZYXXZ5VE% 'G=WX)U*7XA_:(_*_X1
MRXNHM3N$W?-]IC1E "]P3L8_2LR]\%>(Y-*U?PQ%96KV>HZH;T:N;@!HT,BN
M<IC<7&W&1QS7J]% 'G.L^$=:O=:\7P011_8M?M(4CO/. \EXHRNUEZD,>XZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_KYE_G7I% !1110 45@>&/M"2:S!<WD]VT.H%%DF;)P88F( ' &6/ X&:WZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHKE6\?Z.FIZ[8,ER'T6!KBX<HNQU4 L$.>2,@<XY-/D\<Z79VLUWJ9^PP(8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3#Y2Q[UW8XP58#'6II? UZ\]Y<K!:_:I?$L6I)+D;A;J4XSC(/#\>_O7HM%
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MO2*\W^!O_)-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!112;@&"Y&XC(&>30 M%%% !1110 44U)$D7<CJPR1E3GD'!'X$$4Z@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BHKFY
M@L[:2YNIHX((UW/)(P55'J2>E847CWPE/,D4?B/3&D<[5'VE>3^= '14444
M%%%% !1110 4444 %%%% !16;JOB'1M"\O\ M75+2R,F=@GE"EL=< ]:9I7B
M70]<D>/2M6L[R2,;G2"8,RCUP.U &K1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$5,98JRLH.1AB"#3+32O$FJ^*=,U;78=.LX-,6;R8K29Y6E>1=IW$J  !^M
M'94444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\ ("T3
M_K[;_P!!KV.O'/VA/^0%HG_7VW_H- 'L2_='TI:1?NCZ4M !1110 4444 %8
M?C3_ )$7Q!_V#;C_ -%M6Y6'XT_Y$7Q!_P!@VX_]%M0!R?P-_P"2:P?]?,O\
MZ](KS?X&_P#)-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?^2:P?\ 7S+_ #KTBO-_@;_R36#_ *^9?YUZ10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 17-M!>6TEO<PQS02+M>.10RL
M/0@\&L.+P)X3@F26/PYI:R(=RL+5.#Z]*Z&B@ HHHH **** "BBB@ HHHH *
M*** ,W5?#^CZYY?]JZ7:7ICSL,\*N5SUP3TINE^&]$T.1Y-+TFSLY)!M=X(5
M0L/0D#I6I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.
M?M"?\@+1/^OMO_0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,3/N8O)QCYG)W'@^O%78T6*-8T&%4!0"<\"G44 %%%% !1110 4444 %%%%
M!1110 4444 8/B[1+G7=%2&QFBBO;>YBN[<S F,O&X8!L<X.,<5B:E'X^U?2
M[K3)-.T&VCNX6@><7<KE%88)"[!DX)QS7<T4 5=-LETW2K.P1RZVT"0ACU(5
M0,_I5JBB@ HHHH **** "BBB@ HHHH XZ]TGQ'I?BK4=8T&+3;N+4HX1/#>2
MO$T;Q@J"I52""#W[TNG:3XBU#Q79ZWK\>G6J6%O+%;P6<KR%VDV[F9F P %&
M *["B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ QCKSZ=:HW?A_7AH$FD!)I8VTTQ0I:W"QQ1SMOW"0DABHR@&,C .0*] HH
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MS0KOPG.+""WDM+"XAU)XV7<SL5*@D??Y!]<5Z110 5XY^T)_R M$_P"OMO\
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MA]IEN/LX\R61)7^8X+KC:V,XSP.<=A2W.D6%XLRSVJ/YSK(YY!WJ %8$<@@
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M1ADCE25D1I%56D3^%B%) .#@X[C.!TJ:YTBPO%F6>U1_.=9'/(.]0 K CD$
M#!%3VMK%96ZP0!A&N2-SECR<G)))/XT <II5[JNK"RMX+V.R1M,CN28H%)\P
MLP  / 7CD=?0BF0:QJ>NV$DT=U%9+'I$%XR>6&$CRH['<3R$&W'&#UYXKJK;
M3K2S*&W@2,I$(5V]D!)"_3)-59?#FD3Q01262&."$0(H) \H=$8 _,OL<B@#
MD;'6M:.GQP:9;W$AL+&U$<,<2,L[F)7(=F((!!"C;C!!//2M*;5]52'4]2%[
M'Y5CJ'V=;41+AX]R ACUW_-Q@@=,@YK>?0-,>6&3[*$>&-8E,;LF47[JM@C<
M!V!S56T\,6,-[<7=Q$DTTMVURIR0 <@J2N<%EQP2,CM0!F:=K6M7^I)/';W#
M6AOIK:2/RD$21([IN#YW;LJ">W)&.]1V&M:M#IFC:G>7*W0U"V:1[=8@H0B$
MRKM(YS\I!SGD\8Z5TD>C6$.H-?10;)V8NQ1V"EB,%BH.TMCOC-2QZ=9Q1VD<
M=NBI9C%N!_RS&TKQ_P !)% '%7VHZCIXTK6;J[CO6_LZZO?)6,( RPAMJ8YV
M\XYR>G/-67U?Q%:V-Q(5E8&*)DN+J!$593(JE0$8Y0ALC/(QU.:Z*V\.Z1:3
MK-#8QJZJR)DE@BGJJ@G"K_LC IUOH&F6L#P16V(6VCRVD9E4*<J%!.% /88%
M '.:[-J<5CK>G-JDC-;VUO<QW C17Q(TBE#@8QF/(.,\XYK?URZN]+\,7=S!
M*LEW! 2DDBC#,.Y _I5RXTVSN_M/GVZ2?:81!-G^-!N(4_3>WYTYK&W>P^Q2
M1F2W*["LC%LCW).3^- ')WVIZ_#?W=A9O<75Q96Z2JT=O'MGD<N0'R1M3Y0H
MV\]22<4NH:QJYL=7U.&]2U%C<+ EJ\2L",)G>3SN.\XP0/N\&NDO-&L+^Y6X
MN(,S*NSS$=D)7.=I*D;AGL<CFLK6/#/]KZ@SO%9)#(T9>4(QE8+CC&=I/! 8
M\@'@4 5+K4]23[7-&TD-C;WDRW,UI"CRHJJA5BK [EY;<0"W3'>J]WJ5]IMU
MKVHP7KW2;+5;>(HI13*P4,,8R!NSC(SW/>NFNM"TV\5EGM\J[L[JLC*'+8#;
M@"-P.!P<BG2Z+IT\TLDMHC&:'[/(ISL>/G"E>AQDXR.,T <XVI>((T%OF:(2
MW<$4-U=P1ARK[MXVH<$KM!!X^\!S@T0ZQKDVI2BWCN9X[:^2T9/)C$;Q@JLD
MC-D,&Y9A@ 8 &#G-='!HUA;1JB0LP602KYDC2$,. 06)/%#:-8-J!O\ R-MR
MS!F9'90Y P"R@X8@ #)!Z"@#EC=:AJ$>@ZE<7B&*ZU, 6OE@", 2;0IZE@%^
M;.>^ ,5NZQ<WHUG2]/M+M;9+H3&1]@9_D"D;<\9Y[@\9JPOA_2EO1>"S3SED
M,RG)PCGJRKG )R<D#GO3-4T.'5=1L;BXP8[99/E!*MN;;@JP(*D8/3UH S]'
MUJ^N=4MK&YDC? O8Y)%3'F-#+&BM['#'('?-9MG<WVLZ_821WZVSO9W@,D<:
MLQ5+A57:#D= ,G!_7-=,^@Z9):6]M]D58K<DQ>6S(4)ZX8$'G)SSSWS3'\-:
M.\<*"Q2,0!EB,3-&8PQRP4J00">HH Y7^V+F=)-1E6%KD:>J/\F4<K<E"P![
M'&1]:Z/2I[W5+NYNVO#%;P7<MNMHD:X(C8IEV()R2-PP0,$=>M7O['T[REB%
MG$(UB6 (JX 13D* .P- T>Q743?I"4N6.YV1V4.<8RR@X8XXR030!>HHHH *
MXGP%9VL]KKT\UM#)*^N7FYW0%CB3 R3Z"NVKA[72O%WAV[U*'1X-(O;"[O9;
MR-KF>2*1#(=S*0%((!S@T 3:)#%;?%#Q)'!&D4;V-F[*BA06S(,X'? KLJY?
MPUHVKPZWJFNZX;-+N]2*%+>S9F2-(]V,LP!))8]JZB@ HHHH HZTS)H6H.C%
M66VD((Z@[36)X$TVQ'@'0"+.WRVGPNQ\H<DH"2>.I))KH[NV6\LI[5R0LT;1
MDCJ 1C^M<5I-KX\T'2;328++0;N"SB6"*=KJ6-G11A25V'!P!GF@"U\/42&V
M\0P1*$BBUV[2-%&%1<@X [#DUV-8'A'1+O1-,NAJ$L,E]>WDM[<>0#Y:/(<[
M5SR0 !R:WZ "BBB@#D/B?S\/[]3]UY;=6'J#/&"/Q%;>I:5IS:1=Q&PMC&8'
M7;Y2XQM/'2H?%NAR>(_#%YI<,ZP32[&CD894.CJZY]LJ :Q;B3XAW-I+;'3?
M#L;2(4,OVN4A<C&=NS],T 7_ (>NS_#SP^S,6/V&(9)_V:Z6LWP]I(T'P[I^
MDB7S?LEND)DQC<0,$X[5I4 %>.?M"?\ ("T3_K[;_P!!KV.O'/VA/^0%HG_7
MVW_H- 'L2_='TI:1?NCZ4M !1110 4444 %8?C3_ )$7Q!_V#;C_ -%M6Y6'
MXT_Y$7Q!_P!@VX_]%M0!R?P-_P"2:P?]?,O\Z](KS?X&_P#)-8/^OF7^=>D4
M %%%% !1110 5D>);L66BR.84E5W2)O,<HB!F +.1R%&<G^@YK7HH \XM)=J
MO%=W .A)JI61X Z0!#;(RCEB1%YA.3G:3CL:U&DT3^V=M]/"ND_98SII,I%N
MS;G\S:<X+_<]P,8[UV=% ' M(F7)EE_X2?\ M3"Q[VW^5Y_'R]/)\G\.I^]5
MB/4PL=IIQGD-^NMR^;""2ZQ&>1E+#LA4K@GCD5VU% '$:=8>5#HEW^_-S<7\
MT5P[NQ+Q%9OE;G[HPF!VP*9HD4%J=,MK/Y&36;Q;F-6.5&VYV[AV&-I&>O!K
MNJ* //\ 3[.\L]#T&XT\S_VE=:4_FO([,9)?(#*7SW#],].0.*GT5]-7Q+HZ
M::]SN:PG-T'9^7!BQY@;_EIRV<\\\]J[@C((]?2L^ST>*UN_M;W%S=7"QF))
M+APQ1"02   .2JY/4X'/% &3J.GPGQ=]L$)\X:9,1(">&W*!^.,UD06LL]G?
MW<S7#3P:# 8,NV%D,4NY@/[QX&>M=]10!QD6@VS:I% ZW#0/IGF2*TSX>8$
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MW,@S(6 !4%5 90Q #8[D9.*Z.B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]H3_D
M!:)_U]M_Z#7L=>.?M"?\@+1/^OMO_0: /8E^Z/I2TB_='TI: "BBB@ HHHH
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M.6V,"+)!!.\K!\G#OO.58C(.>3@9Z4 =;17!"9#I&J,L[_\ "5 7/[HR'SU
M+8\M"?N[,%<#!X/7-0ZC):^1>KX;NY7MCI<QN7@F9PDNY/*.23B3'F9[\<]J
M /0Z*X75M(BMY?$0MS=*EKI27%LJSOA)SYV7'/W_ -VG/^)S4U.XMWG\3[[J
M<:PDD?\ 9D8E8'S?LT141+GDES\P'8\\&@#T6BN!C-U/XEG6XO[6UU%-14QK
M+,XE: $$*B?=9&3(XR,DD\BIM/M#;V^B7WFW*W,]]/'<2M(Q)C*3$ @\;050
MCCC _$ [BHY)XHI(DDD57E8I&I."[8+8'J< G\#7GUMJ5M9Z;+IP^Q7D)EAB
MDU07+_9WR'.Z5LG#CRP"-Q!,B9(S@):1VTD6BW&H2H8+?69XTF+.D:QF*79@
ML?NEBH7)[@#@@4 >A0RB:,N$=/F9<.I4\$C.#V.,@]Q@U)7!0RP&ZA&OW#1Z
M;OOO+::4I&91=. &.0,A,;0>V<=*DT:Q?5;RVCU,W<ML+.4Q)+(ZED\]A$S<
M@E_+V\GGG/6@#N:JZA?1:;9/=2J[*I50B#+,S,%51GC)) Y]:YJ2XNY/ &BS
M7,MQM=+4W\JDB3RR%WDD<C_:/INK,O;6SOXKZ.P+7&CI=Z<82DC-&)3.!*$.
M?N[?+SC@$GOF@#O3<+':&XG!@14WN)"/D&,G."1Q[&H["_MM3L8;VSE\VWF7
M<C[2,_4'D'V/-9'B9;B2QM='L+=9GNW"O&\A1?(3!D!;!P",)T/WZP;@:C!%
MJ.E7,)L_M-_:74'V2=FPDES&LP#[5(.[<QX_Y:4 =]17(VB:9;>([JUU.40R
MQ31+I<4TQ53%L3'E@G#-YF\'J>@/&*IVNJ+);^'M/-](MY%=3+>!6.^$+!.,
MOZ<[2,]< C.* .ZK)T_Q+I>J.B6LTQ:2,RQ>9;21>:HQDH74!^HZ9ZUG>#IH
M?+N[.%K>Y%OY>;ZVD9X[DD'DY)PXQ\PR?O YYP.;\+LS1:"(K^6_:&QD26 Q
M@"Q_=]=R@<Y 3#9/.1T.0#TB*030I*%=0ZAMKKM89[$=C3Z\[MYK0V6=?NKB
M.7^S;8V/[UU9OW7S&/!^:7?G.,M]WUIXN;ZUO4/FV]]KMU:@&$2'SK*<6V>5
MR5\HLO<##/WSP =[+*(54E';<RKA%+8R<9/MZFI*XF"72SI5DVE7327ANK3[
M7NF9IQF5=WF@G(/7(..XK/THW<S^;+J%M%J:"Y-[!Y[FXD&UQM*'@*&V%2!C
M &.#0!Z-17 R6U[IVFV<FE&Z-]<:).\A+L[2S!8BK$'C?EFQ]<=*-2FTI=/L
MCHMW ]FUT@U)Y+ESM3RY-OGG.Y<OMSG'/#<9H [ZH8+J"YDN(XGW-;R>5*,$
M;6VAL?DP/XUP-PT=AI]K>RZG9:C'&TS6]@EPQ\Y"XP(6SEG4@JO!X(&5ZUZ
MD,41E:.-4:5M\A48+-@#)]3@ ?@* )**X+3$DTC2/#NI1QW<]S+8,]TOF,SS
MD0;PI!/7<H ],X'6LX3R2QWZV5U$(I[&-V_L^61U23S5'WR>7 8Y( /3(Z4
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MC,5D^SS;_,4_= 8X7IQ]WBM77UN)M5OH%EN$B<Z6O[IV7 :Y</@CIE>"1VH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^(/^P;<?^BVH Y/X&_\ )-8/^OF7^=>D5YO\#?\ DFL'_7S+_.O2* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *\<_:$_Y 6B?]?;?^@U['7CG[0G_("T3_ *^V_P#0: /8E^Z/I2TB
M_='TI: "BBB@ HHHH *P_&G_ "(OB#_L&W'_ *+:MRL/QI_R(OB#_L&W'_HM
MJ .3^!O_ "36#_KYE_G7I%>;_ W_ ))K!_U\R_SKTB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU@_Z^9?YUZ17F_P-_P"2:P?]?,O\Z](H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5YO\#?\ DFL'_7S+_.O2* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF^*6-]K)N\MU=2,CD94<]".E5#;6&CWL\IU.XMX,27DMH64Q8)^=_NE@,G)
M;&3G% %!?%<[7LT%M%!J :UGGMQ:JX#M'C";R-K[MW5>F.AS1+XL:.SLPMQ9
M2W%U.\?F+'($A"KN;>GWMPR!M..H/%7[3PM;67D>5>WO^BV[6UKN=?\ 1XR
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M- L<:QI)&5+J%QC[P([=Q6:NAZ59R1I-+YUS.+A0MQ(H:Y,@!DR, 'A!P!@
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M+"DTWVD+"[DJ@8I][?\ =  P#A<\4 =+JU\NGZ>\YF@A;*JK3YVY)QC Y)]
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M3R0J%5_,B"AL2.<;<'9T[;AR>:T?[$L8'7[5=3SW5S<Q.)IF7?(\6711M
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M@9-=!;Z5IUG \%MI]K!#(=SQQ0JJL?4@#FI9[.UN5E6>VAE65 D@DC#!U!)
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MU6TMQJ#;MVU[=092Q[[UVIGVKH_$\DPM[2)+9989)\32M9M=>2 K$,(UY))
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MWM=\04N9(T&_I\SA<_K0!9HJGC4_[]I_WPW^-&-3_OVG_?#?XT 7**IXU/\
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M]^T_[X;_ !H N453QJ?]^T_[X;_&C&I_W[3_ +X;_&@"Y15/&I_W[3_OAO\
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M."#WH T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*=E_Q]ZC_P!? _\ 14=7*Q4UG2['4=1AN]2L[>7SU.R:=4;'E1\X)J;_ (27
M0?\ H-Z;_P"!:?XT :E%9?\ PDN@_P#0;TW_ ,"T_P :/^$ET'_H-Z;_ .!:
M?XT :E%9?_"2Z#_T&]-_\"T_QH_X270?^@WIO_@6G^- &I167_PDN@_]!O3?
M_ M/\:/^$ET'_H-Z;_X%I_C0!J45E_\ "2Z#_P!!O3?_  +3_&C_ (270?\
MH-Z;_P"!:?XT :E%9?\ PDN@_P#0;TW_ ,"T_P :/^$ET'_H-Z;_ .!:?XT
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M*T\%_P#0N6/_ 'Q_]>NJHH Y7_A6G@O_ *%RQ_[X_P#KT?\ "M/!?_0N6/\
MWQ_]>NJHH Y7_A6G@O\ Z%RQ_P"^/_KT?\*T\%_]"Y8_]\?_ %ZZJB@#E?\
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MI$5  $ VR &-2"<>A'%=/0!RO_"M/!?_ $+EC_WQ_P#7H_X5IX+_ .A<L?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>rcus-20250422_g4.jpg
<TEXT>
begin 644 rcus-20250422_g4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6FA&*ZT.>TTUK**&YGGN(I)A(ZEXV4$G<<DDCH3UH 5O&JK%>N=%U+.G9_M
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M'>Z+)9PQ2SJTCRG=RY#,!G<.YZ<F@#H+6[F7Q9K('GS1Q:;:21P*V26+7&<
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MXW0>2V\-N8,1E<9^[D\=*L>)K&ZO=*62PC62_M)X[JV1FVAF1N5SVW*67/\
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M((J_6#IEM?Z7_:#"T$QNM4:0 2A<1-M!?\ "<=3BMZ@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JJ:=9QZC+
MJ"6Z"\E4(\V/F*C'&>PX'Y"K5% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5%!:P6JNL$2QB21I'"C&68Y)^I-2T4 %%%%
M !56TTZSL9+B2UMTB>X?S)F4<NWJ35JB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\
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M $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\
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M $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\
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M $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\
M^-T >R45XW_PA?Q>_P"ASM/^_P __P ;H_X0OXO?]#G:?]_G_P#C= 'LE%>-
M_P#"%_%[_H<[3_O\_P#\;H_X0OXO?]#G:?\ ?Y__ (W0![)17C?_  A?Q>_Z
M'.T_[_/_ /&Z/^$+^+W_ $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&
MZ/\ A"_B]_T.=I_W^?\ ^-T >R45XW_PA?Q>_P"ASM/^_P __P ;H_X0OXO?
M]#G:?]_G_P#C= 'LE%>-_P#"%_%[_H<[3_O\_P#\;H_X0OXO?]#G:?\ ?Y__
M (W0![)17C?_  A?Q>_Z'.T_[_/_ /&Z/^$+^+W_ $.=I_W^?_XW0![)17C?
M_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\ ^-T >R45XW_PA?Q>_P"A
MSM/^_P __P ;H_X0OXO?]#G:?]_G_P#C= 'LE%>-_P#"%_%[_H<[3_O\_P#\
M;H_X0OXO?]#G:?\ ?Y__ (W0![)17C?_  A?Q>_Z'.T_[_/_ /&Z/^$+^+W_
M $.=I_W^?_XW0![)17C?_"%_%[_H<[3_ +_/_P#&Z/\ A"_B]_T.=I_W^?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5XU^T$JIIN@7*C$\=TX1QU P#_,#\J]EKQS]H3_D!
M:)_U]M_Z#0![$.5!I:1?NCZ4M !1110 4444 %8?C3_D1?$'_8-N/_1;5N5A
M^-/^1%\0?]@VX_\ 1;4 <G\#?^2:P?\ 7S+_ #KTBO-_@;_R36#_ *^9?YUZ
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5XY^T)_R M$_Z^V_]!KV.O'/VA/\ D!:)_P!?
M;?\ H- 'L2_='TI:1?NCZ4M !1110 4444 %8?C3_D1?$'_8-N/_ $6U;E8?
MC3_D1?$'_8-N/_1;4 <G\#?^2:P?]?,O\Z](KS?X&_\ )-8/^OF7^=>D4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>.?M"?\@+1/\ K[;_ -!KV.O'/VA/^0%HG_7VW_H-
M 'L2_='TI:1?NCZ4M !1110 4444 %8?C3_D1?$'_8-N/_1;5N5A^-/^1%\0
M?]@VX_\ 1;4 <G\#?^2:P?\ 7S+_ #KTBO-_@;_R36#_ *^9?YUZ10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5XY^T)_R M$_Z^V_]!KV.O'/VA/\ D!:)_P!?;?\ H- '
ML2_='TI:1?NCZ4M !1110 4444 %8?C3_D1?$'_8-N/_ $6U;E8?C3_D1?$'
M_8-N/_1;4 <G\#?^2:P?]?,O\Z](KS?X&_\ )-8/^OF7^=>D4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>.?M"?\@+1/\ K[;_ -!KV.O'/VA/^0%HG_7VW_H- 'L2_='T
MI:1?NCZ4M !1110 4444 %8?C3_D1?$'_8-N/_1;5N5A^-/^1%\0?]@VX_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M86QES%O(8*'!SE%^7"]!@^M2?#N\N[#Q*VC>))=>3Q"]JTC)>7OGVTR[_OH
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M%TZ7?OMW9I%;=][.XD\UK44 <WHW@/P[X?OUO=.LI(YT4I&7N9)%C4]0JLQ
MI++P#X:TW71K-EIQM[P.T@\N9Q'N(()V;MO0GM72T4 <]:^!_#MEJ&H7L&FJ
MLFH(Z72%V:.0,06^0G:,D#H*AT?X>^%]!U%+_3],"7,8(B>29Y/*!Z[ S$+^
M%=/10!DVOAK2+*'5(K>TV)JDLDMX/,<^:[C#'D\9SVQ570_!.@>';V2]TZR9
M;J1/+,TLSRN$_N@N3@?2N@HH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *\<_:$_Y 6B?]?;?^@U['7CG[0G_("T3_K[;_T&@#V)?NCZ4M(OW1]*6@ H
MHHH **** "L/QI_R(OB#_L&W'_HMJW*P_&G_ "(OB#_L&W'_ *+:@#D_@;_R
M36#_ *^9?YUZ17F_P-_Y)K!_U\R_SKTB@ HHJ.XN(+2!I[F:.&%/O22,%5?J
M30!)16=!K^C7,R0P:M82RN<*D=RC,Q]@#S5NTNX+ZV2YMI1+"^=KKT.#@_J*
M )J*** "BBB@ HHHH **AM;N"]MQ/;2B2(LRAEZ95BI'X$$?A1!=P73SI#*'
M:"3RI0/X7P&P?P8'\: )J**AN;N"S1'N)1&KR)$I/=V(51^)(% $U%(2 "3T
M%16MU!?6<%W;2"6WGC66)UZ,K#((^H- $U%%12W,,$L,<D@5YW*1KW8@%C^@
M)H EHJ.XN(K6VEN)W"11*7=C_"H&2:>"" 000>A% "T5#'=P2W4UJDH:> *9
M$'50V=OYX-34 %%%% !14,MW!#<P6\DH6:?=Y2'JVT9./H*FH **** "BBB@
M HHHH **B^TP?:OLOFIYY3S/+S\VW.,X],U+0 445%#<PW!E$,@?RG,;X[,
M"1^M $M%1&YA%TMJ7 G9#(J'J5! )'T)'YCUHN+F"T@:>YFCAA3[TDCA5';D
MGB@"6BL^#7M'NIT@M]6L9I7.%CCN$9F/L >:T* "BBB@ HHJFVKZ:EY]C;4;
M1;K('D&90^3T&W.: +E%%% !1110 4444 %%4[G5M.LIU@N]0M8)F *QRS*K
M$=,@$^QJ9KNW6\BM#*HN)8VE1.[(I4,?P+K^= $U%%4[O5M-L)5BO-0M;>1A
ME4FF5"1Z@$T 7**:CK(BNC!E89#*<@BG4 %%%% !114*W<#7LEFLH-Q'&LKQ
M]PC%@I_$HWY4 344R6:*")I9I$CC099W8  >Y-/H **** "BBB@ HJA'KFD3
M7WV&/5+)[S)'V=;A#)G_ '<YJ_0 445#;7<%Y&TEO*)$61XF([,C%6'X$$?A
M0!-1110 44R6:.!-\LB1KN"[G8 9)P!]22!^-/H **** "BBB@ HJG_:VF_;
M39?VA:?:@=OD><N_/IMSFIH[N"6ZGMHY0TT&TRH.J[AD9^N* )J**I/K.EQ7
M9M)-2LTN0<&%IU#@^FW.: +M%%% !1110 4444 %%12W,$,L,4LJ(\[%(E8X
M+L%+$#U.%)_"EN)XK6WEN)W"11(7=CT50,D_E0!)138Y$EB22-@R. RD=P:=
M0 4444 %%%4[75;.]N[FUMI3)+;-MEPC;5;N-V,$CN <CO0!<HHJ&*[@FN9[
M>.4-- 5$J#JNX9&?PH FHHHH **** "BBB@ HHHH **** "BBHYYXK6WEN)Y
M%CAB0O([' 50,DD^@% $E%(K!E#*001D$=Z6@ HHHH **** "BBH;6[@O8!/
M;2B2(LR;ATRK%2/P((_"@":BBB@ KQS]H3_D!:)_U]M_Z#7L=>.?M"?\@+1/
M^OMO_0: /8E^Z/I2TB_='TI: "BBB@ HHHH *P_&G_(B^(/^P;<?^BVK<K#\
M:?\ (B^(/^P;<?\ HMJ .3^!O_)-8/\ KYE_G7I%>;_ W_DFL'_7S+_.O2*
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M,5:M=-CM=2O[U79GO&0NIZ+M7:,4:MI<&L:=)97#2(K%762,X>-U8,K*>Q#
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MV40I$0K @G*C[V#]/:HK7PW.FI6%]>ZM/=R6(=85,:1KAEVG(4<GIS[< <Y
M(O#USJVN6EKK<E^D%I<_O8K)(%($1^[N<\[B,$D8 Z8KG]+NM8TOPE)JT=Y$
M+:WOY_\ 1/)!$D9NG#9;.0W)(QP.,@\UU&F^'Y](E6*RU25=,61G6S>)6V D
MG8K]0N3P.2.F<4X^&[<^&YM%\^7R99'D,G&X%I3(?U.* -JBBB@ KQS]H3_D
M!:)_U]M_Z#7L=>.?M"?\@+1/^OMO_0: /8E^Z/I2TB_='TI: "BBB@ HHHH
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MK'*I="R@GY<Y Y[U<EU;3;>_CL9M0M8[R7_5V[S*)'^BDY-<C#:06?AGP/\
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M(H!A5&Y1O8,<9/16ZURMLD5]X<EAE=+J"3Q/$"PCV)*IDC)(7^ZV2?0@Y[T
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M%)Y>(V<!EQ_$ Q/!(K-UBVM4\*ZG>2ZG9ZK:W>L64EPFGPXC4B6%74 .^20
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MO8VD%O\ #'PN\4*HZW>GRA@.0SSQACGW#,/H: .YN=6TZSNX;2ZU"U@N9O\
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MAOWGS'@.R[#ZG#>]9URL,WA'Q?=VB*=)DN_.M&"_(5"1^:Z?[)<2'(X/)[T
M=W-K.EV]@E_-J5G'9N<)</.HC;Z,3@U:BECGB26&1)(W 971LA@>X(ZUPVMW
MJ#Q9I.H6^JZ7;:<UE*EK=W,7G0"7>NX*PD4*Q4<'/.U@.];'APV6C:'&7U>T
MNH+N]?R);=-D1>1S^[C&YN-V[O0!TE49]9TNUODL;C4K.*[DP$@DG59&STPI
M.35ZO,/&.N27>C^*;=[_ $^R-N)(4L3!ONIRJ K)G<" >H(4X SGC@ ]#NM7
MTRQN8K:[U&TM[B;_ %<4LRHS\XX!.3S5RN(UW4+?0=:N-1L]1LI[R?R(KK29
M2IEFYPOEX.X-ALX((/MR:[>@#.U#6]/T]FMY;^TCO6C+Q6\DRAWX.,+G)Z=J
MAL]>M5\-Z=JNJW=I9"ZMXI&:601IN90V 6/OZURDMWI%E:>+[367A%]<W$K^
M3(1YMQ&8P(O+'5N %&.C ]ZIP2SV=UX7N9=0L+"W.@QQV\]_;F2,2X4NH.]
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M);C0;@R31Z:;-70;6O2MPZL0"RH5P<$GC/('4=*QO$O^H\?_ /8'C_\ 1<U
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M#G.1C![>N* .K@M8K>"&)06\E B,YW-@#'4\YI(+.&WN+F=%/FW#!I&)R3@
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M7%W)9R&XN=L$4D><CS IW;L?+P,Y[=*ZBV,[6\9N4C2<CYUB<LH/L2 3^0H
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MP0/0')XXZU5TWQ#J<7A;03<6L-SJVI)&D"+<':_[K>TDC%/EP Q( /. ,YH
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M]I]FE,B-)(0L;9*CNV3[ \T =%15;3[--.TVVLHV9DMXEB#.<LV!C)/<U9H
M*\<_:$_Y 6B?]?;?^@U['7CG[0G_ " M$_Z^V_\ 0: /8E^Z/I2TB_='TI:
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M1-,$M8PV$4@$G)'=A5>7Q=IXM+&>WAN[LWLKPQ10P_O Z!BZLK$;2-K @^E
M!)I]\NBQVD.CZ(XDW?:;1G9(,$\8Q&=W;.5&:ATF#4]"BT+0U47,8CF:ZN2K
M;8E7[J*2?5U4 \[5/I5^P\16>H/<0)%=17ENGF/:3PF.7;V*@\,"1C()&>,U
M1B\81RZB]@NB:P+F-$D=# GRJQ8*Q^?H2K?E0!T9&017-:-X:N=-A\,I)/$Y
MTFQ>UEVY^=BL8ROM\AZ^M=-10!S-YX7FNUUDK=)%-=7\-]:2!2WE/$D07<.,
MC=$<CT-:$+^(7LKGSK?3(KL(!;E)Y)(V;G)?**0.G SWYK6HH !G SUK&73[
MZ#Q;/J,(MWL[NVBAF#NRR1F,R$%0%(8'S,<D8QWJ]<ZE!:7]C9R[_-O6=(L#
M(RJECGTX!JW0!S2>&[A?!MEHOG1>=;RV\C/SM(CG20X[\A2*H:GX4U&YN->$
M":;(-6! O+C<9K=3&$V!=I! P2/F&"QX/?M** ,"XTG4(]1T2]M/LTC65O);
M3)*[("K^7EE(4\@Q]"!G/45OT55U#4;72[)[N\E\N)<#H26). J@<DD\ #DF
M@#G4\.:D= O-'D>T$1O?M%O,KL693<F8AUV\$ XX)S[5KWNDM>:_97S,GD0V
MES;R(<Y;S3$1CVQ&?S%/M=<L+KP]'KOFF*P>W^T[Y1@JF,Y(^E0:=XDMM0O4
MM&M;VSGEC,L"W</E^<@QDKR>F1D'!&>E &5H'AFYT?[%9R:;HDUO: (E\J;;
MAE484E=F _ R=WJ<5U<WF^1)Y 0S;3L#DA=V.,X[9I]4M2U'^SHXV%G>7;R-
MA8[6+>?J22 !]2* ,;3-!O%U?4=0NXK*R^V6XA>WLG9U=LG,KDJN6P<=.G4G
MM!;^']7CT714+V4>I:*56!E=VBGC$?EL'^4%=P)/&<$#KTK7M/$FFW6D76IM
M(]O!9LZW2SH4>!DY96'KC!XSG(QG--T[Q';ZA>BS>UO;*X>,S1)=P^694! )
M7D],C(.",CB@#-F\,W6MMJ<VM20PR7=E]BBCM&+B!,EBVY@-S%L'H -H]ZLM
M:>(+_1[W3=273AYUG)"MS!*^7=EVABA7Y1R20&:I#XIM8KZ&WN;+4+:.>86\
M5S/;E8GD)P%ZY&3T) !_&GW_ (DBLM6?3(]/U"\N$@2=_LL2L%5V95R2PYRC
M4 1:/H-QH5U&EE-&-.DC_?VISB.7'+Q>@8YRO3/(P<YA7PW<+X-L]%\Z+SH)
M8'9^=I"3K(<=^BX^M=#;RF>WCF,4D1=0WER##+GL1ZU)0!SK:9K.FZGJ-QH_
MV&6#4)!.\=V[H89=BH6&U3N!"J=OR\@\\\)IWAA]-DT/9<B5;!)_.=AAI7EP
M68#M\VXX]ZZ.H;69[BW662"2!CG,<F-PP<=B1SU_&@#CI_"^NGPX?#=M<6":
M>CCRKEF?S?*#[A&4Q@' "[LG('09XMWWAF=-?OM2M+#2+]+[8TD=^"K1.JA,
MJP1L@J%^7 Y'7FNE-Y;B^6R,@^TM$91'@Y* @$_F14] &1#I#QZ]:7Z^1'%#
M8/:F*,8 8NC?*.RC:?TJO:V][IM]J]M:0HXN9/MML925CW-@2(S ''S#=T_C
M[X-;]4;C4D@UFRTTQL7NHI9%<'A?+V9'X[Q^5 '.1Z/J6F6&M/##;6]SJKI'
M!:V6YH;=R-IE)(7GG<W ^Z.I//565I%86%O9P#$-O$L2#T50 /T%0:/J2:QI
M4-_'&T:R[L*QR1AB/Z5>H PDTW4+*76KBU2TN'O[M)EBG=D78(8XR&(5N<H3
MT/6LS1_"=Y:7]I)<O:1V4%S/>I9VY8QPRNJHBID#Y0#(W0?,_ &*["H+B\M[
M5[=)Y C7$OE1 @_,^"V/R4G\* )Z*** "O'/VA/^0%HG_7VW_H->QUXY^T)_
MR M$_P"OMO\ T&@#V)?NCZ4M(OW1]*6@ HHHH **** "L/QI_P B+X@_[!MQ
M_P"BVK<K#\:?\B+X@_[!MQ_Z+:@#D_@;_P DU@_Z^9?YUZ17F_P-_P"2:P?]
M?,O\Z](H *IZMJ%OI.CWFHW6_P"SVT+RR;/O%5&3CWJY3)H8KB"2&:-9(I%*
M.CC(93P01W% '#:9'<Z=XRTF/^SHM-CO;:XWPK?O.\NT(09%*XW G[P+=2,U
MG)'-8_#U=3AFG>^O;F.WGN'N64K"USLVAN0@"G&X#C.>M=S8^'=(TV9)K2PB
MCF0$+)R648Q@$\X]NE6AIMD-.;3_ ++";-E*M 4!0@]00?7)H P/#^EZCI^M
MRO\ 88[#3)+;#0+>-.#,&&& (&W*E@?7 J3QQ<W5OHMO';;@+F]@MY2LQB.Q
MFP1O'W=W"Y_VJUM.T33M)+FQMA$7 5CN+' Z#DG &>E6;NTM[^UDM;N".>WE
M&UXY%#*P]P: .$O;#5-*T#Q1,MJNGV#:3(T4$=XTNR94?+KD#;D%<X[KGUK2
M.FQ:-KWAR2UDG\V\DD@NW>5F\\>0\F6!."=R @]N0.*W+?P_I5K:75K%9IY-
MTGESJ[%_,7!&TDDG&">/>KLEI;RRV\DD2L]NQ:%B.4)4J2/P)'XT <);:;:Z
M;H_CNXM$>*:-[A$<2L2H^S1MW/7/.>M7+C2[.Z\7>&;B>-FE:QG<MYC#)40[
M>_N?KWKI6T/3'N[NZ:SC,MY&8K@\XE4@###H> !GK@4Z[T?3[[[-]IMD<VK;
MH#D@QG&.".V.W>@#A]2N;J"QU:*VW8NO$:6\NV8Q$HR1Y7>.5W$!<CGYJDO8
M-:T#1/$-W;VZZ;9FR4Q1QW1G,,@)#R+D#;\I!^JY]:[:72M/GMKJVELX9(+M
MB\\;H"LC$ 9([G@?E3+'1=.TZ.:.UM559@!)N)?>!D '<3QR>/>@#EKS1].T
MCQ9X26QDD0R7$^8S,S^<!;2?O#DG+#.-W?=SVKL[FWBN[>2WF4M%(,, 2,CZ
MCFLZS\,Z+I]Q%<6NG0QS1',3@$F/@KA<_=&&(P..:UJ /-M-MX[+P%X<MH'E
MMH-1O(8;R1)6#;#NX#9RNYE5.,?>K?M;:'1?&]KI^FETM;JPFFN+;>62-D>,
M(X!)VD[G!QUQ[5L1^'])BL[FS6PA^RW3%IH6&Y&).?NG@<\\=Z?IVBZ=I)D:
MQM4B>7'F/RS-CH"QR2!V':@"GXL6== EO+4OY]@Z7BJAP7$9W,GON4,N/>N;
MU/4I[NPUC6;6\DBLYKJUTZ*>-R!' )56:5?0YDD&[ML![5WQ 8$$ @\$&JEO
MI6GVNEC3(+.!+$(8_LX0;-IZC'3!R: .<GTZUT7Q/HMKIOF1Q7XGBNK?S697
MC6,L)""3\P8*-W7Y^>U8:PC0O WB"ZTP/#.VJ2V[2"9@4C-UL)#'.TA6)W=N
MM=SIV@:5I,S36-E'%*R["_);;_=!.2%]AQ3TT33(Y;R1;.+-[G[2I&5ESP<J
M>.>_'/>@#"T'2=1L-=$J6$=AIK6S)-"+YI]\H92C@$<'&\$]\C/2M;Q'?06&
MCN9X);CSY$MHX8I-C2/(P55W9&T9/)STS4NG:%IFDNSV-JL+,NS(8G"^@R3@
M>PJS>V-KJ5H]I>0)/!)C=&XR#@Y'X@@'- '':'9L/$VJZ-=6<-K:R6$$S6EO
M>O,H8O(-V2JE20!D#KM%:7P]LX+3P'HIA0J9K.*1\L3EB@R>3Q]!6Q8:+INE
MR-)96D<4CKM>09+./]ICR?QI^G:58Z3$\5A;K!&[%RBDX!]AV'L.* .?\4Z5
M97WB7PR]Q$79[N2,D2,ORBWF8#@^M00:%9ZOXL\3&]\V1 \"H@E90A\E<L,$
M?-TY[8XQDUT^HZ79:M D-];K,D;B1,D@JP!&01R#@D?B:FBM8()IIHHE628@
MR,!RY P,_@ * /.XKW4=9MO!]K<0_;H[K26NIHI+HPBXE41#+$ [L!F.WN3G
MM77^%[/4;'39K?4%" 7#FVC\\S&.$X*J7(!."6 ]L59GT#2KG3[>QEL83;6V
M/(0#'E8&!M(Y7CCBK5E8VVG6JVUI$(H5)(49/).2<GJ<T <[XONY)+C3=(@L
MKB]\^87-U#;[-WD1$'^)E&"YC'7D;JK>'[Z6#7]9TZ;3[NPBO =0M8[G9DDX
M68#8S#&[:W7.9#76BU@6\>[$2_:'C$;28Y*@D@?3)/YTDMG;3W$-Q+"CS0AA
M&Y'*AAAL?44 <!I=BMEX5\(ZS'-<-J,[V0FN'F9C*LH"LK G!7#<#M@&KO\
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M6EC'9001QVL:>6L0'RA<8QCTJIIOA_2-'E>73M/M[:1UVEHTP=O7:/0>PXH
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MI%OA>#S_ *M^1D<?2H;S0M2DMM7DAMPTXUJ'4;:)G $ZQK#D9[$[& SWQVH
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M/%<J5*?+ J%3SN!ROIWH L6?C&RO/L,HL[Z&SOV5+:\EC412,PRJ\,6&>@)
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]H3_ ) 6B?\
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M/4'K3J* ([>"*UMHK>! D,2!$4?PJ!@#\JDHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KQS]H3_D!:)_U]M_Z#7L=>.?M"?\@+1/\
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M)M/T[6;2YNUS^ZCDR6QUV_WOPS0!NT5RFE>*(X;/5;O7-8TMK>WU%[:.2V+
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MMG<PW$88J7AD#@,.HR.] '@T(2Q^&FH>"[SP_>R^)Y9W4*+1G\YR^5E$F,8
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M_N95L< ?-TQ7O%% 'E'A:>'5/C7?:OI^F75MI\^D;5GEMFB69@Z98 @>F/\
M@-:GQ1T]M2N?"$!M7N(#K<'GJ$+ 1DX.[VQZUWEW>VMA")KRYAMXBP4/-($&
M3T&3WJ>@#R76-#OKGXA>+X-,MGB-YX=,<3JFU'D.T ;NF<<5C>%;-=0O/"UE
M=:KJ<=]I<J,MA_8@B\@J/G5I0!\IP1DDYR"1FO<ZB%S URULL\9G5=S1!QN
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M='TI: "BBB@ HHHH *P_&G_(B^(/^P;<?^BVK<K#\:?\B+X@_P"P;<?^BVH
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MGV21S-;&090ONX;CKC_ZU2P^.M?NO$FN6D&FV0TO0[@F]N79@_DA2<*,\O\
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M855E "EB"2<8'Y?6H9?AIJ=O;:EI&D>)?L>@:E*TDUJUH'DC#_?5'R."..G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7CG[0G_("T3_K[;_T&O8Z\<_:$_Y 6B?]?;?^
M@T >Q+]T?2EI%^Z/I2T %%%% !1110 5A^-/^1%\0?\ 8-N/_1;5N5A^-/\
MD1?$'_8-N/\ T6U ')_ W_DFL'_7S+_.O2*\W^!O_)-8/^OF7^=>D4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>.?M"?\ ("T3_K[;_P!!KV.O'/VA/^0%HG_7VW_H- 'L
M2_='TI:1?NCZ4M !1110 4444 %8?C3_ )$7Q!_V#;C_ -%M6Y6'XT_Y$7Q!
M_P!@VX_]%M0!R?P-_P"2:P?]?,O\Z](KS?X&_P#)-8/^OF7^=>D4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5XY^T)_P @+1/^OMO_ $&O8Z\<_:$_Y 6B?]?;?^@T >Q+]T?2EI%^
MZ/I2T %%%% !1110 5A^-/\ D1?$'_8-N/\ T6U;E8?C3_D1?$'_ &#;C_T6
MU ')_ W_ ))K!_U\R_SKTBO-_@;_ ,DU@_Z^9?YUZ10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG
M[0G_ " M$_Z^V_\ 0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 444
M4 %%%% !6'XT_P"1%\0?]@VX_P#1;5N5A^-/^1%\0?\ 8-N/_1;4 <G\#?\
MDFL'_7S+_.O2*\W^!O\ R36#_KYE_G7I% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[0
MG_("T3_K[;_T&O8Z\<_:$_Y 6B?]?;?^@T >Q+]T?2EI%^Z/I2T %%%% !11
M10 5A^-/^1%\0?\ 8-N/_1;5N5A^-/\ D1?$'_8-N/\ T6U ')_ W_DFL'_7
MS+_.O2*\W^!O_)-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\ ("T3
M_K[;_P!!KV.O'/VA/^0%HG_7VW_H- 'L2_='TI:1?NCZ4M !1110 4444 %8
M?C3_ )$7Q!_V#;C_ -%M6Y6'XT_Y$7Q!_P!@VX_]%M0!R?P-_P"2:P?]?,O\
MZ](KS?X&_P#)-8/^OF7^=>D4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M"?\@+1/^OM
MO_0:]CKQS]H3_D!:)_U]M_Z#0![$OW1]*6D7[H^E+0 4444 %%%% !6'XT_Y
M$7Q!_P!@VX_]%M6Y6'XT_P"1%\0?]@VX_P#1;4 <G\#?^2:P?]?,O\Z](KS?
MX&_\DU@_Z^9?YUZ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44
M>-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?
M4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@
M18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE%
M 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_
MWU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\
MH$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)
M10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18
M?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_
M *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>
MR44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$
M6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP
M_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 7
M7LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z
M!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\
M</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\
M%U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</
M^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H
M?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_
M !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'
M#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_
M:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'
M_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'
MQP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T
M?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU
M!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_V
MA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q
M=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]
M]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?
M]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!XW_:'QP_Z!%A_WU!_
M\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0?_%T?VA\</\ H$6'
M_?4'_P 77LE% 'C?]H?'#_H$6'_?4'_Q=']H?'#_ *!%A_WU!_\ %U[)10!X
MW_:'QP_Z!%A_WU!_\71_:'QP_P"@18?]]0?_ !=>R44 >-_VA\</^@18?]]0
M?_%T?VA\</\ H$6'_?4'_P 77LE% 'C?V_XX'C^RK$9[[H./_'ZN^%/AMK=W
MXGC\5>.;];N_A(:WMD(98R.A. %&#R%7C/.:]7HH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arcus Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001724521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses additional compensation information of (i) our Chief Executive Officer and (ii) all other named executive officers (the "Other NEOs"), including &#8220;compensation actually paid&#8221; during the specified years alongside total shareholder return ("TSR") and net income metrics:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of initial fixed $100 investment based on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary compensation table total for CEO<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation actually paid to CEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average summary compensation table <br/>total for Other NEOs<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Compensation actually paid to Other </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total shareholder return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer group total shareholder return</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ millions) </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,279,504&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,803,366&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,793,357&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,696,346&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">147.43&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">95.43&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(283)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,120,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,480,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,193,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,953,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">194.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">94.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,048,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,065,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,191,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,394,074)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">204.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,483,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,577,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,939,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,091,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">400.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">117.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,685,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,015,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,363,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,455,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">257.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">148.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Our Chief Executive Officer for each of the years presented was Dr. Rosen. Our Other NEOs for 2024, 2023 and 2022 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett and Dimitry Nuyten. Our Other NEOs for 2021 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett, Carolyn Tang and William Grossman. Our Other NEOs for 2020 were Jennifer Jarrett and William Grossman.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">TSR figures assume an initial investment in our common stock of $100 on December 31, 2019. The peer group referenced for purpose of the TSR comparison is the group of companies included in the S&amp;P Biotechnology Index, which is the industry peer group used for purposes of Item 201(e) of Regulation S-K. The separate peer group used by the Compensation Committee for purposes of determining compensation paid to our executive officers is described on page <a href="#icc2494da21244caaac1fc3f4262a3d24_22505" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:none">26</a>.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 7,279,504<span></span>
</td>
<td class="nump">$ 10,120,945<span></span>
</td>
<td class="nump">$ 9,048,432<span></span>
</td>
<td class="nump">$ 9,483,339<span></span>
</td>
<td class="nump">$ 5,685,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 4,803,366<span></span>
</td>
<td class="nump">7,480,720<span></span>
</td>
<td class="num">(2,065,105)<span></span>
</td>
<td class="nump">14,577,932<span></span>
</td>
<td class="nump">12,015,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The adjustments made to the summary compensation table total for Dr. Rosen for each year presented above to determine compensation actually paid to Dr. Rosen in such year are shown in the tables below:</span><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary compensation table total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,279,504&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,120,945&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,048,432&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,483,339&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,685,664&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, value of stock &amp; option awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,924,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,909,833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,292,320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,548,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,356,475)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus year-end value of awards granted in fiscal year that are unvested and outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,156,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,634,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,788,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,142,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,893,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change in fair value of prior year awards that are outstanding and unvested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,390,550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(573,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,490,389)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,923,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,828,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus FMV as of the vesting date of awards granted this year and that vested this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,363,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,648,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,608,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,783,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,108,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(679,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(439,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,728,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">794,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">856,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,476,138)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,640,225)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11,113,537)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,094,593&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,329,745&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Compensation actually paid to CEO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,803,366&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,480,720&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,065,105)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,577,932&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,015,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 2,793,357<span></span>
</td>
<td class="nump">4,193,925<span></span>
</td>
<td class="nump">4,191,618<span></span>
</td>
<td class="nump">5,939,512<span></span>
</td>
<td class="nump">5,363,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 1,696,346<span></span>
</td>
<td class="nump">2,953,574<span></span>
</td>
<td class="num">(2,394,074)<span></span>
</td>
<td class="nump">7,091,681<span></span>
</td>
<td class="nump">10,455,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">The adjustments made to the average summary compensation table total for Other NEOs for each year presented above to determine average compensation actually paid to Other NEOs in such year are shown in the tables below:</span><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary compensation table total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,793,357&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,193,925&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,191,618&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,939,512&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,363,707&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, value of stock &amp; option awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,918,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,364,997)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,444,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,298,516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4,864,788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus year-end value of awards granted in fiscal year that are unvested and outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,345,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,127,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,848,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,797,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,969,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change in fair value of prior year awards that are outstanding and unvested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(591,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(367,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4,050,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,678,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,656,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus FMV as of the vesting date of awards granted this year and that vested this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">441,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">622,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">528,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,094,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">509,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(374,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(257,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,467,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">678,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">820,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Less, prior year fair value of prior year awards that failed to vest this year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,827,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus adjustments for stock modification</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,097,011)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,240,351)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,585,692)</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,152,169&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,091,852&#160;</span></td><td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Compensation actually paid to Other NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,696,346&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,953,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,394,074)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,091,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,455,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years: </span></div><div style="margin-top:6pt;text-align:center"><img alt="4029" src="rcus-20250422_g2.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years: </span></div><div style="margin-top:6pt;text-align:center"><img alt="4027" src="rcus-20250422_g1.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text">TSR figures assume an initial investment in our common stock of $100 on December 31, 2019.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 147.43<span></span>
</td>
<td class="nump">194.36<span></span>
</td>
<td class="nump">204.75<span></span>
</td>
<td class="nump">400.69<span></span>
</td>
<td class="nump">257.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">95.43<span></span>
</td>
<td class="nump">94.37<span></span>
</td>
<td class="nump">87.61<span></span>
</td>
<td class="nump">117.83<span></span>
</td>
<td class="nump">148.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (283,000,000)<span></span>
</td>
<td class="num">$ (307,000,000)<span></span>
</td>
<td class="num">$ (267,000,000)<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="num">(123,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Dr. Rosen<span></span>
</td>
<td class="text">Dr. Rosen<span></span>
</td>
<td class="text">Dr. Rosen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt">Fair value or change in fair value, as applicable, of equity awards in the "compensation actually paid" columns was determined by reference to (i) for RSU awards, closing price on applicable year-end dates or, in the case of vesting dates, the actual vesting price and (ii) for stock options, the fair value estimated using a binomial lattice model as of the applicable year-end or vesting date(s). Key inputs included the contractual terms of each agreement such as vesting date, maturity date, and exercise price, while additional key inputs included the closing stock price, volatility, dividend rates, risk free rates, and an early-exercise factor which were all determined as of the revaluation date.</span>eflects after-tax net income attributable to stockholders prepared in accordance with GAAP for each of the years shown.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (2,476,138)<span></span>
</td>
<td class="num">$ (2,640,225)<span></span>
</td>
<td class="num">$ (11,113,537)<span></span>
</td>
<td class="nump">5,094,593<span></span>
</td>
<td class="nump">6,329,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(5,924,960)<span></span>
</td>
<td class="num">(8,909,833)<span></span>
</td>
<td class="num">(8,292,320)<span></span>
</td>
<td class="num">(8,548,858)<span></span>
</td>
<td class="num">(5,356,475)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,156,034<span></span>
</td>
<td class="nump">5,634,249<span></span>
</td>
<td class="nump">3,788,462<span></span>
</td>
<td class="nump">7,142,260<span></span>
</td>
<td class="nump">7,893,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,390,550)<span></span>
</td>
<td class="num">(573,908)<span></span>
</td>
<td class="num">(5,490,389)<span></span>
</td>
<td class="nump">3,923,736<span></span>
</td>
<td class="nump">1,828,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,363,210<span></span>
</td>
<td class="nump">1,648,267<span></span>
</td>
<td class="nump">1,608,814<span></span>
</td>
<td class="nump">1,783,385<span></span>
</td>
<td class="nump">1,108,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(679,872)<span></span>
</td>
<td class="num">(439,000)<span></span>
</td>
<td class="num">(2,728,104)<span></span>
</td>
<td class="nump">794,070<span></span>
</td>
<td class="nump">856,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,097,011)<span></span>
</td>
<td class="num">(1,240,351)<span></span>
</td>
<td class="num">(6,585,692)<span></span>
</td>
<td class="nump">1,152,169<span></span>
</td>
<td class="nump">5,091,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,918,678)<span></span>
</td>
<td class="num">(3,364,997)<span></span>
</td>
<td class="num">(3,444,851)<span></span>
</td>
<td class="num">(5,298,516)<span></span>
</td>
<td class="num">(4,864,788)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,345,900<span></span>
</td>
<td class="nump">2,127,890<span></span>
</td>
<td class="nump">1,848,729<span></span>
</td>
<td class="nump">3,797,282<span></span>
</td>
<td class="nump">6,969,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(591,055)<span></span>
</td>
<td class="num">(367,886)<span></span>
</td>
<td class="num">(4,050,985)<span></span>
</td>
<td class="nump">2,678,504<span></span>
</td>
<td class="nump">1,656,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">441,522<span></span>
</td>
<td class="nump">622,491<span></span>
</td>
<td class="nump">528,662<span></span>
</td>
<td class="nump">1,094,353<span></span>
</td>
<td class="nump">509,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(374,700)<span></span>
</td>
<td class="num">(257,849)<span></span>
</td>
<td class="num">(1,467,247)<span></span>
</td>
<td class="nump">678,367<span></span>
</td>
<td class="nump">820,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,827,217)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Plus Adj for Stock Modification [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,396<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=rcus_PlusAdjForStockModificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=rcus_PlusAdjForStockModificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee has adopted an Equity Administration Policy which implements a framework for a consistent process for granting, pricing and administering equity-based awards. The policy establishes the terms of all equity-based awards issued by the Company to officers, employees and consultants under our equity plans. The policy establishes the terms for such grants including the grant effective date, pricing and vesting. For example, all equity awards will have a grant effective date of the next 8th or the 23rd of a calendar month (whichever occurs first) following approval by the Compensation Committee. If such day is not a trading day, the effective date of such grant will be the next trading day thereafter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, we did not grant stock options, stock appreciation rights, or similar option&#8208;like instruments to our named executive officers during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form 8-K that discloses material nonpublic information. Our Compensation Committee does not take material nonpublic information into account when determining the timing or terms of awards, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">For example, all equity awards will have a grant effective date of the next 8th or the 23rd of a calendar month (whichever occurs first) following approval by the Compensation Committee. If such day is not a trading day, the effective date of such grant will be the next trading day thereafter.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">Our Compensation Committee does not take material nonpublic information into account when determining the timing or terms of awards, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>75</ContextCount>
  <ElementCount>29</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="rcus-20250422.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rcus-20250422.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rcus-20250422.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rcus-20250422.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="rcus-20250422.htm">rcus-20250422.htm</File>
    <File>rcus-20250422.xsd</File>
    <File>rcus-20250422_def.xml</File>
    <File>rcus-20250422_lab.xml</File>
    <File>rcus-20250422_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rcus-20250422_g1.jpg</File>
    <File>rcus-20250422_g2.jpg</File>
    <File>rcus-20250422_g3.jpg</File>
    <File>rcus-20250422_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="5">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="139">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rcus-20250422.htm": {
   "nsprefix": "rcus",
   "nsuri": "http://arcusbio.com/20250422",
   "dts": {
    "inline": {
     "local": [
      "rcus-20250422.htm"
     ]
    },
    "schema": {
     "local": [
      "rcus-20250422.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "rcus-20250422_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rcus-20250422_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rcus-20250422_pre.xml"
     ]
    }
   },
   "keyStandard": 29,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 1,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 75,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 267,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 139,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcus-20250422.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "rcus_PlusAdjForStockModificationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://arcusbio.com/20250422",
     "localname": "PlusAdjForStockModificationMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plus Adj for Stock Modification [Member]",
        "documentation": "Plus Adj for stock modification."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001724521-25-000052-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001724521-25-000052-xbrl.zip
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M7GMWQ ^.=CM[;']WV!D>[AZR_>&(<79PR.W:[?%AH[W79(=LU^;[SFZG<="
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M5B&IR</*[0/^6!$@K&,A?KQ6=-A *M3K?X.=N5JG'^(3JE4IAEF@3 VFW,:
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M8BQ]5)\; )?;Z.S!/J=!Y-+[0U2#W#O^^MYUXO%QLT% ,7XEKNZXD?Z$#:/
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M(H #]QRK'>;>4<>LD#A,A%, WS@.[A_;5AZ[\/WT7K&%]+UV,,4?S@ ?K%$
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MUIT-H9<0X"8$& "/?"<*_IO'D&[F<4T1,^" DY#'#G&NB 4):2VHT\ V0/L
M?3)_2/^<B]B/TEUBF0*FL)H0IT"*T<^L$;/1I81FFT&&DC!T)?S4+/VQ1L!
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M!652OG4)A"QV $U&.KP2D!L#H049 J9H#[ \K?GX85)S5YGB!39OSEQ:X#5
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M'OUEZA9\J#.>BX%V45L"4H!Z)/3Q3&XD6[34+!H**7@G$;#D$GAGGX/PBZB
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M"H*0$CXN0"23!Y8&WZ+3="2&E?9"L&1^A_=S%4Z2!B*(A5C'Y RJE0-Z,5-
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M(1)7(MW/R(+$=@$^H"FBPA5@NTX<^(-%F(L8 ]2R]6R#&. :)"XFOH&""3S
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M5F2/N9-@ZGHJ:2)!(A0.%^-< ]^;+?)V8&P;30".]2A=T?X -V HXT GE"#
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M5>B3]+"DS/=4Q!_K!^),FA?ZFN-D*5"G ]WL7%M=]0Y+"67#4]=XH67X3?U
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MI >+\8YKWJ=$1OE_O-/3;3!*=^%\-)O^?O=^/N\+I%;[X- _O.<E_P+)U6F
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M/75[GL2A=Q'V1+;S;<"'KK#F;@"@=;]3=T,CUHUVP"5^W\SL2R17!Z2KZ?J
M-^E>W'8O@5;=RDLIBKQ^D:8RSF=F<L]/XZYJ_*W;BH!U>\BJB?>ZT?4FL.(D
MSM[LXNW:J._@B$26\$WD@OUVH^7O'^Z48;Y!:K7J"#IXOY&[+XU:C;J_WVC[
MC>X.#D?<&-$.:]VG!+O:V#X7(%W]E(M>)!?<D6.1#L-X#]4_/GSVRK0W^5>1
MY>%@RK\*XP#NYK=[&[M6_\^CW)_KO+M*I"X2X$).4ID!03*O)V,)=DDH(B^Y
MB>&R'X43,%6\2&:9EX]@K4DLT0KHHVT#?\A'8,H4>9:#=0-/A0,X'B>XHZ3_
MM?3![\2XQL$:G,,/;89UKQMOMH1YC4:MWD0RO <C)P#.>)?]D0R*2'J-U@=O
M$$;PVYLP'Q&7+D^.\2.?1=H?>1W?:X(OZ/6FWB?XF AJ'L[?C NL+D2^9B,!
M,H$LS[VQF()@>*+_[P*,67YD&'O=NA>(:>:%&3U_O>].BC0K!,A.GM"W<IF.
M,RU(5Z,P#;RCL00F!V0O7TB0K!Q^.&:YND2Y\LX+V /LV3L:IE+"QW,?EH(?
M^T7$A4BG7O.0-MB&=^<W4L9JE_3,(O.]FU$(5%!+5AL8BV_AN!CSNF]"M.%%
M 2_AKU*V:?_=DB,"NX%=X@3Y'[VLZ&7RWX4L-QEFN.>^).(4\&*F$--\DH9Q
M/YS XWI%!OR&@P9,3O&_\'&U;EABJ]7R?A5?918&TON0@MGK>Q^3# CH'8?Y
MU/>.X;@,DC0.A7?8;M?;M75.7VO73E]S)T[?IY^.EIR_+\FU)*D[T!(Z]6;'
MS]//:?DSR+J78?5O$&;L_( #.4ENX"GT>!"6"3B9*&X"Q)9/$TBN.H@H]/3U
MZR1'';WXFV9@]>SWK?5X'\&\\(Z"ZS!#CQ8/MX@RDOT #V+ !T$?D&B*1\3K
M_.@EJ3=.4CH 29%6;@RU2/A+]>ZX_6S,D@T.2:?CG8@L]SI-6.=E#MH!5 /R
M_L\DA8]]^=-KU.N=SO,\&JWM/1K"/AP?]WZ^6'(Z/LI>2@J\T> ;R@<1G20I
MR2TI9D&L_R#[?(I:_+FV[RV;'PVG)Z!7K'F".GZSV?6[K<;L.?#Y*?CO0'T7
M/LX/),GNUOV#SO["X[?HFW :)?^Q\I1&O>'O-P_F3R'<CIEU9='!$P$*(9^[
M5 XBW,/^/DYFV;<.%AXY<[C@S# EZ2::O<UP03_!:0W!&!0#8%((]VJ&US;=
MN' 3Q;09T ,RO4G#/(?+%6X[N($PI 6BHQEU([U^E*BO&+XB3Y_GZ6MOW>F[
M5 ( ?$4F]*,B@!^[H.4/]]M+]*XWDA%QC%?IY2F0.<-?L,GT(:WQ $RZE.($
M?(%^ 28'L#:,P18!>PUT=0["F(LPSO25@V(^=_2>IQQT=D0.&G[CX,!O@E6Y
M2A)Z6@2>)[.Z6\<L/&",:@TFU42DI-Q!X8(#!"O$4U8Z.2MUJ7I5NX,\F8N8
MWX1!/GH+QM"/U00*IY#>ULNOB!Y<G$6^_"LSOKS%;0P2R/2A64OE9NN4+,W0
MQO[?45JF689RKY=*\75/#&"U;T5T UXMQA/M/<(&;8*N1PNU\W_\WUZ*XY/G
M%_-,3M'^UIVB)2JOWO0;]>Y+5G@'V\VJ?A)G(1H<P)O7XHW7J7?\>J=^&\<8
M4<<[%I,P%Y'O_?KKL>^][KWQFIVFWVFN-G;*[Y_&UV"_8#PI4\] N^5U_XW7
M@.<<'C1>LN0<;K?DF$-^X'<Z+]JFL?+<&^;4@6+4L76J%X:*9]DT&T*2Q#2,
M;<T74"C?PE19T-,XRJUB",Y&6FHC-5;82+C\,/C[J[#5DZW#?J=7%VW9[O6Z
M/?#SI6@=!MUZIU,_D/][V'BU$X95H[D1VN\OI/W)OTZ.?[LZ_?W$._OX\?3X
MY.)RW6S9+;JGTWYXU;.F/&$,;I!$47)#82#,VGJ9A(,_2-)\!#H:_CL6>&2\
M5 Y%2@%@C$XM.M9TD(\F:1CI@_QV'0HM9;):CC[#:2!3S)1'8I+)M_H?[S!*
M$8GIVS"F[=&7WJG'JX/?F2\SHO?QGY4('Q[6#MH'*,6J#$Z]6 EX#<CUT_SO
MVXU:]["Y\$_U6N..OV_7NW?ZQK)%-9JU1OVN+W_L11&E.BL?=4L1XHIR&9:9
MIRFO7%-=?#GZ?+)&M<R:-42[M?>C3R]VZ^=GEZ=7IV=?O)]/?OW@_7%Z];-W
M]?.)=WSV^?SHRY\/4G.K5"'JSGJM"<H-,R5AX.'F[MTHLI';1Z;IE*/36]#>
M=U^R;E0(ER!R;G20Y[.1S^-1* ?>B3%USMC4\;T/RGLA5^9X)$(PDN*-]GEM
M@CP7"2*;><<U[U,BH_P_OG=ZNJ7=%UMX1N^)4/GXM-HZ.>-C^#&,14QY;W4,
M-]&_LE$Z_%+ .X]%&B69]XO8BCMSMXY<=UMA.[=.U,Y3*EN,\Q=WJ?TBXS@<
MR!1.6)K*?%N!.[?P='7NUTOS8B^TLXE,!17;O-0+[2+LC[#X[[-(OQ;9+N"\
M;..Q>[R>K&<F;GSL/LL %_0PAVX7E8](DV@:>U<B'FZIPM["4];>UCF 6R=?
MGV0,]UKD'<,^,AG=OSGPEJQ9J[NQK-E'C/QXO3 9IF(RFE)]NRZS];U,2@^;
MCYKU=^=I,DDR($:#?M-HO/-.L.0;\VGX)9T$K]'G&^\>**'XN*2A)[[%NIVP
MOT9 ?#9*9 6)-L$[[LV1Z34VK&64RUP27_"R$%O CHHAD!C3F?6:]SDUV_@K
M";',H<B\09J,O=^^G%[]Z;T/DUSV1S%L9CA5[0ROOX@L$/]^Z_WV_E]O?!"<
MD111/NJ+5&(1!16)#I)^H3LOAG)/9%G2#ZE!+@@S*3))+7 2OH%]"6;URU:.
M8<E+&8<@I[_#+SSCSO%:+^4DYVZ,9KVQCZT(OQ01E:?6_;)R7!=+X"MOX&78
M<H%U(9B4'6#' 15?J2#HI.B!.'A<BI'@&$S1[X,&0/O6]P9FA9-(@'^E"LQ%
M+*)I%F9^)=&<33-878:-)/ %[B?$3V1%BCUYOC=)@5HIM1'28P:B'T:P5.RY
M.$]QT["CWV+JL;,8=G,O@@D0W2EHTW]AOPH<=UF ILUF67M\]9EYV[,%8!%[
M^[B'%*MJK(<15SX+9$&C@ZM7_]Z_#SLL'C#=Y5JD]"TZ$CT6\,2B+[:,5,A[
MNU2"QCN+I]_ P!?PW#YM7D2:EE1SPFTLV'NJ-MN;>D?CH8SI,XI09Z SE?"V
M/!2QR- .%RBOPZ3(HBKSJ8X,#!^N78*##13)4 X-&7'K4V2W_3XN4L// 1_>
MZY:V#_):1LF$J8:-KH@R#!O]J,E]\=]B/'GW0?^"TP1).DG X0.-8DX&[Z=9
MK[>1I+B?FO>S]'IR"(H1NX=026#+4Y)^58O <BP!2\J!=P)N$FY2/4ECT%'T
M5N]/>/C0^_77\XJZ@IM&AL0@[WWM?>VH5MD1K>-DG*13/#A@3F1$##JCX);1
MY^DS^/K?CG\]\HZPGRCC)LHDB;B&*P;EA52A79B6)^\8S9-!""\_9S6A*(!M
MQ:^!1'W,KKQ9J[AOUVZ_6V*V&[D!PTPUF.T-$FH+(T;/WXNE$N2;L#QD:.W@
M;IC!Y;>$-Y:Z4A EY7V"[CT)#M<%D7[C(VLU1;2KQ]8\W:PP\%Y3UY^QLMYP
MCZQY,;[,TMGPMY^Q"QN6<2'A_L3:0ORE=7#QI'^,Y#>XO^'2SOJAA"UJ732O
M9N!XECN@NS@&746*V+3*8V-P&H(.CO8^3[$BZA+^T.O-*4VSOW+]B^\>LBN+
M(=B)63^!0ZE.)&^7M>PE+AP/5]]6L\<C.4Z.X0_I])NO5!G=39.*ZM7WDV_T
M$!D#%?, --+'JI*J=ZTM( 'F5XWO!T*D,_JTO"^//G_ZPCRD-S<.#[OJX6WK
MX:2T];U'!68F\9HH1QZT1V2_#IYXRW*NBDBDH6Y!7L8:>G4&XH*N3+D$T)D!
M<B2H< 1N4? $QM[8*$!?[^N 1 ?WY^/+24Y%^E7NX72_;.8J+(45E!_<@.PE
M_"%2\*CVU" IW5>$#%W,S87',T/; ]_>HR,)CRTK<.&'<1'EX22B!NYKO*-0
MJ,@2*&] .M RB@1FO-.0J_,^XODD&\$'X9?BZP3,XKQB*WF?QKV??3B0W\00
M%@&G38OD1?.SHH"V = , T7T[U#]PNQD8O2#/C4K]W-^='Q5??3LD>XJ-53^
MJMFTWC=*HB"CN_*2;LI2A,IK4%V4@2"TBPG6$X/'ZP6H*8,T9/ *H=!-X1EG
M*5SK<%!7/(N:<KW/8.^%\-GG>2,N2;!LE3,X%YM75Z E+> -7J(MMO8-6%YX
MC<,E=Z#21>A:XKLI)I[5-*6LUU1UG&\9EY4K#LU.;K&A&#L6]H(2^JV'-2Q*
M(?]Y>8*>Z<D%N2\+?!=0;M<A*0"!WEN.3@$Y'..$;68?)#X*C3(<I$1A6FQ(
M5^K\[F&/-B65$JUHXM5<P2_,.QC\HB*6^)8#\FNMM_KZ]BP?:.Q?VP]<YKXH
M)PW5<^DVJW>I2]*8"-VY>[1;9>5-Y19?Z"OA_7:M5.L:5SA[B;,&R?D CD.Z
M\*ZK2-8$Y04X,87[AZZYT+16>3T1?R4W?IQD.3D2<0YZ&-Y$%C_RHRR(RA'<
M)F0 2L4/"BTTZA4;JJOC&=D2=W:L'PU4"L$#PC[U?H)0(1%H#T\;; O6:1RC
M&EQ7 P0QF=\OD:E:QK5X+T!&,/,NP1\%S:ZMI+KRUNJ^=I%,P :_]"$!HR3(
MD&^_%@-8DG+,0//ARZ6Q>0Z4S0.JY$-!0 PC# W(&%QR4B9S;,"#:^^#C!#D
M="7L0,=ID9B$>!R!!7!](%: <B<OX3T?,2" 1HWW'JS\([C)6;TI5%1][=YB
M1EQ.P1A8YN ;X^_RRP<,EEP"N<<RMW[_Z?,5_/Y_BE2@E>#]F@?E'__GMXNC
M-XB9]!?LYHLL4FVSTVY_!9GX#$>Y:GBP6EEE.&1S6X"MQV+)#BKRO*]T^(*(
MA3IT86S41;/I>T<%ZFH@866-ZS[S*,O1]M(FHP+0J?26@SA>B" $C^9GBC#:
MJV;?K=E<_H)/!9B9N7=.]IN^-9""YZ"#4/[ F\&0I?X3O+L,C395B",&J<>(
MQ][/'_\ +[]\ 5Y0:BD&"H94?[D>@Q@$LMH#A4C?([?/M8,M:P=K[FK+_&*K
M=4-DO 0EE_P'K'YC8/CF?)4RWJA55&_I(7 L[:2?Q,F8PKG]8NQ% HZ[LGT^
MB#0?)P5(\G$217(H%T76+G.! 5>$0A)!@5=)&5G3=LJS= BJ52"/ U2]IB"4
M.9T9U Z\J.GZJ-J/,[4$[#^J?:")43682GMOKJ2<0CTBSN%>MK6VA<)D?(92
M(-O+$PX$Z!2P*T QWQ@,A:AJO\<@$-Z0LK6D:N'U82\)IGL4X0!I_JL8(I:4
M93B:)5K[7.&5?(J2'E!G)NK&\2"3S8H47HJ.F5,TF&,/N$IRHD)0U,!ND986
M.^9W.&Z)D1H3O^ 0OS;45% ):%>&,3!! 9PGOMDKT[RL&(7EWL".V(,S'<-U
MKC]Y-!B($*R&7S'4B&N%72=9,18][_6_/IW\?O3?_]78;[\#JP7_..%K-.,K
MK8>PK&#]@$&+V3U>,;A:E*)122+?0YV-=B_GC'!!"2:.5#]%7HPQ=URRARCK
MSPKA)?XXMSD,)*5%9H(D<_R8$&!G4QN3\.^6EJBQCJO!)9(G,6^S(OPFVX!)
M#(JA!!*A/RF4,H7+'TP-8_U0/H%8"1_&&C V.RALHF)FU?C()>I2>(:%H/DL
M->.B4ITM"9/,5'FH\$C%XT6'FW)Z.IQQE/99LZ*E:\+*G/#D9"?>K[A9DEL[
MUGL)^C(M4Y-7X*UDHJ_"POG=7>55GF=FW@4WN8FK#-'3*K-Y68Z_'89]+[?7
MPBH:)5:]S*#0+G01E*Z?";!C@J%""=CA*5J9GXM85C:X.M4\*:)Q8KF$L!<$
MA!Z$O30!BEBE!:@]Q[ ?N*1&XGI!6E1KXME=#5G#(Y)<A(4M!4;+4[AS4O@2
MPD .0%,E#)IHT8G]YJR8E$B1\\\N:<^:N)2 \H98ZLU<)'UXY,]@H\'CM?]F
MB%JJ)Q#/2-QH[<2&&%YR<$<(<$,MO5-:8[_"%_CF28WU]QGNG3YF%M@1 FK@
MK<55(*3P@?!RC'HTI"- 'FQ/?V))'-@"" 81>"_3KS*2TT=0=8NL]QU^[HMW
M"UL/@Q+2=B@AWX$2@BW?)U\NC[ ;?%Y4UV3!_JO;][ZAG6+.2X)*)Y6+*>HB
MR]B/"+PC5=FU$U;9+0@IH+#7V:I*E)"%XJ&Q<!W""E0:""_7-%0V")C^<6YP
M?DLDE;[]%IU3UC<O!N8]QME?@*5,_IQ /.]Y8!:T=Q"JN/+X$ VZW,"\<!RX
M&(_1V:SL]HK2O*7K47D*Y8#QIHX1/%:##6->.TV^33&DD:MZH(]K;0/IH4IG
ME^U&5<IZ(I5KH<O,CQFIWRYO>QL4.-I@]]WF[/TJN5K-6@=I,8_5X%N!D+F
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MLJG \3!,YHX:'1$CE'GPC+<?T0 5I3*\)]PS'ZN-;1ON=CDS#-*?9_N=Q7]
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M3<?2#&M/&%7[ )6GHU9+Q1W%'<4=Q1W%G4/ECFFH?8#:!U0:HI9A:JZWSWW
MN]1O#WA.]1*>AGY\'X2GR#R<BWS9*<+QS&A-TO4_69(&O2?Q41!V 7]GIWC1
M?JCZQBC ].IOGR*4T=!-),.G*&9IG[-1%H. <!;U6)>#D Z#$"YF0.QO/&4/
M_B#C&GODS$^2;,B[S(?!1YUO;!0'';KK!\-NM#R-'M89@*S!W8D_X/**$8=]
M7=^/Z=HHBT%^AL,HE$^!7S[R#A^VX2K+T!CN9<2C!GZ2LG8&C^-)PKK^4WX_
M?=$+$@ 0>^)^W)@4T_F L>H&&+-R@/D*3"%&)BS)VO_AG92E$; J2%@T0OW*
M'CAP)@B9W<(KDM0/T\ ?#)X8_RL#9@'7TS[\%83PU6 P!!(GA 8>=A T\(1?
M_##SXR=F(+,1!<A@_/T^AH<!HJ*'H L@Q*^B7@_P%;.8#WUX)+Y8P O>&F91
M!L/D\0-",.V#LKKO,^YW^C1(?%O73WF#'21VK!IB!Q5$+T.P((-X]S"EVJXA
M9UXNU>?9/?"!"?5N:ML7XX/$BE,GK-S>_<;\1S_N%G#I(1<%1/PPQ!^+$%(8
M (8S5^WO ##LO-.)8ISBX$F8&V%&0X!WRAG"8_%S,D;A7;T!3C<* >EI'^VE
M>83@)3JD?3^58V19>,A*S3T6H-[Q49HCE729=0S0E.2V'<3ES%;Z,>BF_3-#
M1R24[Q*;NC-]?(O?3J)!EBZ^96I_MW/W@:&ON".>HDWY7QQ^T/WG26"UN>5U
MG+;NV]QNM]UVK\>Y;WE=5W<<O<7_;>C>27Y7OPAUC?Q[?MJ.N?_MU._!',_\
MP:/_E.!FN$P9($N9#:M14-+K U6-G3>%^7<:YO8UR0RIF_/]8[#[8]?"[+C\
MSN-.D,##_;#+[FBW^#M!=26CW7U>9UKN*TQT/J9 08&]^XC_A!'CQ511QL6^
MF(B0L/:34 $^;KWANDZ&4I<K&M@79S%JCF+-Y"'JHIDM=8.A2FSS0?0HU4:7
M)YTX:,,[YZH8O_-7%L3PJ&PD34"RY7JH11)0F?%VAK4*)Q&/<Y6!F$BA;^(N
MC]$?-?!'"3_+?WG?#9+1P'\Z"T)B ]WT7CY>*BEGU@]([Q-?CZ6MH0N)HVAU
MX0V37S?@JW>SGYM>P]'=N5_I#6/NYXL>95D-T[/6>M3BS^UM#LI9^B@9W5_D
M@EX:!O"JUL:EM9(B$^KJ'%?;9,*)NB(MUO6Z[V&*5R#[JV0="+E$0=8;)D@:
M RL@Z#(<7U5R+5:<\$(=.=:0M-2^^=O;;1'FN226#8E;F0C.:I3_'9W08+#"
M2/X[06ZVDXV'TS!7&-;BL%)K:5C)>+MPT:L(N=_\,"_R]8SF6A@3V@E&]V*S
M\3A^@@<E/-Q"^X5-R?** <,5Z>)Y6M/>ZT&4E6FY[Q#LBA0U--=T-</8L//"
M.M#:-%5S=1[WZ+]:2?IM! M]RBX:[*>(#]+_:NSSYXWP_?S<JP<^D:.RC>FN
M+<YSR%43B;6LIN:VULV:F ^/W8OD"U-\]D'@7S)XYX4?#Z*$_>)O906NE53:
M3:WE."K+>RVB-5L&F"9[JL=X# OE+SP,@QYLBG_QXYBGZ=$LDH;I:::[616F
MXUTE3<TT=4U?NUV36B=7)O%4PT"VY6:!]8 9[)U,M5:N:6!8GN8Y>VK8H/)^
M7S<WPA\"$S$%8!3SA+(<RLF[,O6W2/"=E[2+UY?3%M@P&Z3!:!#P;A&SG/:7
MPV\3CZ$T!)%](!X)?RY(YUHQQ&Z8)\OQL\?8]AT'^/LAD!3CV1=]/[SGF,EQ
M 7?&T8#]R$/>"]+D((+;,L@L LXR14: ;!3!NH0)A&SD/PTE]H#QE @CP;8P
MK/P898,NZ_L/& WH</BNRT ;(<K@MJ2@<%O2DHT&,/TWP=L\90:N -QCDADE
MNON4:? 8I/TH2UG'SS //H8;UKUC>9B>XN7W4=3%&$8"]\.S.U$8\D[Q-.:S
M3@&)CH"$"-H+64TD+446OB 9Y0"!9KWG%&R7(^UTLE@&I6;B[00]NO>QST/6
M#9(.F.TP!C^6N487T1 0\\0XYA0EF#H$;,(!)<#!6,S^F>C__\!8HS!+5@KN
M+TKTJ45LWS ;5LO>2AB]V?"\^=_L+[3O-CRK:F/R&KJS[KMW/29:6JLVJ"HR
M3X&\WG1:_J27I/F8S7KF^<R8<2OL.I<3PJ@G(:ZB5%)ARJI93B&5#E7;=*@+
M/^FS8E,C$I]^J'KB4_7(^".:RHIZ&U+O9^X/0,T4>^=ZT+%FZ7>7?V5!^H3G
M4F!7*/> *O'NU1+OJH??ZNF!KU'J#]:0_J,CD%JMU6J]=^K5<[6N'AT7:[O#
M3=*>ILR+<[0/*:]X->(8FNWHFQ<@VVE:L<H8?PEG7</=O-&,XFMU^=K4#,]1
M;#TPMIJ:838UVVLISAX89VW-='7-LS?LIZ0X6UG.-DU'F4X'R%=E.ATF7RU+
M<]0">W!L-32K:6LMNXJ<K?6)G]7(O];)V)H=8ED5@+JYB1-E2V=8COB0T8I[
M*]/3',6=BG+'<S376;>L@6+.ZS#'<5S-,6S%G4IRQ] \W=#<IJ'X4TG^.(8R
M"ZK+'6465)D[6-W"7'=+IYCS2I[/5E.S]L6=6I_97XV^ZY:VJ=GY\U6M&_,E
MN0DU<\K5CS_8%FS]]5-QI_IY HHYN_9YZ#8H-E-QIY+< ;5F69KK;5AK4_%G
MUZKM)7%WQ1UE%APS=UX0 U?,V;59T#0T?5_<.8)0]<JU*0_2:;/I?EHYU:J\
M<"KNO%8D5+-<%::N)G,VVT\K[KS:?MHTM):[;B51Q9\J[Z<5=Y19H+AC8I./
M/14O5\QYSBQP'<W8%W=>.TQ-U6'V0.05RLMO=52S%8'F5[K>K"*0^5RYG8-T
M/!F:T52A]NKRQW2MS4^D*>[LW'[6+'W#X[V*.3MF3JME:N;:[644=U[+-6 U
MFUJSM:>&7(H_SWD]6RK47EWN*+.@RMRQP*IVUCV:HYCS2F9!T]-L?4_<4;VM
M7K>WU8,_R*AM%77O$:6+_7+I8M%$J$U?^@-L<8-7RAY5DVVL2IV#.GXBFF&-
M\"&)Z);#OW=XDN0O2[&G#G7?"5,F6ES)'EH #GD]CSL!/*CHK86?RD=2<YYR
MZZ'\E;=WO\GW+7I#@WV2/7E&63R*$B['%"2B$9/&'KEHFP0([60#'UMNI=/$
MFJ!21JW _,EY]-@/AMUH>=I$O[#$'^0S&L%$B9*+^H;-M"02CQKX2<K:^$ZD
M9]=_RN^G+WI! N-F3]R/5VXJ5"M),BLG21_CAG3R_>^_M4RC^3YA?#@:1-2R
M2_1VR!+VZ"< UH=HD(6I'\/(BBY9H@'5+WZ8^?%3SFRGP=CG$*5&-(7 1E(^
MBP%T$NF=@1\, >N XB3SX44@G).=O49Q=!_[0P+TR ^Z;#Q0>-0@&XY8D@T)
MJ=*<A4O[0:=/8S5,!FA,^R0>*!WH#$3\XB!1_*8>(7-H4"!!)63Y7=1*BWI<
MT4V/P6# AOXW/FYIAC.[N/[Q]ISUJ>9M!T5B%/-AD T3.>\4J[B6AM2+HR$)
M _73DZ\J=1UKL%6Q7]W6<#<EQI+6G68L\T?8+F[<11 ;DO$P$4H)_A@&:<I!
MH4VT9Z.69O["]FLE.O+N9/,V;5DGLZ2T5H1ID Y0:T9%Z[DS]L9_BXW;L+8V
MXN84<2,Q,%Y=QAQ^@^\Z&3<"O $B1MV3M\5J!2P+L.^9$#7._V<"H>_%"M%^
M2PWB@C"#X<A^;:<D"QU<:'P0K*SHB2<[X5$C/!"L)&O_AW<$^8&O(+ "I=3N
M#2BL%<W=ID?)WL 7(.;!0*YDHT"N%$L&+\<IKIL:G7BQ?-O,S8 ,6.?XK-9)
M H"E7TPL>=M@?W"0OB<-U@\  <A9&&%K2UCY8\&O-R#Y72X0 )\ <DBG1/"Z
M<0>\MQIUNJ/U6,+&'S.56"R[9I;-AB!&X,:$*S\,Z0N019[*%GBH[L8P33+0
M0^4^@M2L+Z&)(9X?^0# EZN#:#"('L4B/-,:4"/HS>43::,V7MS!;H."!/#H
M,'TZ[>'$Q?,U E)YNOF-9:@;NOYWR6"8JIR:G*A0@#E><'&>;I-(<.V B,"#
M<UNGZ!%(M@S(89+"93C-W%9[].-N(D:#S4$/0>T!"I &A(*$=!?5H2HI$V&\
MY<L'$BX'N#:7225\:PA,H%\$UR$O@)9PDU!FHMFH$(B'"%8HG]W#<V-@W\RR
MR_Q[/P@3T5>R(_M XNWPWA2^811<@U>.?-CJ\"7]'>7<;>R].!N:*UHN_GVR
MVXELV*B/;_';(*0PB86WK-!(<A_LMLPIVI3_[<?Y<$:@#$_;(*3?3OT>C/;,
M'SSZ3PEN&LMSA F6";H:+>3,/U"5^'F#J:,875"[U2&'1PBM*A>+W$0]VVAS
MX.DK; [V.&N<G>F^W\D.8:4A3)(+P.T@+;+0S\"0BN$Q72;;X.)R"IO"K+S_
M"WM!5W;\#4)8+89RZ0-5%?M=6NAA!4YR,WWV262GP<X<=$^,3X'MY1 U9Y:\
M5_Q^/7X7]$>-)7HUTP)Q'W->WA0JINR#*3T_&*"P@%S@T@V&/;$#1? QQBU3
MR$;1(.@$Z!J*69P-N.+4:W(*%.%#T)$;)@UY, +["Z6(!JR_O\^"0?I$?QCO
M\7OY>1B1T0^6</X=F7RLQP<1R)_83 D?VF/ABOPM#-!2NTL!'\1P%%7ZZ_W*
MYK3B^LNY?A]'2<)"?@]$X[A)BX0)W\L&; A+7!1VLTZJ!/%U!1%]$KCC+"G-
M$8_1-F%^D@ M072Z&>YQ&!GF<I.&M^3*%+94 >S()CP@^>/(D9<EN6_CQP@V
MM"C1BLNOQ^6)]3 :852#_"?W4=1%1L':*!L4WZ-;*D0+!I918%F &\>0K%5T
M/P3W!8\%2W%)[<+6NY-&,5BMA:L0OLKW([C%[Q4A%]RJPX, 4^3_R8>#'MWZ
M>S9^0GJBGPE()#9FZ-!'&2K(-N7! R:,/:)"O**PB$&-O5ZH&P,1&.O[Z$H<
M(@.!G_Q[ -1$99I[<DL.DB): ;<G\,I\6Q'S(3HW8+E$MV(7WH_@Z /!+!WC
M3?E0NGP0 !XH_H0RWN%BJX%_2_;)8>63\>3]XY$C0DACC-)9MY=\J/P\@'4:
MS;?QG&;>HS:UKZ@V$+RX(B-_981A&EBY][,4.6H_E?!DZ'_7"E^<'TYXW/)'
M4[PB2,B31ALI8'>2GHXOR*,A(K#1ZX&V2<B%*-W?8-\G09J1.Z[0.CCB)&NC
M0Q5!-1#>[,0?4G1E%,4D3<K8>&4\#:)),V$:4*,X"#O!" #R&,7?1@,?M, $
MHDP';$78KPG#(@ D%(^$>R-R(\^)$2B3X[5Y7>S&QX(,/(?E< 1R%[2#08 V
M)6S>A.,L?2)/5R8^Q+!GT*6\#)#YD >D0N"A''U@!7,I-@.J -?,$'?R7)BL
MM+XNC1D)F.3.]4('Y0$U&9$MON_S07>,+XH)S#PQZ:-.PJ46AD71AGDT@!O^
M$[5GZ'  UL_%#$6$#91'3(!W]](V1")AJQ%?F#3"G!0^FEC8-7XH5@V*OV&P
MEQ)K-+SS@3_Y<O<HKND&2<$H7#\&9+I.*G\9=4-K!"!"+E9<!F!HA+L\V^9]
MOD_Q.W]E@7QF^XD\!G!Q(GRUXC=8@X"E""^T\S!=;H2O$*&J#G(]>H2U+ND'
M(XH7@_I#:A'R.A2PFGLM!<!E E;,1_ #:4 H'OK_D9(BE.=#1%^,HD<>E_.N
M3LN11/FHW 7MCP*T[2D':0[H@NX_3P*KS2VOX[1UW^9VN^VV8<WEON5U7=UQ
M]!;_MV&T3I9#U3!? 8<+NGM?7K,;_XG=(KKJ+U:_D4_K[O)"^"DIV0<#^^6@
M?I'(1B%*&2X0853:7.7<'_)N #.8#A45T7I*PNF4DTRDMEM\ 3P9LXYDEV%\
MR44_X#UV6>2/7(LE?IR65\I@ _E&+;\@$6[.ZS#"7KR/TIA^:&IF$^N9VRB(
M(#%@VHG$!LH(R(9#M$HG,F>^RC1 4!ZP8"Q[U1RBB9>:MJ4930OU."9)@IP%
M:-UBUD1!<<K>^1[@(@ :R/0:'F41'("J_P/4/,6Q>I@;.DT@T)>9B*7[N=\6
M%3YMZE+4Q2.14SI!;5@K,,"5NW7?7)Q??'DKUF4"L[@OIV<R@4J1B2%8*+P1
M,QA%1A9[@P:[&_$.N:Q@;2")*DT'GSQG2O[]?<S1_Q'>B\0@"OP45[PI[7(*
M@+Y%2,+;KZ('PK=(NC8< ?(S2JDM;Z%&F+E#6:^34Z.,&S",<8R8D35"D&>P
M78;+9:)L(/)78*,$I@\ES?7\()8YK33<B8P2NDZ("0ZEP<YIQX^L><JW[<@"
MH 289UW U?TJA&JP:UR:YY&0TB.+F^E94_FWZVLGE+E.)XJ[?NX!$3I/J$:1
M/B+7Q<6*X #D\:O(EY&JI]"!?AMPAV:M+[U2/F65P=!1ALKD)^4%PP ;A(UE
M55"TM/2T*84J$CECA6\0!"Y"3"$2!1\+R+ N3SIQT,X'TV XU.*)!$P)"H)=
M"08%HTN[>C3CHD>9CX,>:;2ENM$(\QT?_#C@PC8:#X V$W@1XKJP1/GWS@ ,
MOCS-'+ZGA-4Y-!(7@,68#65>.FFDF/<&E#E(F6#%Z$;1".E9/'@"JZ,8S<4.
M:I]SPBS,%Y5/.I]WH'&$1AE/=@A78?926V8DQ334?*NR@/T:J:"I)Y$KMAN
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MW(:FI%9QMLD?^1VT:XCV"?<!]W 3!C<;<J,#FW"X$+Z9534_F':3\@'@:;[
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M38XD0O=]=QB$XC1+)$H5BGUW+^AFG8#TM71NWN/ 62_#LDE!"HN +TZE-9A
MOCBBE_OHZ'PXC5?LNC& TF#G@W%IFF&& 1*X0NSX@8QBK2 JQL7AZ'XP*H9
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MJGQ+7JSZ;P>TSHFC#)#2.>AAD&RN,3EPC]T' =GY(ABU?@-02P,$%     @
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MTY7N#TO0F_1/TTKK\^L_8?T,P"4!M&[<"2:PM:$)E1 1JE2)*U69EDB%S25
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MY(THLOV.E9@,?N5\?7XUR>3W;QU0770^4(9$M_[]A+'O_%(&*MUS>YUW8OE
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M?76*D-YS^= E^+=8I9=/8?ENWB.?R'P2#HY\A"3Z5RH%;?5KR(<O%3ZBOCP
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M-O?!,2@1:L-D4G.)?Z)2B3]^C+6/6:Y,/8J3M&FJ^/"/;PHYB,CLS( ^.F*
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MHBIB.9M8"(\%8+9?Y4U_V3UKT(AG0O)SM V).X#]:W2;GJ$6!>6-XXHU=*#
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M9#+YETNS4<9@_;LED<\_6@)'_<Q@]335#P^2PV\98;<%G1H)V0?M]Y^'85F
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M>K=#Q2?ESX?T>0-P:YSL_FD&/U,.T2X/:RN3D%-GNTFXR"TX;T-ZX:]1PMY
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MQXYF!QJ\BQ56$_&IGBF)4UPXNZQ'CLBXAKNA!=FNG+UT9=HUU-//C,@B;=T
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MN4D[J4A0/DE].'!QK@/F@0W%B6A;4!3:=63(?71!")&_E?M@Q<@&RJETN6K
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M7J.O0[<.F:$VZ!!/4&D/%YL_H+7!5L^"$'F1!GI4FN5FY2NT'> ;2$J##U,
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M1](M\&T/=\*F$FG)(%HJ%_VF44H-17_) (TK20B^+79L4V5KDP0;+ ?72F1
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M+ER"GR1JTO2V41LD^/;Y7EW09=LF4'A_\K1_$/\8[OQQAM@D+G%+^-,&:MM
MM@6U.R=JW5@KN-/_S(]*WVUI_'!KZ@>=1LN"?QL( ?_VFQRQ?WSO:0;^*I)R
MOQ@.6A50O7]<'"PFTR%WT5]BNM"+W7#J$5C78Q#7'>&6H34:K-F!YF0H>_]/
MI;QZT>R'TZ>,EG<Z3W=)C"B4VGU(/Q86=V*']^;!I(/">0'F'TU;P'4*!175
M5>3)VNJJL*"-Q&W3!*8C#X3>PR>LXP*F^ZJ?*O*-+*W?Z+81*I'7\N#HW17S
M=8%/Z(+FSO>'LVSMR<<IIT'M4X,#"-0E<KG"I8,WLRTY:24T"!<X1ZCE.C;F
MOM<L?IM5M1ATAB_*_LWJ^<$AW&,_N/G;<[9KB[]K-"<!\4E*3F$3C"PYP0]B
MOORJWYRN]:.IHCH<B#K4R%NH=;NR"[6]"9.K%O7&WX-<.51>UY1R8@4<_';?
M0(8.@)+XB)H)>O[O7T=^W^7)^Y[DUJ&:6(RZ6KXEEH&F1AK1HF,:>NKE2> G
M378&Y_<9M!I?'Q:/+?X=B_C],Z] 'W[?:X##T5.ST"VM;\^_QQ? -9@KC'[<
M28NC0WYP^Q\W: ..+;VCFC2NX80-F5V@.JTF.Y*0>#AHPV_Z!SMVLOEL224T
M%J#3X2,5M LR[^ DE7G$MCD72A->V4Y)=^= #8,K[I,K EQC>HUBO2>MQ-_A
MY6H;>^X4X2>/VWMWCI=*=-Q*-\C)\W--L7\[9&^9IB1(O%AK[FJ53[+\%E!#
M4>.A/8?10)M&UH(1"(CM/-06@@Y9YEH+XOK>#9H]K 6QS4:'=%Y&;5F0Q;?#
MFE'KX&I*&?C>DSD/CIM";^B"<!>T:UC)?AH$"9*$SQ6XJ"12#D^.H$;6\@(U
MQN>V,A\\GKMVO; !>09A1'N'6#T.Q-+0(*\_\C>2,3+L;[JB_-HBF&1;/?N2
MLX:/G)SXF&+9MN=;7<Z)-K4CF"VS,^:<X;E="M..W<KUR0&G%&N2UED/&(.\
MPS?]FZH,\:LC=0VH<>+*8Q"<*VHG7(-P= BC7Q^F.5NXQB"Q0AVTTI88M1H>
M-LN3;D,+Q&LR-5^LG*^LC+U0046"3LRR9QY%8C /2"5,8OC;X]PV^ 2T8O6(
M_E8L9/]O%KGF626Y?KOKI8O:.WSNGWESR['5OQ"CKNT.0:H"BU.EUW&BMHI!
M(OC&5Z@R/TM\X WRK=2BJ VN!RR/M8YM*>][*EATG:7L#&\)*D0%NLQ$*,3!
M6^"QL(K()7*0:RZ08M1W2^, \LB0FLG-V4XS;1Z>R*#V)$>6DD]ZI',/4>T5
M##.5#R%"087+K?AR5C]'/-LCHLD4M418B0"+5HC?J\Z":3RD;!8P./OB(*WW
MBK1]J%B<JO7!%*1%W([/MW:KVE"KD8Z$K'JKJ<D$%/--J7J[I\ZU6M]"\H'K
M+8;^SOC= RN6S4,G"[,G>,);/[/K-<IQ7=%5WAG2:H%D!.I*@WO2L<))!,F6
M;53">HZP4^.IVD$U]Q*G48IC,79A__B%NA(9:8[/O,LM)W*7$A1EBXX8/Q1O
M!97*9"73\A%\(D?PQS0ZA/D;4NJ%T[9OA!T!?H^B5VPAT'#!1L:2-O1&OJ&D
M_\R.SK--W#?40E=>"EYD\BX/'D (U\,+*6<)T.A&+L#W/!""@^Z4B?52M5&U
MRKG4[UV\?XTI2E733=23J<9/5_*N?7S35?U$#X)YK)<[S$]9CS@9*2XWOSWT
M:#?U7M[5>GGMUX<HIN'(:?SBI)!.,<6(6A%\'"D-2DR>TR13_L=*&R;KQHIL
M&C'UFW1A:NOC_G,Q/5<C1#GDW^[3M>F$5@9_$&8<I/$&=R.@&@)^X7LG@<!W
MVQ<RD:4#AKL?&Y\$8>.#CTR>OS+>_SL&UVK-<@Z^])9,? 8J(E@6]#-D,.X1
M:1D.6<5^J-9MQA W3T?QJ(,-R889\=VM5<V6[?L3!C\):@EFYHT?&JV$!)EH
M(9=+7&%\&AJ4.T2CYL1(>*724YPA_-T$RZ>RY2IWJ/,0IY#CY0'NA7/9USWV
M=;I=4O5['Z->]Z$[_9UU@,Q2*C'0'-@BR_L)3,.B;N)K!I":N&*K!GT![\.*
M;R5VU3'T\/A=8[S ()@!6=?_Z73$"_.)PY\41FA=J.<Z!^[N?)5X\@E+I9D[
M14R#EPYY,@#;'(01'@+7:6$749.7&8"1'^?DVZ&GEEFOGQ^LF@QA,FS0JZ\S
MXG#_'&!?^0%UC.)?/G+2BG9. ;6\0CVFDQI-4Z75[@;UR>FK0: GP CBA$ZK
M1CXZ9#@;1#<%KEBJ^JW"143Z),'=?KDLAP[9[0 X^P:JM/-C7>NR:O=]'7Z&
MOOC[A8V-M5"".57A0:_((JB.!C_4(@A1\CW-6S9(YDOY>!L6(X#I"=9V(4GG
MF$#I^_:DS.=15-9@W&]JP&RUQ\!6C?I!C +.L<\AH(H+=&OW)$; ORHR43=T
M?L6>[Q5@^"__78[E_VW3V. J5/-U7.(VZQG0=3+_@J (Q9<Z6]9@C$*["A$Z
M)PQ]+:7WKW_XFVK$K?R_%[DQ0S7MEUXN04V]R&&Z53;+WI8Q\\GQ5ACMR(\Q
MV%]M1AW;C!Y'M-3&/GVOW+\_2'OMLNL_OCN5$-S>"(K09*B23PWV@;&N3-D>
M;;6IAH#$7S,)1>"A)%GX4OT+P4GD;GE&@P;M&:BTACN";_8]JT#A3A#:J8Q/
MP(7]O6E7.P:VSA]&VRXO51/1C^G^U9U<&B=L'^JC"Y2\<%>AJ&02.(\\08><
M*8*OO(#_ZAD[,>[P:1C:J;4>,>Z4,=+E<SG&;*LQVSH,_BUD$7'6>][6F&PP
M'RQ(G,20&OJ]>6\,**0K<^.,I+-$C=XS;C\!P0JD46I>0PSP=F6K>_$,,8]9
MJCFLV14.$R'/>*0LL'H-4&>.:!3K;+/#? R%D[0<0##Q[]_4^%>B8MV:\3O"
M\??I3O^>3/T>F>D6.'FFBZA.%:3B]]P;0U!";A4B<G]Y@.E6#?@O=!>WE4 4
MM8M &&S,*6J73(P-<.72[(%75&F@+/^J>@OK?UR]A>]9#;6.MJ=7/OP<4(.K
M]E&'\.>_%7O9BJH%L0L+)1(6#:M'"Z&_5/CETC U\&W987$;H[9Y7"W0A'?-
M]-^9N^B[+TYE_PVU82G$M ,*](?&$-0@<(+Y\F1E25!8[:$$'1!UG0$!;K(O
MS(S6A%@U5$21V7*HG%R!67Y,2_)E7[?-,5F6K#H7$WC<;KXNSL[M2,P@_5I$
M: 0"Z$$<9P+@I%F4O$<ZY0%03@R.^AT!K->X^O=_?0*]!_\12HU&3\W(L#ME
MI%,X.4VJ7@[DIFE.JQ]<,NE1:R^?<_A'M]/6Y<GG41T^1'$J"DKEKJ*LTKJ_
M)=$^TG8D:S>7QRN\;B'!7&/03]VQ*@L3F].HJ+)2>ZC 1&A" _/G*DK8>BT(
MNGV_;Q"7TR&Z2=MS]^"K)UM0PVAJK3@GR$.",Q7"M0ZJN]UTR.'>*-#Y@E(9
MBF?W;IN0.(;6L\0QP0<-M;=/&DR>O7QJ04DQ.'^JE_)84!EP0<V_A?'@H93D
MJ@8[<)ZY7SLEE7]9E(F_YC86_KC[V+&RG-)YE>+* &^*I]R^EYH?35_\M.-;
MSIB2;^5BSM]=_<A=:&;,(W^P[^PSO53EF^97Y9I\JQGFWTP_+_[+]B#7AJ&X
M_O#Q3,.ARJ[ +D=[QYK:\!O:]E<[]5\>O-_)&[ ?ZO+J7]M@^(?#/)[V$<4&
M=X'!_ K@S!1YX'F><S8+4?J1QW6\_0#R*.N7[4O^QY5'7[U)##QOY3 BDFJR
M^U7B _*1 PQK #5.S970>['F+35=0^D,3J* P):.$[)37&$3LIBI[D_675HY
M9/\VK+,NX52>38]H_.N\]M6UQ4GF1EX_QZG"YDDH\C#AFKY".:L3:=LM)"M,
M]Q.&]W3/:3Z?-OQM.;VRF)_WW8^=NKDLYK9FV;:\\'[/<XDGS*@*T!G:(D;2
MJ'OAOUQFQ$ BR:J@,YW#BUKYF/O+Y?.B/TG^)TB@G3F RK<A+'0$ABL^X\[/
M211Z;0RA0])98BB'RB=@@.I.FB$/KI#ZP ?$*^!-X?)A/TW:N?L;Z;/^?N73
M)SX:*59V>+K)ZXC>Y#_%'F5_]0ZSR-/R_MYX @:$6%)T2*B5\R2?UV>SN7;;
M'?%S:-T!/G[\^(Z)UI"/AFQ==W.3S[DB'BJ2(BGLYJ1TH_"<2J[>=Y.<$^&?
MU(*8(T;LW9.E]&7;A.NA)PQ:=(@GHGS*-4_F*FN?C$$)B7^H'S9=T_;"-N28
M=,.G4G2344T&&LRB,;RP*.RM,WQ,F\_0+C3Q%^4MY?M?%$%<TZ]"5(*W%M<$
M<,I+'^F0U[T4'@.<;XC7(B=;>!%2O]_;B'7_&\0KPU.'045C/::&('T0WMCV
M)NK0]!VCT#_%HW*ST8F-:8-/HYIF3.TJYE"A\.N$$,785G$L/%.VZ%D,31SN
MO7=[DB1<694S-8[I=A/(6>YHLV" +^#+DR47T9\=:;K=[=1(1]#9]S!?TF"D
M0SKNH!=!2Z8YA=3['LV@0Q+@SQ=!(XA%40"0@\'AL%\N#;50]CF]>?"_\R-$
MDYH%PJ#>./CF5^-?+B\/7-SU)\E_&8F<I*O3'EFK9YP#SQ@R@O[-0_/CB47?
M;-!LTN '\HD::QCNF@D8P3'^N-I1W*+7&[+\Q *'8HE\E\?MF=R(\5OEW(?)
MP5K5J0G4SMQ"P+N<-JQBU!QO:12-8*6<*/%KFS1.JKQ2F<.3^A)=DSV3H>B/
M[52^:]6\$(=,=]XE$#&+O,A4;(PX!5^N($(Q:&CC4>5$#:@S]X0\8//"N=J\
MUB$+'RW6MT*;J%YQ/V93]:*#=_2D=.D>^]')V^U6_XMS6/^5V9Y_,[BFLN6I
MK]V1>YXBK8&L(%RQZPHK$DX4R\(U\#,7D-5J:A\_&[DE[#SV(&;< 5T3U=@[
M'NL_MO+>N ^I2(0N>Q0@98=F@:SOD:B:&-Q 02:&^'5"!L0P#=5O:I-PX;.N
M$AD,;CO;.>$I(KJ')I154Y] S9\U^B:27@*C\+NT$\XJB<W=+!> $$),#\MB
M)HO0-1N=\X-7DX>7BUYV?K+J?*UV5#30@K%=8E+NL7F]GT'+-CR^7K+ KQ<S
M+.R34SQ/F/C<%><><:4E:C+FI0+#TY]#"?KD%DNQ3/B(^X8$_C[$Y\3< 0:?
M/^0*_3$'ZD^J_SS5*IG&]HX.2=$"G+_W'4"OA^+13,6;5C2VE\->\>8D?<"-
M.PLE^ '-?@7$Q4'@KWM=-R;V@\Z.J+K]5K:M)/#AV%!DZ<($_U )1>?)9(=K
M4.&XCJ>]-XL=+I573B6[1797T+%2KO5EL9(>3]+DE%M.).K6L@')D?JZ7M%]
MKROM !"6WU&,89[A^B82NCTI=#ME5RIHO])<=,D;*X@#J"\%?K$_M:(_M;@&
MHS&;DR]U3<G$U*8OC9<MS+(@.$\.J"ETBZDU7#BX4SMGV8 C%(X-.3U3O+[2
MLGWK:=GB,);<!<L,])5J>1YGE]6U'\Z):(?I?F/#'Y]CO9>;]M';E,\0JU0;
MEUR5XMQPJ](PI]C/,<O^D9ET7=OEBW-Z8BNNA9/V:Z]Z/YGTYB]P3RZZ64,O
MRL%/7#0G"JM*?;A3.]'.IWVY$.OA@?+4RT';O?*SMM= JNOVJ./[$0%[MU=(
M?* MEO>@0^Q&Z)!U:]/5(T$(\@&_,.T^VGXCMR*7$RUS5H]"W\X)6UL/+V3_
MRHKC?V7%ORG\'4?;E)J&TO@?]M[_)/NGR$S[-QK$37T2+Z 3',ZD,0?LK?I/
MI).V YQ/0(=M;S G11-X13X9W%LS5 N/5J"*3>-TFFVNMRKUW,R_8>?AYSOF
MSWV[MOM S@V]2$J@K+"57LA&'/^%5+?GUJY*6/MZWW2/MG1SO;W18I?'7]G<
M[=H]\9FI8#JAH.0B4W<.(Y*G'+@^I1RC)D-D(2D2':,VA,QHZ@:MU339!L),
MRX1\PYLDK0]=@KZKHT^BKQO>U__TK"U)^UZJV!LF:G+PT45;82 2#VHC](Z#
M@+>==[F?B37!""-03)8PF[[X::5QQ--#U.>.@;/#IOZK=SM.=43;GC?'7K[(
MU#4AW4 <"$"WT"&CROCVYF7-)A7M>$* #8O61^^NQ5,K*WRV^ 5_:XMN!=V2
M6>9K9T14[[>$CSTAZRPU3;DA<)%+@X0U7$W4Q5(Z)+(>FC=?TSE^[J-%*V<B
M>=[01Z4@)=\US;!@T=*^8:;B=<7H^-G7(G(O[8]<V:]KOT^=F:GJRG_+\>3_
MU-'F1QJ\MA, )P8%4V-!$0ID^,:^UU5SKY(R:-[D42+&:^H-/*FIXX!6TF:U
M5K\\4CJUMVV\_V#,'!WBN,PY78Y!1&C @4&R0G"O\I &C"@6GF>#E 2TBH&"
MT2]O;\\&CBDVA3;S)#@)8O/>)=T<TU[:'>3(EI)OM>"YZ+-M7VMKHR5HKNR\
M-]HA06Y6P7'G\1<W[CQYS+K\DZ1T">][.QS,&-PQ>8"B0S2:ZHWULG$QW$&'
M6!*5HRGF@7F&RM$;>FY9S GJ*J2YSITW+K;NV5N4?4D:SYOC27VLQOZ"(D_-
M5MM-F+1E6@9!KFUZP<27N<V7EEJ<=,CT>]>2085X2>L*%9^J JL)JXK<2IZ+
M)5$6@BI*0[OL+4Q#EBZSOR_^.8QQ^<X(]OSH;%7\Z.!]SDO&IT$#Y0BJSK5I
M*'7[ .K?+[D4#S! 23XY=(B&+!TR^53G5]<F?U+]ZZB$C<BF-$S.Z][E*IR4
M\CMTY5QS$<4@WYD_<71]\?+@RG%D<:)4[F1CC].C1G.["%'/QXX9A'(@LHNV
M9P\=HAU/AZ23T*#MW""Y<8WHR+;C<!WZ)<_JCBHT?GE_^UX65J<-082F4S@X
M:?$"=(C,,@J$/%_ID"@D>NI^SKK3Y!;*E0ZAY" </EG2(:ZSD^OL< H;8E;&
MWF#+? Q92,BE,<?2(;O> 3"B^#F@@8 F7>-WC*H_5=2.RG5A:@L8P$_@Y1^@
MI%W;XPF!<O>_G]>-YO%50G%0SE97O&8H&\==)M+>DLTGU\WGK%'-6X6".ONF
M'UZX][5Z(/E!_@M+\5[&ZL:Y 4)/4 1N:Y#TT-Y,D</,[4AAB;WG6AN4$Z'3
M\CX9:GV5EGIR2,'UFTP)*64P9FY#</BK.M?T53]XO&QE4(3XJ81CZ:OF&.T7
MP:6#<RB ?3P:SP8K-<$:=XV#($11I8<UX @;XAT%H+5^6O%_U8 UTF+-^;AF
MNTR615X!O F33<F 9ENRGN#*<ST5FTRXG'I<$43USKL9HYN>0XU)!]E#Y: 7
M71\299IRPFG'Q[9[0Y?BXH<"_2B/]FQ(">^A>"*TDF\;[?NR%?KA*.[I/JV,
M.WGY%UC5Z1"?N9/E25]FU70R'7C-P[,L]%/[*[$/RM#UN=Q=P4)$!*:7N\B=
M=='2!B>B8<UQR&,#40]GMYS\Q5?V S\5^KK[OK$3;PCI,2O';S!)"O7M>0"[
MIO1R>\T"3@@-'LQAI;FS H^J7)VVM=.O7>7IOS'%OFY)AMOK(W;1UN:V\FIT
MZE _E$Q<-;K*J 6ZIZ<:QJDAH.#VF.=<\DAOX_ ^ <)!<T<<&IN"$T-7JY::
M!<F9T5C/CH7D;*;<26R)>62WT&Z%^.CBX8CZL>MOJ=WPS)5$A]S\6!5K]1D]
MEU_:_!Z=D6*VR)TA\7];>*]8WHQ8&+9^G YQ XHO5(H4O6V(AWXQ5,C\S(+^
M87C#(Z-F^1#!7:\3'<>!:R=86G6(H?;7H2QGO=U'Q=^9C=B(8&KS^]DB3!..
MP!-FX>!2Y\JOM) VMC&RH/7TTR%S;3#RNL0OEY(8 1*XX/'<1Z=RPJ^=];..
M+D/I#GY/O\PDM1 1_#YWO;[<0G^]CPD!I]AA1UF@E2H2%1JNO!W6'*-#?OBV
M1'7)*3ID^>B+A31L3G2C*'-NA%=2Z:1):IC;58]7/';SB[8S%@/W["K>ZM5\
M_'NL+&G[+PO\_&\>_J1R\GF*)&%F,R$2M.E>R\HXW.O$%LOQ#Z='I;H_&!RS
M;']9F7R>P^#.13&]VFAS3XZ=:,>5Q%I$.QJZP)^GP39<KQY8L%"C-,RO$U4I
M.<H2<DOZB(%55OKMLZV.(1RW#^S/MCMK('*1":7E?Y):2=NU@&*E>!.-FC(&
M5Z(4T)$\JY; J\H&=8S5PU"U/IVY71;3NCD],GSV-RY=K(%LEW V>>^PL3J?
MK'.8,>'<5=,'<:',"\Q/F#[]]VZ?, @-9N6OL[H&N0I^.HEI/\9HMAW65";?
MDE-1TRS#>2O9?:^.HR2JR^94G"CJG?D7RE!=P+'<4V?(9<W.ZKUL@W3(]<5N
MN3FR#FZEA6^Y +%AX)-_!35ZA:!#73-5Z\6NX&HF]!2[KE#35GQGHHLG)4K3
MQ-SU1*EZ7VR@T$^@8CEU4QI>04%-"<0ZFU!=+=[N@R\_?BA"VRY;P: J99KA
MG,L)DZTOL?J3J^W&)@S"HYDS\!#%@45AX8](37>2(4JKLB&6YC]N57(7-7D:
M_\:(@]8%V^.]W&?A/,Q_H[2'S!)6 __6.,7TLE7PL_.WC'460__L:#=O-_\=
M8R-CHJ_>=.H)1)@)MW@7#H=9T[H0'&J'5!%(>2#Y\IR&E=Z1BIR;3Z].)NR6
M19ZEOF@4S,H6)Q2[5,\WI2ZU/(':$(0U2C/4[]D3].#O3F''A;>T_)0I4KW8
ME%8U/Q1NI$*;G,QZ=)@.$7Y4G=,9-N6.W6Q%K7(3/?K#-NB0Z%#-1 H38V)Q
M%5%/YJ$G2:>NZ_A%;?L,+2WC-7DE2(F4%;X0XP85,2$.I0O(7&E=D$\$]B:C
M]%?]T#<0W(MW]E#LB:<[1[K<8O0ZZ) 059G5TG%QD@K@Z1PYJ!AO1HPT7;ND
M +]K3:N\8S>TBG[&TKVNZ.V.S9GZEIGD7FH]\7*A.LV(,B9!=7TTB'*#0;7U
MO]HR-[P1_Y99_"!V_>+&Z#R\HK>I&\8(W675B2FVZ5QS)/B(K)=EZG\O,'F0
M,1HW*J#F199ZII-(_K+WU,M/6*GMEU4Z T0CP"DQ45A\"PDCO#RFK,>8H_9Y
M<_P^^F'NTF2U40P=,C0FI,(]OS:*223/R=BN:0E/2.)"*9BD#<<P%$8>>8,H
MHZ$ O."S6CE:EST'"W/C*LP/;A-F#V.R(D;D>B8\PXK>@_4&!2H>R!:KT;GZ
M)7INVV@)0W WP.CAWDJ/>076=4"_YLG,VRBE$"9QM/"P/#])@Y#TO.AKF73(
M2HGC1ND+2>5+>34W\Y+938W//KL+>0?QRG\6$_+7IR7_;0COQJ^,REPD&$4T
M'D4:U1-:2S<C*7S3!M"]?@'CTAH?-FOOQ;ON6QVS/N6$J[$J;HUJG$QRR[^.
MOE.TH"'HBJ[J22<4F[I'H]CJ98K]VEBUM3^9&! ]^(,VZC>/?RKNN7G]+SEX
M27G[;PD\(MHZ$GJ-,]_!V&@J@.050(\G'J$+E)<@%K.YWV2/:(SFNQQ6U[+?
M,<>NWVB(D= YQMN\>%];4I7D#7A/P]F0)XDKL?6J9.6%:5Q-W))7 2&RJ:Z<
M$]OAR571>K A^X3H+/:3@]ZUPP,7#O!:/>S"WU6I,QH-;*$)$R);F&FBR",5
MPE($F5B%7M:F/,"]A7&ARVI \9 ;2>+IVS3F##G+!<4':C=:&-PS0_3*:*,:
M\L"%"2F">SO\GA+WA.S'RO'#FZ?[*"?P8O65Q!T+OJ5VKH(FO>XLS?@EYKQ)
MOKTEH@(A[]:D!$B7@ $DZW2\)BZR:32'\6O:A"H!'4,30,H,5RTZIBQGV&-M
M$,F$7C7NT*5G+]J.V)L;+E<$FJ'_3,#[UP^F#@V!/AK;(GH73=TOD!1+U&J+
MS.T@]E]4J:YR4\4H9<EUV"EEW3EBZB[15GQC84F)M;ANYGW)]_P4&VH!31;@
MP<LT(T+1[%*-1^=]PO0J/VD<==[C7M KU3"J7QMW5"ZU\DU=3:CB485#[+8S
M+-+FSMN!^M^;"@JTTHX34^.46>#QUZIL@D>7=VE*-NVT*NEDW/O^XY9'Q<Y.
MC+#LY90*G/N^K[9["3U94Y,L\XO.!<Y*^T><AXH^-/,>/IWTY+C>P6,AR7K3
M*:=A, K+?3_/"]3G:B)X:!A3LP9_7\F3! /Q0:G"F#9FI'AABQ3*J_N-/_/K
M6WS62GV^.R1!AVM$1>H.;,01EZ<A/DG-RX&NVP\@>QOF8GF1'\C?NMTI9@ (
MN.-RH(J(<-H)UYRE+)?))>QCLQ1_-_6W5V_<JX9V' Z-4WG@ XG[XL7>+GBB
MQ%C[1<R38T6@%H)<W/'=VIOYY..RX*:URKZ<8\5<.]FMN00#]WYZ=O<$'8)C
MZH//S6[2(3NPB<"9]<2MK08ZY%UU:8S$3AAM?Y (+=@=19#ZGCT#TP7Q7>8D
MA<7E\Y^4?U+^2?G_(>6.A-0G%DZK:FFO>UJ'F;H?OJ2Z;/RLPW?[_2.%&?Y2
M-:3\A;.*V=L;V%L_Q3!5)=4;!B0/RTLR7C(-V15Q$?/Q;J#I_X(P\S\TWB+B
MX'R4W03)9@^_7KS0S+I/.G]J=8XK]Z,\Z\DQZW%K79$(WJGJ^"])X^\AQQZG
MV)CZP2@'E+HL!AKY 1XCPK=*A=$MFAQ@?+R*NXHSUN)"_GZ+\S=/!Q4R.1\4
MO'97M7QO<#^:1<V\S$F#;P]>'69,5-M\^=5,0X+@DYO7Y7LD3T^AL]A_UPUV
MP<STDQ,<AG7U-:,FUM2R1A8GK#VIT-F[?%$,TV(>(( %W)M5$O+5:JJ?&G;J
M"%6R]21Q8U=#9B+,#$=#N.80U86AC0?]$"0)HDPBQ82HY@).RL>J=8*+J-@8
MS?6HLKZ"47>XP\S>_L::'3*E]M08NP%1=5H9 P/$S9?:IWHCL&85!6(5+TXK
MH%GT\$&&4E)EY2/(T:RSV[CW5Z;95M2ZLWIZJQA\0?@;"U\.(C CI0B;;:SB
MK9LJU4GXT3!W7)27(?>WU4V3K'/AN)@^B8P[\S,&#?I0F2XW\FWG4C("R9Z.
M:TULH7+3(;:#2QM"VD$:HQ<^J1TJFG YN\K1'.A__&E(V:%DN3A!W=@:P6D1
MN(J?].:4SCLA Y(_L3J5V*4YW C[*@O4G!]N/"Q6N*>?L:'(G\=0H;^8M[0E
M.7^AR($!.7A^5=ZQ&5U5$T*'.)3?F]S?J-! >VP'/"467TK!^9*Z5S]_=M$?
MJ@:!XLUD_/GC9L%N52W+RL1#NW=61O'N_"I/OHJ$I..48HF%!L3PGMQ<OP3@
ML]/^^0RI\=8-ZI0S5^GUB@21VPXF^^KZKQZ=.>7V5$\(WNP>2V, 1G'RTS*1
M 94U2J\FNNW]6<?CAFJ4?"]6C[C-A7KK'4H5"$UXL@H]NV<+UC0,(J4]J.8P
M(-6..(RAB1%NQ>*-#FA-NT>E6<9)%6B5+Z3UJAHI%+6IWG#.=DKWA(0Z#>1D
MBH_0(=<$BHVX7- \P<<!!X0R1E@&R%=<B9 18>H8D,+WWY02K;NW[I>7/>%6
M=O)V9LC!T-/J$W\E\6SFT] V% -R+^&QK3P0Z1\DE-^6[U:(;2UPYE'>Y%$V
MYV#&19R4RO47];T#V5LH.@0/ASM/AF=+#BO ]MTC"B<6 =F!G[TD80?\5(W[
M[.N2^T0S[$WK0^68$PR['KOO$1N?L%K&H::>5EOVY!.&W]6B(KV?%DSV$M.;
MH^V+JHH>6W9Z2X1V7K^V<_FDJAYDFBN%[.(GB6<*!U\ND0.@0UKAG&WE("?M
MZVUP"$ZKKTD6F09=LC?BD:D.9F9&2CP=JKE930<8OM;.+7L3K+3[9:I4#4I1
M%DK"A^L^3@QC@MD'O(_.-%3MO77IY/(3'Z^HZN$'T.-RKV^-,>?GD!J!71K<
M0. T8PJ>G&6E2W1KJB&TJ(C%^OH'/N]Y=I;0ZGS \)37:OY$/E/Z3#7UC>(<
M@K-1_GN:0:AW\(?@?8!;OJO*-5>5O)T&A,IL\8&^/NP"-;W[[8!,F6!X@NRW
MM0\C8TODBSS>7+,TE@: G<!TB9J-=,M'WOFXL1*YO4]#JE]Q)2KZ>;-74[F+
ML%:_H<)"FZ2'Z/. %WQW$8HF:G%W@[@GJS:;^((%KU",/KEO+-OV&@\X]B]7
M+G,V\\?/YLD<.BY>D]S)RX_G$Y%H:HFJ\^B1DY>D#>=4Y"%VNM$A3N3$Z.K[
MP-FE6BL73JL/R5UR\KFCI6^-3A6R'HBQVS.[4P!9S[\U_4>7B$ ^83(&Y2 3
M2H<0C&PLTDD)!-\H*;'JH=Q:8LRB4O.H,5%HR=R<9P\+T['7JKW2[T..BQST
M[#@(,_13;<W@242*Y/O--0]'3)\?JOPLL[X8QGDH;4^NA8A;R4YITY F2-RJ
MI'9].HD;")LRBLIY;8XA]S+XM9\?>M:O=BA_'AN78;-ZH;HFZ<J[(S7WGZJ*
MGH]_?UM;6RM@\"^UX7\>7)T4.Z!W2B;$EC.V#;5_12:W\LU :27Y2F7WX5D:
M?G8!?T90MGUWI;MHPK?3#)>_9"P4OZ-#_F&)/< P[F="R@(L\ V>9PCOC=B_
M;B=&SS5$GGU%U FK$A*S>BMU6*_ U.J]R,&H+V-OVPC);N,SC=B,?UI>RU6H
M56I<Q)W-=,@KG6@D"I\3/6U.3,>\GI FE$>7KNN6=.?//)33;M2OD)04SV3Y
MDO6I9RH&$3W)U\A+AS2IH!W@C$BEOJJL$XI9EQCR 4LCS@5G9S?OX*[9L06>
M8;:S[;R^_K,WO_D$%;'4QD#6+>@0UY6[FCCWR$999PV9MX.5B=QC JA]FL^<
M:GS3:Q\OB,KL,TLZUY]N=,QFX:)_L)7[:)BA.Y8\%8=F.QXL_K5FFU3N6+0@
M/T_"^D3C6+77+O'<3^,<[;#?Q^JQ+^G!5?PYFS=S?'Q;_4V^Z!T:D 5$16]\
M97F"I7 #@0XY$]E:Z]! 9%<\>>&AXK+F^UKG@JPKK;=$4V5,-6599E\X)F5J
M<%%+ZZ%D1:08$$[,7UF?AK9"XRT?Y+"@J]W3VC"7S*HJ:\@WTCGLKE6LN96)
M.Z.CF26$\DZ_@YV5 5E_=A.G\;TD6T;CJ[*OV(T/:=ASML*$*BIUN87X:%=2
M4#*SI9?7"5U!%>GF>TJ218 >T1>WV0YGL* 8 (CR> .=1F>.H]@)71O1!.T$
MW;P84_.8<][V-[SW,9_B6G./0#FC1N9(DM0XKR#-9AA_O<QTJ<X5XN[!_.H:
M]W*KUD*7;)'Z-(.ZPHRI$PE]X\*.2;&">6<N,]UYVF!"XNEKY/V*AK@M!?,C
M[3ZI^:VZ\@QGBQ/AD2O7L[$K%K6/RKYU;MUL/M&(2I5/-7S4\>5N(-=?Q:0$
MR]M@<;0= !?N9+TCD6UU6]4@7G_4J"KV?)^T^S?I6V6B[)A]MZVT5W6_?8%P
M7= K0?T!8 (*8I/FS:HL UQYB!<=PK:H:8C.F98)Y^@R=C4^6?5@P7CW@[86
M)NQMGV2&-DEQT@#!O 7*0FL5/D*D0V*"Q>,1;0BV+K^ZYD:QFD^'*Y32TZYV
M\&\=^U!2DGU3)ME71S548N<G[U[L(@BX"A N/NF6M-<WU;1\GS:41U!$BA9,
MN@)=#HSE>8R>7IIG=RN7$+YB?V/\#;O!/X]'7'L:Q9$.P'4Z9-<"]2&%CS"J
M/^35,N2MRYB.<U8S>IZ?7S5(ELGT+$)8GV(1M!N?>U3Q=H3T1'I!LIO"$T@0
MF6++)ZL!H_K S-/%2>@Z+]*JP'62G=/DWGR8[8!:;$&&\V"<&5[OTL9E>4BC
M2X$_'V1;"NVZ$BI'.?D*R'DVN8AMR,XMZBT<=<:*WU,4Z-:U/7O%R/W( UG%
M%CEMX[!H=I_IQS<<=.&N1J$9.<U9(B"3-PROVW[:6(R66G]8KXX+)"^.S,6]
M%XW"8E@,!0[%G"9_\CEPZ*4'0@TP)U43X$N#A$P\3ULZNC\.?D!#T>424IHV
MTF@EP*IG.=0WN9QLK1<>T]M=_2:K@"9Z\(E/TDYOU+YZ.P(3#KH4GPMX-J-J
M?".\? :\ZSID:.)8&^>U$9M%^?.;Z2_XIX,JK;)]) 6RFI1"DO<<A)VFB %5
M4[ $X5T50 JAWUIYVW"Q2_!.0^5]/<$DW4\&!Y+TBT4OB4:]?[_ RW6*J\^\
M%[0=AE;STFB'K6614,EB53C?HK$S[5CH46,U<_:&9,V2\-2'B95ZHG&W6_?L
M*MA?!#O]VY"3]3\IZV4OZJ&TO0+V)0L(5B1+(>!KR>]&H4/XD!)IEK&6T:TE
MA9>BCA<H'=3H#ZN\SW;BM-#P'X \S\N"AQ&[*]WDR":5M<,;*79XR0;69:0R
M3DCG4K;5Z,6"&9$$+).C;JR;_^E5C*38\KN8M?)1DR;$?C49\@&_]';:42!;
M$<6'5)7"K^P%,B;/Q7S VEJ$B;I^*99[_=K_9:/>N. WYGP@BYB)2Z1P%I.N
M$QPQ;I(6_9P6@P?Y$>%Y1(V"M+1A\Z5&MYZG0;>_'/>(],UVZ)ESQ-ZM*WH"
MU?KGP8_"$+6\D;F+@&_'!\>BREU( 0FY&CENA4[9^P?<%0_Y[[%3KT^[^&YX
M?P>?-INHUFB"1U).EMH?6AX5. 1V%#3"%>;-[E$(?ELZY((LY2(P^%R/4$=V
MV+IY4_&(JY4!JEK/0XQ;$JZ$Q?MD O=#0[#G]C&LTR%AP7#*0>)*4S^1C+%5
MJDEIUKONZ>M1/*8CRN+&]=8#GI%\K-Z0+QY3+&$O<8;+?6JSE0Z!4/P!ST*D
M.6!7;!#T=*'1]W.9XZN,D<^M\IB#3@6F7H=UQV]WJ@28?[ ] * \2VB]M@R
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MS&RR1OAVSK--JZ71ZTZ- [JSR;0GX ,*BY,6]=C/*XMR=VV"DI,]RGO&#*"
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M]3"R*-UG#:>^6)2=R/!0?D!P:F_TSR4.=2%KCSH#ZZ%NUY6?62HU 7AF.31
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M9>,3Y"%,@,:5Y\^PM'[?6P][+M,65*KJ&3#GTITGQ=W^ [)G ^[HF4F_SO
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M D_  W9%T7L.X5-NL2YI^'2%=!Q]EN%S,/[3Q0L23S\AR71MULP2E)D*7<[
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M'\DZ(#=HI(E\,)8XK!M[ 35HM*1&-2LJ\H#$*YM.F%H%7#7+OI-^(\.R^<C
M;=]J/<N!84G!HXJ7&?5&9%4"!G<!'<L&A%A* 6C^4'S"/7Q<*!L0#LK5HAIF
ME@48-FSI!<P<M@F3@</W/!I62<RY^0**R'O["1#;HA6 ,]3YY?"X>G1"!P >
MSD-$]WC*4=9;1A/@H?!=#9@0-8=$97_MJVXNT>^JK;!WJA1R");G0KZAQ*D&
M:2E(U2+$\)DX?W)]A+'P/.*[U/6DC/[*5_&^7'%6%<A-^L4TG"*)KY: C;_
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M1S.2[K- O^*4?G[915%EZBC'"#S!0L.:XG!W-J9&7NT]+1\/DSF,/.VPW'R
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M>:J UIB!*10X.9V>X])QSY(%.A""B<W4/O30,E]I5_[O;.:_GJ+! J6U_0D
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M)^UK*,%?A4)@;X"WXT<N(@9@=>FIWR_+7>]:-OT1RM^PM*2TJT%_!HS8,%Y
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MF#C3Y^V0L-VRL:P+I39UEL\E77W[ZGD]33I+VPSU15N\L>3@CX/?=9IXJ/Y
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M.V?2N$-F?7B<YY2Y4M2[560KVO8>7SR^,'>A8]]5DEM(#,6Z W.:58%T,N'
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M\2*._PME$=%(JD]X)$:/C.L7)ZL/[^J9]Y[$<H^(!HAG/<@7=0L^)Y#"K.[
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ML11W-T.A$?3=G[9IN^\HX@H-901M*^YMYCUO]HET\#"O5TCK.HJY&M2N*Y!
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MB* M*:4QWL>D(1Y^,C[LT8FK.W'DJI7:7%UZ@&"W:4E#^34/_F>VK5Q['(6
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M;-S-G=2Q>K% J]?6(?WI3;XZIPU5W'1_\!3#&G2K7]FMRWJ-=3WJN:.H_,Z
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M.'O?2#^R^/5K]IN)PJ*GI:UNXJ4Y4G(9+^_M@;YTLH')!@1C:=]OI_M=]VU
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M,\EI2/-R+3^AP1QA3@$[88F K>TO[QV"@31W!W+R^PH;V-"/ T\LX597J]C
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M."'OT_FV-D4+%"\B((2AF4FE/G/-2YH#:CT-?GWR^OK7>%#:A%YPMHH0MP9
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M"HM^%)>4EOVNJ:VK;VAL:N[NZ>WK'Q@<&IZ>F9V;7_BS"-G8W-K>V=W[NW\
M.SN_N+RZAM_<_L,+ 4!"^*_M?\@+_YD7(C(R$C+:/[P0$+W_&8"/C$+_"I5
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MX+1R;50AC97LB[UO:#;<DGD, '=)0$?E_>-]!P9H;Y@S:"_/<1\CU+!H(Y\
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MQWOIA"I,W-B"BZ6A%+']?A[7[:(+$0E)Q0X,V*BB0DH:#%IEPCT)A5[/$3S
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MH6P(A?&)A$N,Q&D;;9AWC%W-0>%^'QKO)+\OJ8:>*0%=ZU<""+'YJL^QE"A
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MU[=\33#AN@HZ93L#<.9T^$A%V!N[6$I/PP JR#W;>5W%Q.*(&&?7NT@K/28
MYW3= D>4<9G@;UV>A )]=:ZA*7(+_A8=_=^^!J>N/3*)]2OR;P+R\2G6QX,&
MF;G(-^@17R7 &=FH%ORYV"00)B]WSO1K??Q!T.XOC+OE%NE1H77WXVNWZWA
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MRBB>7*6J-U/YC?53G!8MZ8;.E@WRZ<IN;5]8ASX2\!^&.5S^+\N"_M.S*I5
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M!-]/)BGW=%%RLJX]L$KRFG9U2^9&?6M#UKOQ[02MT4814> 69DB22^7OB-S
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M+=9##"$;W\\J_P7$O%/.&1T\6-M9.] (MWOGP9.AY!-&33]RH_QGM_]\1!4
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M0$:&R@)\$U,A]-9J(HE^X"2_@X9O=K/OSDA5^)ZU(U"1D ,%O+P]NHMPWCA
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M^[Y)3GPC,C3=R&WS@Q1ZRU3)CXZ3)?"E1H2M5U5#Y[CV(C3"RC.1?29-16N
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M--.9;L)1MHV(%QER&3)D-F\0X5H:Z.KW0KLLIR8$9&A(]9(3#H*A-7^DBY_
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M=J!8'57LN/MV^JTRS,V-ZF-C=!<N/-G)[=VOE.U0HBY&2 22?V:Z@6A,P63
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MQ!>J^6$[!PD3JW)*(%C"Y\<SJQ4R41#T;4$]E.\";!5JO^^.$?S0'I^\1)-
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MDZ;,Z$-6P887)<*&1[PVT]M-)LFI:O?">V3=&J'8"?@;B7U&+;-9T]IAJS[
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M!V1<F;?6\#1 J8^-CZ-DQ=1K<K76C!?I/V"W _;1S_)W=+F2&$NQWEID&3>
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MK9JM==XI_ ;PT7R+OM@MNY6<=7KQ,K'GIT<Q:\/&B GCQ,K0:TM'6^)[W28
MV9'Q9W>Z6&OH0RIJXX;=))).1[2P<A9S 26I0#'$(AB3AFH^;7H/<U.9LYN)
M%_J>@0:..@<S0A[@"7CCQP_@M9"%7U%W4)[B?HJX0'O;^+1QU _ILPR=$SPA
MLOJU[GU!&>^9LR:\^WY#DHY)F$N#3$M@30ER]\P9+E"[!W^1(# J=L<)^&ZR
MXJPY/=5W7)5$=>?6U&A1&)(@QB+7*>WB+?7<O7)_SOC#8_>^0?663>_\6$>Z
MP6!N5SRQ3PP2F6-?@MMY'"H*XDU_^/?&F9AE%M: 7@TW=^YXK%N[][D99Y4Z
M?/IQKO!E&N*-4<[T!R8.VV U(F4L2 #_%WMO'157M^V)%L$E6' /%!(T:' -
M%H($$JRPX 44[AX([A"*X.X.A7MP"&ZA<'=W[WS][CWG?N>^UZ^[;_?X7K][
M:HSY3^VQ]YI[[;U^ORE[S>E$IM]%C;%'; N?M3B!G3T!"K7H7)M'3-@S7IR7
M#LE^J!ZW8FAM:XA<G,9KE#?FQV#I*CU<G7DDN7;Y =<M'>IIHACC6[%>L:KM
MTVP2 &#S+U^52UQGFC@XK<QA!D.,F_QZU>J:FNHB7'@J,H5\]1XD>FL 5N:+
MW*.\=[6PB?*K^:]GPHFTKJEQ=P,4SV3K\SK6?+!UMHFU]P631),M'G7.T);6
MK;[XU2_<2]6Y;UC7@,1(77]C[Q45]1D[W<3["3T]-%TBH'%[.!01F#:U12QH
M<AEUG,8RIZ"EMZ05<F"3]4E 7G4EZ97=8>:W)T"[.>(2J$M0>]["^0D 9H!P
MT4,/B-XP\)JPYG\9%F<,GQ!;81KS[LQ;#%LWYQ4@$N*3-N6J=@0@Q(QNT45>
MES%/Z$\(BYTH=T<4#8^R3:HKH)_J=L8';QWZ[[YJQ3G^2:2/?W%=S:VY?4?^
M_LL38*K=^F-SLNCWWM$DP#EFA.&/"?7J\:UZ=#?WLNF3>+%F-*Y?_+V(BP5S
MKIWBS8JZRY,?9N06+M<J@^(B9G<%[DHG1%@P5\T2\V>W'X%^Q%!=:A5Y7163
M<(Y3?FJ=4C?8K6AF[B\PF:/MX*9KM6(H9L(G,=8A6Z"SC?+"0.=Q!H[-1+-4
M[NZ,LJ6)T^80!9X.EYM5CBS- )7XKI 3Y9Z@#;6KZ7.^P0]><@_0BP6V!8.8
M\/ @K&<!(T@NA(-2V18:8@3-DDEZY:(Q!,[.88TLYNO8SZ)1A]%(>FVTUUCO
MYZC1/<620+/G2PRG]RWPN9L(;*V&7Q_]TU*%1E$KHLA</6NAI056D$^SK%W1
MC:1:(#!%02\0VR[E1%N]L2;B,-LK?VZ8:K<KHR$*3*7E--\<XQ\S0KA)=IE(
M'.YD@P:*D+&\WH2U81; J-30"=AGX "X%-,^=^C8M;Y+@?YU6'>==F[UW&(B
MFV&J7#N7+)XLW:]XH >>."6D-QQ&KNMH7J5/U+88 _O0"?Q"^KAM^HDY9]V)
M-E^4:8QHYD.CER33\H3I:]U^&F;::".6OO5303.!<N'I"X25$0IECH :@?S)
M\B-#T />@=;T>U_,XK6-]BT!NM-NDZ6=JUBI,MTPTK(#UF9##O:#;,DA5HQL
M(,<)0DSOM0IJ'OA1X/@RG_(GM"[V6VV=9:*V@I;1,_K=]JJ(SIVD-&IB<PVR
M3Y'Y1!E19CZVM;7C7VW2U.DEUTA1:2ZZW2ZV0LMJ6J2ZB-R]*^#0"/8 E]?A
M6F[Z9G$DFH.XZ/R,I0:I@F=2_AU\MG-]<--"ESS]\%?=+3^82S)N49!!NV2^
M(I^%'59F>:'C=*TN+0I1U3R6D%>8#':PVH46CRU"G'M69?0(B?UTS4B!6-,Z
M&[XW;_$1_9H& H:]]D*.RS)J105F('DGR-TAZ?K?\U)8_7.'5P$,BE_+E"EE
MWPTKJO=[TJU18XO$#QT6>Q7KA5GR'^CVL[;3;9&+(YD)'(A3+4U7G;?A[9!-
M'3RDI;HG$!/ANVDP942Q5<D(4)SFQZ3%Q[AY.:W@!,KSMG-;$&D[VGWV-CS;
M1Q-MXV/Q.UY,+[UF[$JCJ)]T#*BI;0K>J8OKM6?@?K<_SAKY+"+?C0Z8ALW=
M#7#_U!9^+^*49R$83A8K4I:RP3Y/MTDKN&[$>$R(G;UVA+7SQG#Z3NTT[Q1J
M*!Q"@F33V!5 @U/JNK&8[)%SC?EAFO4@U_4"G7V?%^V3DL]T9:".!T69%XF&
M/J0,_$AY<K%_6_!=FB\$3&$./7H5[RN@0D#E#4/8Y7.!P@-R-)P=>D6:BQL%
MC P&.B?Q="[*N_31%_7H<[2[#+6 G/G)Y#TE[6L(B>*,HA?**\[);GFNPJ4+
M.5!#CX8R&ECTYXR09.8<YXO>%K>IEH>:JQ_%Z>@=1@X>93IZ[U[6*IB)?N F
MPB>FL_ 5&/8I!7BPUZV*T'7&S/47Z^46Z;Q[&5S!Z$ UCQA5N%I@\2ATO!E0
M0$[Y[F&Y 5G#9C;70)X40*B*WIM9AMCE;EV].H*G"SX&@PM!8$&S7UAQ.C?,
M[+DJVI_HE58!B%0MNUJ\0BTVG52(L8>DT@_YP32US>IJ\:Z=A8Q['2,M .<Z
M:MQ[#DL@YV"!'# )3Y &]KU24@[)-Y'"?SIGTM-K)97A;#\!GA#W!EH5;1 =
M($.J*J>#TU.?3JCG8^:I#5VYV(O YQM;D[ C_)[N=J:YWZ&..'-<S+%*R?WV
M.K%T89>-N\,I=PY-$B0<Z.!G"Z"4$\$6'$7-A>O.+<&EG<#"#G,#3=E0/JP2
M$0E"7K>KSGQ1RN/-U'P+YS,MY2+=>043\['*USU*RQ%? M;2[&:F6U#^74<9
M_J\1;+#:R17HQTF09A)37WR;I^BOG8HRVTY3627 ",D0Z/@Q_;+3AVWA&P=!
M0D+(5G("UVMB[&??>@  H\!]%N_G=.]KFSR:O 3'61)8A[@DB_8U-T(,N/O7
MQSMSP+4S46XHZ9:$@U"./X[(]P._Q,5-^_)O2]>T!1WLQUO[[[Y1 QY95\G3
M^ GHV]W8MQM9&#LN,B_$GUEB9FLN#7+UAJPV8I$Q)+G6!JBC(J&HCD-$Q$E7
M&_M*V3)LQT#=Y(!V0G$TI$.Z$^%T]T@OOIY=@>RTX<6/B?X#Y20O?P$0!';%
M 6:_5%#X,BG@UL79H!V^$T)1GT,]TPA.&%4FZ+1;>64O!+ZD%GME;)U0=?A,
M==<782R8POL9[.!\C^53".2 )EBZ:?"7+V1$Q]VL11@.(LD+GNLR2A>U("")
MHT.U/8KY[2M;QY<(62Q91"\Q6YST!Z0M?I1+Y/J,H8G<'^5LZ\;,7!OCYF0)
M7O'BVUS5<,-0QBI;3S3DJXK-N6+Z12T95.I2-=<IR*R +U?4\4W0#X$2[:I@
M*"#QC@]"\P20?@)$^2Q$+7@V>>L?WN=$"MF)4Z2%X6MI72N!M$R(WU32U(</
M_*17IJD64+6+[O"V\33;++C7WTI5WUF3JJ(4T!EF-+;4Z6O_621Z\N$,+^;'
MC)91#KC1]*@"? E-]D7M"U"C<:3 2"W-<'%Q-3)S/)T-]=/R:?1J$/881>7]
M;'Z5QC1M#)TF75;(C1KQ@&+[PKN<BY [2(WFO=:NQ^Z 1'R-\5T(V>8UR>9U
M-Q&GW5OBFO:N),,^9+L)TN.Q!]83BM6@^)[9KQ@4!L@4:\( U-%/_F"K,<47
MH"ZCE#CF;_\RA[T\"/W765I)CY<DW^L.626B?C+GU(R1 !W[D,PHF7U#'R7,
MGL-&+%VH2CD5]$527[ZR[I+1/.V[?CZ1DX+P1;>T-28/WCXZ]PLD_4*PKR^&
M"?F;'_I: 8W!97NA=Z_E913,*XU#R/F(VV AM<DA73>?6HD)D;C3I;^XM>[-
MR$;-:OZWK>\CLROS0:.!\V@70T;*9I01Z<$,U>$EQ[NOI;%-#)[%6#MOI3R3
M/YB?L7Q>VE+]?E2"0I'[)O:;>.X2P-K*B1]@?(LA4UUK$J.]2$MO!_3-N/EE
MA.4E!V^^PWD'6+OP:%&^4_KL1.'<)0VN,6@ (PR-^[E]ZJ7P8E%6_+KC?C>W
M^):^OIE;'GD[NM)QH6G02<S%G ;+^+-/4*[UH!E$Z BZ^(HB@#P1@1_5]CZ*
M;C&K;OS\3B&1'5)2NI*F<Q1#AY#,R AT3_N-PD/*9FY>JTU'U2_5 SU,[^3K
M638R,(8S91?GN5Z[;A9GT1RGUC8RQ-V9+/*!A:?[O_<19O38U0'S%I<^)!VH
MD\3* ^7&]-X3&[P&(2(RMA%^-+\U7'JH!U]F'0DUG^ ?#7.FK GTDF9@R[Z/
MU'(Z?]%CZ+=Z>X.UNI)\0,/C*]G?KH/SG<HUJM9";G^E&M:8-,\EQUM/@T59
M'W6 Y]GBKO'Y4DB% -.UHHKTFQ6% !!*M1XWTI#+Y]S]+MDU%.:GRH=%C(2[
MI./KL,^$&,&4?AS27W8S[F,50OHUS=)L!!^":\0_UW3EX5/.J[I[NJ<TP9L0
MNZIFX^%B'R/@<)<(E4&0V"_)_C)*>&%Q$!F51_X$J*,4G3EP6]BZ46CC[W$(
MWZ(PS8U3KDY:.-B ?5EV.2/C"R<T76BRHT1?&/9RR\ :<D2_>,XPX$;*>LA@
M1Z/.LEF5R4)*5]G!?U1'R<62-GFPKOM.D5&Q.6EQ@8,MB4$#*,$-S,G8.KRO
MY%1*Y]RWK&V$U;;6F;,?K*81=7 .?/FV%M-1L#S!RO8YDH3U8#7TS1D>_NMG
M;5=!;8QI,(0^AF+>RT:2ZD[:>:UN881ANFC2SO()&H=Y@^F4Z1FC+D19K;Z)
M0Q=]SD67 G7=$YQ+K410N>3>!,EL_=CY8#5G_40I S<7K-68>?'SAP"VF'[$
M//>/%9IP[>#NEA).M.@<;YW/SJ]HHCE'\1%^.Q6:?^YK+&,0JA6,@2(O LA
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MLW3G=+>1\C+]^83VH -B5UP!L$>N9\5/T$L:H/\'=Q/4MCT!I%&> (\/\D^
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MSK]0'QZ3@LTE=**VY"E34YWV^';<)G\<-A=5M;C+N3]+D CPS3DTR F/YL_
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MK^^0U</=2N>[2SMM)CKDPXL=<F-N/>VI[;Y]0)K30E'\U+?G_)T!HRY1UNM
M8C&]N"-<!73RVP2+Q>;OH<H=W4(Z1B7CUD;J$(291^OX$54TQE3"ME68R*W
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M8+[?]95\W?H0W$2* !F>](B]!#L', 'Y#<JVYC.56@UMC=8I*@A>8L_^A)=
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MY]N RB 5 (4-YL$T/"&@CSKZ+,#W5U/=\(= 4_BY!WVDJH)>2F<RMU(O'VJ
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M$5P*%LNG16!EYE HITOG*B30<T^-/OQ2?E4Q)AK'?LJDW;W9$IUX).1G)UE
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MN<+J27XNXI25+*2OI U3YB]B>Y JLD%SQ]@JJ_W]UH&5ZHPXR9QTAEC)&Y[
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M[\"\ C28<F,3P(!AJV9>0Q@(Y%"6KQ>5+R\'L?,B'DAYQ6\\USE$*>2_[KR
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M2P;^8/77O.^_]J)MUHL:=)HGQLP1KZH@"G]B:?(N?],01GIU3Y:BN3U#@[I
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M/CT3>]@BX6WC4@5O)PMAP)'&P:_?@7N"!2Z(+[/15W#U%?''(D#DY_-Y2\]
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MZ?%;,8A#\Q6<Q(>&!D;'W=\#WC-+9:U3-Y!9#$ZK&9JV]]69+*G)O-@]E1%
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MGJ$@JB-0PH-H +AG(/AGH(=N@/+13D30/R_@WRX0'#P"(A(R"BH:^N,'ZG
M.! \/!P"/"(B L+CN[Z/[P,(SQ!QJ3DDD)ZK&B/3..)Q!L1FH]"^_M:!KS9^
M1,=EXA2(BD9 2$1,0L_ R/2"F9N'EX]?0%#RC92TC*R<_+OWZAJ:6MHZIF;F
M%I968&MG%U<W=P]/KZ"/P2&?/H>&Q<4G)"8E?_F:DI.;EU]06%1<4EU36P>M
M;VALZNSJ[NGMZQ\8G(!-3DW/S/Z<6UU;W]C<VM[9W3L^^7-Z=GYQ>77]#[]
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M,(LIMC'SYP?B!_!C2RZ;1/CTCK;2D@I<I^?$X^WG-Q'5;=;)MMWK )<$52D
M3TVHS&KD%_Y[LS@/N,9H%(\;F>-2@XHD]F?E:)]T/Z)I\3H,!3KQ<X,F__E5
MVDTA^:Z6Q;O0*K#SHJ3+KQH]:7%=(Z##7F_[M(2"\/CU98JBL51V_?WP)-TW
M@7CWKS6731B6L!1@QZHD)?\(YA(^?Y=A! W8FL7BLU5SS%AD+@QQ_;8FACD+
M@<.N"6^X'65J.VB)C5BQ+,P'(*IZ(^5KI>D,,]V$[W9JPGV9Z9->I(B7NL?&
MX:VLDV/K9"H=XT_GLD>8CF_?L.>:U2N[D.'5T[LC"#OY[L!_"!N9.!L6TO&>
MA!T*KYL[3,-69>=IS@QD^$=5>ZP>PPI/!23EE$%T'#P:QA.I).1+UI/W4Y&^
MJLW;_VU<MEYE<H2_Q(CS7'+W!^%O1TOUMGER!=;U,\DX7\=9V;H+K>@H^.!G
MS[.P2L+ZCI9#:T?Q=RT> (78.1YGO% :6X\%5PWR:!HH)Q.0$_8/!H[Y/ML*
MLV3I[?.-#]/7M2WNPP5N.R,2(01,1IV"RJ6<FS0CN<L-.Y][I% *"A&I:2;2
MJ] IOQ0* &(S^+<;"BZ%>N?L(\L.[6IGV5<5/!'LV%7?QTE[=)$ NTRYY996
MUUOIE7-#K@5ZGD<R7*]'\(J66F6HO,X>$X2I)"5]85K0?'BJ-2\Y_DUPW!)7
M2$Q4IS_;N/JO"KHFV,$A0[TWF#Y4?]7YC[0L0O$%.0MI3QN3(;HNN(8GN_'&
M]E9#')779CDS-7N$8\)?\'' IL13'8-D]R(EHBX(^BC#>'S=^V]]*TQP4_@C
MET+=?$N,X\GOFR?$:K)2L6U$)^@Y>_T^KV!^E]\I>A1BI&F&>Y_-HDLN8]WV
M[/Z//<&$^T>U'\X1&* E?VZK"N\WQ_+[HG0SIP%6QH)O8JD3!IJ'EU!'7G%$
M>*7L6#W>WWLL$_I+F#9'M+0H5 ??-=(T6,+=@A\D046Q72EN!6\1-CI65ZJ,
MLY.44A=J:NN2"O, ?3+!XNJG"CHM1P.8<L+^&Q7>'8\^$EK9%I=GU\%Y4I_\
M2+W?[74.>)]W&9DKN?[]\@U=V+']18EG#^' POAO>*&:?O[=:7_!/9;8XY?=
MMJ2=<W<9D=[X&_6:\A%MKUF8D6QS'5DY^D7K9AZCBIPYZEN9EA7)^^N,0O[
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MB$!V7IP.H:?.>__\5;[95#\:+]2-WI?1K!41W5G,%^PC>EUXGFJ5XMFV^/T
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MOZUN;HR6"/LU7+S<6M=$K8Y\>#)\<@]_W$O>NC%CB'$K&*=DH>!'((,AX^F
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MGP/W2[JX. *>F& I W_,K#NYLDH**Q*,3();'O9"-'IH-GG?W$:<FY13K+'
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M#0Z.3!S'?:HG&=:$8W5"X.<J@8L6#773EBT*?AP2*<3/8OR50557Q'UO'5.
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M/^]?Y_]2X,<7+XJFEVCI#W#HON";'R%:?1_;2';ME.^W8N+/4U0A?2A@)RQ
MOE%C4)'[X;+N35,2-7'B=S>T7,#M!<(#T#0Y_Y.=1M]@U]ZN99'9RKA>F?_
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MH\@;D,ZQ_1.H6O%+F(LJG X)4)70$>(]5 3@ZM72C4OHM_>4#-7K6N3.$N(
M)J^-[+7S(26D!(CP.9^<Z-_UG5BPLUV7^DEL=>'I';F 6NQ.R:K:[QU3 RSV
M:8F)]_FKH=V"*%%/[.#G'-&,0EF'T4N0.WG?"/><6;A?<';>L#J?(<5?4<>S
MBNN(K6?CXY^6Z@8UAX_.RG-5OT&DW344>&E$Z+J@.-.N/:<O<B\8V5W[6! ;
M%#><03JZW\GU+%#-WBWX!,ME:57 ,UC@Z< EYU9P:DTY_:IO%?8YR,?'>63G
MP@#:3XF^Z@7M)231R.F5<II,9LC(B5??!YO5O7A5^\J=0Z/H+PH#Z.=9&JLX
M3NQ(%IE]^5@8_+#1SC_\$!$\?__JM*M,HLQ+=$P'QL,*[G7RCJ6+1F;DE6<J
MB%1U'O3QK&:;&Q1\R3L?TNT*5<N\%.#!L2HT,C">V*WKL;P;^GR5<A!]S>C@
MYXT94U)_T,JZ]KU7PI<R^^)[SGK;3T77RYLIG]V">X-R@WL^0TAG2P-TP1TT
MXX_OT?WP[K2$6I9X'X@7SW\4#>CZ,5)VK[=E41->LE@#T2.74N)#A<TZ>NVI
MNH8NR:D-=4'<7O@O .=#H1!R93(%,CTJBGKH:)>A8D#0(EO8YAGVNA=<#-\K
M4XC9V]ZN<\3>T8;:21[8^"5IT$6<XF5E8KOFK9'7D/*,G:%TC%2(9>YU99BY
M!^(;PH0:T9=YA-1SF/KB,21'J;>3KB/M2#F:J,8DS9+EDV#U#=*M)I6_J_Y=
MN)]2M<3%IU]&AYY<!X2"D+UOB2/4C&AE&!0H=L\S]S IACZ;:R-"Z\R[B.K]
MC/RD'QUZOXM=SFM[4.5$.(<HFLL;G@07Z::?9,E<EF5+5\ 1&G-TF$Y?/E!!
MR<@<;O+10[?\'97OVZQ82')&K5T.DVTNEEF^R+Q\!K=O-[,L52]O#1;Y%CX)
MSK-S_RZS=U#90F/YK!%NKNPD6U<90QF1&9_;B8S3CNX699FG[++/=FF<W.ZW
MLN,:#ZB.V6*/J/%3V\A:I57B0,O(Y.P$VQNE+B3PBX0!G#()(VM.GLR>4XJ\
MON_WDYBWZJ<3<G[JE0)3:=+B(ASBFSV7A_;==K)TW%M1QE3Z&97E2--F6C:U
M6*01O^,SUD)RDC,*\&=>I)FIJKS6J3RN8JU:DT/]$/TA.,N!TXEYHK$&Q4\"
M>JX>@*W3J$>*6T,& P.3/ZO\3$/]@'*!<WWZ'D%8-K#T*!!=:\A#][2L1!^-
M>R*G\K<Q&_#G$-&4JN\MP;(7K5Q+[2QU1RN,1T3^K&KS:]5Q0?_':L5)9*ZV
M:P(UO7,]RK 4+Y"L!5O3 ;X"ESVZ5#@P:8Z?X:(Z2Q:2//2QMC'+,>MUH[/H
M7%*J,J88$Z#MOYJ-_Q_F#%O'?R(O7I\R\RR7)^_';63+,_^V.;\1)&E\*:01
M(Q9)0O&C_.#=.U97@86/@VLJ;S]2*--!'?HP(\A(>N\S_@!H&8+^ (YY**]T
M*[8KB-W98R@P&\-O?>G3T/*MH%1R%;5IJ+ZXG%S+ OE8DHL\VFX*]-LJN8R[
MT0 TNE9'UV04Q"Y=B"/GRK*T8 73:'"W20@"\8X/+ 94 291^O)"?3!2N3[N
M%O,M+&>^(460N79X'9;_K*![H0]_+GP,@)0I576%XRE$C/O37TL!51,Y3[G2
MCZYW7 \1CMTTI5>WQC8>SNSV$W]H<]>.RZ-+)# M'>6&MQN=P!<2>E?9!P^V
M)E3]%1P(1*?H1JP-/%,O1P-QND<8&&H@ -]G@MW$XIKJ)^T+@A1P9FI33@D:
M*+41^BUNHDYQTH?Q 8H 2_BT?U+#$Z>UN?AC>\E/HTS/-G'\A+Q1[:0I!AQ$
MPV&&0DON+VNX0;$O[345^V1095UW[]GO8[\RX5MF8W'J%F[I-7<GT;Z10V@C
M?#TIME:A&[=6L+F.ZB74O_A"U3G/2I,CUKCC&V&1*^!3AW2MUHU2+.L#N!F=
M$%Q![ ^5NF0+F+;OG-M[,&I=;G/@"_2%M]2\,C(\>JR)=']PV$]1S#Q?MCG/
M>!LK2SAJH%4R[ON;I*C<Z CCPF4;5-N9_&&-S-LX;.5!,O!#F$L'UURV6S[6
MQ^_M%9L+NZL147HR%V2MEUY15;J:\9=74TT9GL_7@$VY090F,&C+G(*&ZP#J
M$WC[)9.N.>F&R&VY &D__HV('$7H'T U0 2SP?W98;DODV"MQBNYHZ,\W/W+
MJWY<%$"BT",L@[=YC7Y!F#K?)G.MPN:'T=*(TYV,/52M_AV%3LH\@<"0_MU6
M T^.Y,NZ^'W$9M0-:9SBV.=X9&A+B_\E_67A#[Z+OXN 5IRBP7Y+#U2E.J84
MOW8VWMY 6#=L^@PO.)[(1KZMLBG"E@".$U7::H<1 Q%RF<=H%R&D6$2_$B6$
MS^QR\7\K+2'FL<GC\[XUS-A G\]]#>E8$*;Q,_'=$M$\4LXE#;=^/?/N(JE%
M,G(($(MX;(W86G_!F^59 #^<'5WDO5/:[8?F?]R](T +\4G&?&VG-05OU-*=
MZIU".H3"FXKHQELS]8851JCVY .]IRZ" !@_M:2V2..T[[?8T23$(JLK*]UV
M4Z7C#@><A=*&,H"Q,AN"9HM!(B%U^1>LJ4,Q#D^\29/L]E5INRNEEZ-U (!K
M]M6!H8%GF1>D<>KMO:=.1\<<7==\$;2Y34?#RBO=H=M 'B'^4F3T;E\P +/.
MGFM;L\O<G3GF C.#I!+*WJG\5@J2U4)\Z/U7'7?./X$LBO[AE"7Q'BT+GT.0
MI5\3&B.= D,$+X+ ENW0+8NVU2>)<]9Z(WE3R^0]L<:/XNY(5-3RO_J=L$S!
MS);MZ9W\Y\59-8>>8L9-T:>CNZ<Z)?&?D3G.R')68@-O?B$N'4)N"ZR*=7D6
MGN=Y%X^"9C]OJN--F\,R[\T&^#H%+F0CX(N7UL?'W%,06Q!^F*9>^ .2'8H^
M 0O"75F @/;;)WQH^.&A&(V;$;V Q^#O;RY'*[%.ON;3*&#O+3UF=OR#-8ID
M@8G5)U407GE<$!7P5&#2ZQC##I;D%2'QU>_SN4<"9ET9^R/=-!B6YSZBSX73
M'M_\X/K3GYG-$0_<279>$V=G/']ZFJ<P_P,":6L)Y-3^D;BQFZ *Z&8HX$8X
MY4G8HL3_M4;0%+ZMT\9[H<203HPCG)5%/(B/IZ\4NG7!DQ!3-;U\M/XS_=TX
M&V:--]FN!2+3+XTHXE_BVWDCZX0#8_*;")8S53.+W[$;\[]B/=$%[<1N<R/\
MO/<=>,2*UC3[8?O697I[7"$VMN4@U1A3Y,BA_9.(ELHY+.K)WC-PQ\ K@[O
M*04>.-0ZR%N-BI/8G<H W,&:N.,Z["0Y/PMKU[#?\E=2;I^OIM++ L4D<!+W
MQZ2I*VW2Y@]] MR6,P^TVU2L&(*V1-2DVBX8GCX57N9N"5V'SZZI PAP4M+W
M:\A2KBO28;JPJ';PY@0/S]B)X++*^:.!@7^\PI<ZNBC#T?X@KMAMFB 1W=M3
M(32TF!$IHI,M&_WW(]02#!1/&@J(NDT7[R)L*I8*RQS=LF8L !^(:1/?DG>
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M7AS7-=!*O1PQ(OE>3?F '!'O7>;$6V>HYW#LV"8=\,;]9[/W61Y6?'Q@4M(
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MDI="9*^5.>5%@Y21OJHR(RN/2B"9XZRE_8_7%-H[;'0$*=F_3Z89SXKX7$%
M>TZ5\.]C_Q_ $KNDPIEO.])N(AKA$D^,?[D&\R:866.A_=.8_1OK&SMJG-B:
M1V%R$<%%MACW2IL K/J%USM&EJ "XH9+"0R\%3M@IVO;WHJ0&Y$(N&GNNOGZ
M*$[&>L>##R9FX_3S02DM*OCD"\I%N5F?QW:?S?>'RP=&FF'@ML?'[TI['.)$
M@B51I^LZ"U7VCG'?YJ('2#!$0<'"Q3RN'5_)V,=_(**437TZ<FL;FN>.85ZB
M\J+80DHM<)*2T9%@<EVQ(LAQSE=L+9IXR2H'F=Z9!,P110%E+4BE@OK"X8!K
M*DS^JL;7*NIUILAH%"7KT8!=MSC%ES/MEL:N^;BB7S;M'2(G(66Q'&\N6OX
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MEL&T2[E%&%/N(%L9&27$'90CR3M7.2KU.FQE[V*'V!M-@5I#^KCY<#_^#;$
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MJ'ENJF^NS\3)C@/H%TZY266:O#I_/K;,9>J<P#^,I)&.6[U6!-!Y[5!D;.W
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M3B?Z<9.-F/N(@VPT&*TDPRG F'_2A7\[6,NH=_H/P$K*$6-E>D5O;<S7T:4
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M\5"=>(\LJN:HA0(M(*$K'& 4$&65(T)GO^@@RSMHB.$FMNDSJ.#8,;"W4I"
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MFS+G$H"TF<+-9 CNP0 -B=0S&;HPJXI#Q+>DP[M;^ ?^2)YW=1"I2,P8I<9
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M5I4.8]9)9@IU9/-<>(P\"NZ]63GKK?JZ&;W'37](N["BU&O!ZN4LW_)3V+]
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M?64"\4N2F/SRWSI:+<U+7[!+A@4M9-J;UVSA.A1J(=Y),CV@/0H.7\E'E==
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MQN-@ZZ66!]W@1*(([@.V&\(@HC:[-#3CHQ'<8DD.5G7\>&R^NB"VS"KC*D>
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M;$U#<;X5:^I1\,=@8%0.V \,$: -*3?)]A<9VW#_LJ9/QX.^IER-;JP61[?
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M"8A[S_8RR,4<76N L@',!Q<U+77'H!/UX48QEJTJ];=5"PQ==V;R,H#3)^0
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M.<=9 :B[R/?"W9^5> B\2:4^NG)X,RDY@ T&X+A-Q@?CHJ??QOCO6X\_:)O
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M2P$"% ,4    "  I@99:>':?L=,X 0"@,PX $0              @ $
M<F-U<RTR,#(U,#0R,BYH=&U02P$"% ,4    "  I@99:&\.L[1$#  !""@
M$0              @ $".0$ <F-U<RTR,#(U,#0R,BYX<V102P$"% ,4
M"  I@99:9-4R_XP"  #T"   %0              @ %"/ $ <F-U<RTR,#(U
M,#0R,E]D968N>&UL4$L! A0#%     @ *8&66MDE9D3-OP  2@X! !0
M         ( ! 3\! ')C=7,M,C R-3 T,C)?9S$N:G!G4$L! A0#%     @
M*8&66KEG1D2 T0  GQP! !0              ( ! /\! ')C=7,M,C R-3 T
M,C)?9S(N:G!G4$L! A0#%     @ *8&66D -O&@VB@$ ]^X! !0
M     ( !LM " ')C=7,M,C R-3 T,C)?9S,N:G!G4$L! A0#%     @ *8&6
M6E.DM_/O,@$ WY8! !0              ( !&EL$ ')C=7,M,C R-3 T,C)?
M9S0N:G!G4$L! A0#%     @ *8&66M0Z8<.3 @  X0H  !4
M ( !.XX% ')C=7,M,C R-3 T,C)?;&%B+GAM;%!+ 0(4 Q0    ( "F!EEHC
MW+:A(P(  %T%   5              "  0&1!0!R8W5S+3(P,C4P-#(R7W!R
;92YX;6Q02P4&      D "0!/ @  5Y,%

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>rcus-20250422_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rcus="http://arcusbio.com/20250422"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rcus-20250422.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">rcus:PlusAdjForStockModificationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="c-1" id="f-2">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-3">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-4">0001724521</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Arcus Biosciences, Inc.</dei:EntityRegistrantName>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c-1" id="f-5">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Compensation Committee has adopted an Equity Administration Policy which implements a framework for a consistent process for granting, pricing and administering equity-based awards. The policy establishes the terms of all equity-based awards issued by the Company to officers, employees and consultants under our equity plans. The policy establishes the terms for such grants including the grant effective date, pricing and vesting. For example, all equity awards will have a grant effective date of the next 8th or the 23rd of a calendar month (whichever occurs first) following approval by the Compensation Committee. If such day is not a trading day, the effective date of such grant will be the next trading day thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2024, we did not grant stock options, stock appreciation rights, or similar option&#x2010;like instruments to our named executive officers during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form 8-K that discloses material nonpublic information. Our Compensation Committee does not take material nonpublic information into account when determining the timing or terms of awards, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c-1" id="f-6">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgMethodTextBlock contextRef="c-1" id="f-7">For example, all equity awards will have a grant effective date of the next 8th or the 23rd of a calendar month (whichever occurs first) following approval by the Compensation Committee. If such day is not a trading day, the effective date of such grant will be the next trading day thereafter.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c-1" id="f-8">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c-1" id="f-9">Our Compensation Committee does not take material nonpublic information into account when determining the timing or terms of awards, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c-1" id="f-10">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-11">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-12">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses additional compensation information of (i) our Chief Executive Officer and (ii) all other named executive officers (the "Other NEOs"), including &#x201c;compensation actually paid&#x201d; during the specified years alongside total shareholder return ("TSR") and net income metrics:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.023%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value of initial fixed $100 investment based on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary compensation table total for CEO&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation actually paid to CEO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average summary compensation table &lt;br/&gt;total for Other NEOs&lt;br/&gt;($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Compensation actually paid to Other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;NEOs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total shareholder return&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Peer group total shareholder return&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($ millions) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,279,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,803,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,793,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,696,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;147.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;95.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10,120,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,480,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,193,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,953,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;194.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;94.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9,048,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,065,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,191,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,394,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;204.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;87.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9,483,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;14,577,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,939,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,091,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;400.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;117.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,685,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;12,015,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,363,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10,455,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;257.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;148.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-13" unitRef="usd">7279504</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-14" unitRef="usd">4803366</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-15" unitRef="usd">2793357</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-16" unitRef="usd">1696346</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-17" unitRef="usd">147.43</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-18" unitRef="usd">95.43</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-19" unitRef="usd">-283000000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-20" unitRef="usd">10120945</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-21" unitRef="usd">7480720</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-22" unitRef="usd">4193925</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-23" unitRef="usd">2953574</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-24" unitRef="usd">194.36</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-25" unitRef="usd">94.37</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-6" id="f-26" unitRef="usd">-307000000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-27" unitRef="usd">9048432</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-28" unitRef="usd">-2065105</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-29" unitRef="usd">4191618</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-30" unitRef="usd">-2394074</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-31" unitRef="usd">204.75</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-32" unitRef="usd">87.61</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-6" id="f-33" unitRef="usd">-267000000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-34" unitRef="usd">9483339</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-35" unitRef="usd">14577932</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-36" unitRef="usd">5939512</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-37" unitRef="usd">7091681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-38" unitRef="usd">400.69</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-39" unitRef="usd">117.83</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-6" id="f-40" unitRef="usd">53000000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-41" unitRef="usd">5685664</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-42" unitRef="usd">12015409</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-5" decimals="0" id="f-43" unitRef="usd">5363707</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-5" decimals="0" id="f-44" unitRef="usd">10455559</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-45" unitRef="usd">257.03</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-46" unitRef="usd">148.03</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-6" id="f-47" unitRef="usd">-123000000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-48">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"&gt;Our Chief Executive Officer for each of the years presented was Dr. Rosen. Our Other NEOs for 2024, 2023 and 2022 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett and Dimitry Nuyten. Our Other NEOs for 2021 were Robert C. Goeltz, Juan Jaen, Jennifer Jarrett, Carolyn Tang and William Grossman. Our Other NEOs for 2020 were Jennifer Jarrett and William Grossman.&lt;/span&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-3" id="f-49">Dr. Rosen</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-50">Dr. Rosen</ecd:PeoName>
    <ecd:PeoName contextRef="c-1" id="f-51">Dr. Rosen</ecd:PeoName>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-52">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"&gt;Fair value or change in fair value, as applicable, of equity awards in the "compensation actually paid" columns was determined by reference to (i) for RSU awards, closing price on applicable year-end dates or, in the case of vesting dates, the actual vesting price and (ii) for stock options, the fair value estimated using a binomial lattice model as of the applicable year-end or vesting date(s). Key inputs included the contractual terms of each agreement such as vesting date, maturity date, and exercise price, while additional key inputs included the closing stock price, volatility, dividend rates, risk free rates, and an early-exercise factor which were all determined as of the revaluation date.&lt;/span&gt;eflects after-tax net income attributable to stockholders prepared in accordance with GAAP for each of the years shown.</ecd:Additional402vDisclosureTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-53">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"&gt;The adjustments made to the summary compensation table total for Dr. Rosen for each year presented above to determine compensation actually paid to Dr. Rosen in such year are shown in the tables below:&lt;/span&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary compensation table total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,279,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10,120,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9,048,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9,483,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,685,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Less, value of stock &amp;amp; option awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,924,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8,909,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8,292,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8,548,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,356,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus year-end value of awards granted in fiscal year that are unvested and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,156,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,634,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,788,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,142,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,893,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus change in fair value of prior year awards that are outstanding and unvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,390,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(573,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,490,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,923,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,828,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus FMV as of the vesting date of awards granted this year and that vested this year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,363,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,648,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,608,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,783,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,108,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(679,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(439,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,728,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;794,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;856,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,476,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,640,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(11,113,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,094,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6,329,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Compensation actually paid to CEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,803,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,480,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,065,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;14,577,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;12,015,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-54" unitRef="usd">7279504</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-55" unitRef="usd">10120945</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-56" unitRef="usd">9048432</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-57" unitRef="usd">9483339</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-58" unitRef="usd">5685664</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-59" unitRef="usd">-5924960</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-60" unitRef="usd">-8909833</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-61" unitRef="usd">-8292320</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-62" unitRef="usd">-8548858</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-63" unitRef="usd">-5356475</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-64" unitRef="usd">4156034</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-65" unitRef="usd">5634249</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-66" unitRef="usd">3788462</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-67" unitRef="usd">7142260</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-68" unitRef="usd">7893097</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-69" unitRef="usd">-1390550</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-70" unitRef="usd">-573908</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-18" decimals="0" id="f-71" unitRef="usd">-5490389</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-19" decimals="0" id="f-72" unitRef="usd">3923736</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-20" decimals="0" id="f-73" unitRef="usd">1828423</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-21" decimals="0" id="f-74" unitRef="usd">1363210</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-22" decimals="0" id="f-75" unitRef="usd">1648267</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-23" decimals="0" id="f-76" unitRef="usd">1608814</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-24" decimals="0" id="f-77" unitRef="usd">1783385</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-25" decimals="0" id="f-78" unitRef="usd">1108163</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-26" decimals="0" id="f-79" unitRef="usd">-679872</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-27" decimals="0" id="f-80" unitRef="usd">-439000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-28" decimals="0" id="f-81" unitRef="usd">-2728104</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-29" decimals="0" id="f-82" unitRef="usd">794070</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-30" decimals="0" id="f-83" unitRef="usd">856537</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-31" decimals="0" id="f-84" unitRef="usd">-2476138</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-32" decimals="0" id="f-85" unitRef="usd">-2640225</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-33" decimals="0" id="f-86" unitRef="usd">-11113537</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-34" decimals="0" id="f-87" unitRef="usd">5094593</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-35" decimals="0" id="f-88" unitRef="usd">6329745</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-89" unitRef="usd">4803366</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-90" unitRef="usd">7480720</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-91" unitRef="usd">-2065105</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-92" unitRef="usd">14577932</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-93" unitRef="usd">12015409</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-94">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"&gt;The adjustments made to the average summary compensation table total for Other NEOs for each year presented above to determine average compensation actually paid to Other NEOs in such year are shown in the tables below:&lt;/span&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary compensation table total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,793,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,193,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,191,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,939,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,363,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Less, value of stock &amp;amp; option awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,918,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3,364,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3,444,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,298,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4,864,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus year-end value of awards granted in fiscal year that are unvested and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,345,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,127,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,848,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,797,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6,969,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus change in fair value of prior year awards that are outstanding and unvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(591,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(367,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4,050,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,678,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,656,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus FMV as of the vesting date of awards granted this year and that vested this year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;441,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;622,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;528,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,094,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;509,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus change as of the vesting date in fair value (from prior year-end) of prior year awards that vested this year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(374,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(257,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,467,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;678,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;820,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Less, prior year fair value of prior year awards that failed to vest this year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,827,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus adjustments for stock modification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;29,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,097,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,240,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6,585,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,152,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5,091,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Compensation actually paid to Other NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,696,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2,953,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,394,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7,091,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10,455,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-95" unitRef="usd">2793357</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-96" unitRef="usd">4193925</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-97" unitRef="usd">4191618</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-98" unitRef="usd">5939512</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-5" decimals="0" id="f-99" unitRef="usd">5363707</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-36" decimals="0" id="f-100" unitRef="usd">-1918678</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-37" decimals="0" id="f-101" unitRef="usd">-3364997</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-38" decimals="0" id="f-102" unitRef="usd">-3444851</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-39" decimals="0" id="f-103" unitRef="usd">-5298516</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-40" decimals="0" id="f-104" unitRef="usd">-4864788</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-41" decimals="0" id="f-105" unitRef="usd">1345900</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-42" decimals="0" id="f-106" unitRef="usd">2127890</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-43" decimals="0" id="f-107" unitRef="usd">1848729</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-44" decimals="0" id="f-108" unitRef="usd">3797282</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-45" decimals="0" id="f-109" unitRef="usd">6969591</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-46" decimals="0" id="f-110" unitRef="usd">-591055</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-47" decimals="0" id="f-111" unitRef="usd">-367886</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-48" decimals="0" id="f-112" unitRef="usd">-4050985</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-49" decimals="0" id="f-113" unitRef="usd">2678504</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-50" decimals="0" id="f-114" unitRef="usd">1656950</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-51" decimals="0" id="f-115" unitRef="usd">441522</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-52" decimals="0" id="f-116" unitRef="usd">622491</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-53" decimals="0" id="f-117" unitRef="usd">528662</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-54" decimals="0" id="f-118" unitRef="usd">1094353</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-55" decimals="0" id="f-119" unitRef="usd">509856</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-56" decimals="0" id="f-120" unitRef="usd">-374700</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-57" decimals="0" id="f-121" unitRef="usd">-257849</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-58" decimals="0" id="f-122" unitRef="usd">-1467247</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-59" decimals="0" id="f-123" unitRef="usd">678367</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-60" decimals="0" id="f-124" unitRef="usd">820243</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-61" decimals="0" id="f-125" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-62" decimals="0" id="f-126" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-63" decimals="0" id="f-127" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-64" decimals="0" id="f-128" unitRef="usd">-1827217</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-65" decimals="0" id="f-129" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-66" decimals="0" id="f-130" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-67" decimals="0" id="f-131" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-68" decimals="0" id="f-132" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-69" decimals="0" id="f-133" unitRef="usd">29396</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-70" decimals="0" id="f-134" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-71" decimals="0" id="f-135" unitRef="usd">-1097011</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-72" decimals="0" id="f-136" unitRef="usd">-1240351</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-73" decimals="0" id="f-137" unitRef="usd">-6585692</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-74" decimals="0" id="f-138" unitRef="usd">1152169</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-75" decimals="0" id="f-139" unitRef="usd">5091852</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-140" unitRef="usd">1696346</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-141" unitRef="usd">2953574</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-142" unitRef="usd">-2394074</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-143" unitRef="usd">7091681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-5" decimals="0" id="f-144" unitRef="usd">10455559</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c-1" id="f-145">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:11.02pt"&gt;TSR figures assume an initial investment in our common stock of $100 on December 31, 2019. The peer group referenced for purpose of the TSR comparison is the group of companies included in the S&amp;amp;P Biotechnology Index, which is the industry peer group used for purposes of Item 201(e) of Regulation S-K. The separate peer group used by the Compensation Committee for purposes of determining compensation paid to our executive officers is described on page &lt;a href="#icc2494da21244caaac1fc3f4262a3d24_22505" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:none"&gt;26&lt;/a&gt;.&lt;/span&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-146">TSR figures assume an initial investment in our common stock of $100 on December 31, 2019.</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-147">&lt;div style="margin-top:6pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="4027" src="rcus-20250422_g1.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-148">&lt;div style="margin-top:6pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="4029" src="rcus-20250422_g2.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
